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Summary 
 
In addition of the provision of effective treatment to each case, malaria control is heavily 
relying on vector control with either insecticide treated mosquito nets (ITNs) or indoor 
residual spraying (IRS). The effectiveness of ITNs in controlling malaria in many different 
settings has already been comprehensively documented. On the other hand, while IRS has a 
long and distinguished history in malaria control, its health effects have never been properly 
quantified.   
 
The present thesis aimed at generating malaria control knowledge on local and global level. 
On a local level, new insights into the malaria burden in South-East PNG were generated. 
The work was carried out within an oil palm plantation, which allowed exploring options for 
malaria control, together with the management of the company. On a global level, this thesis 
aimed to quantify the effectiveness of IRS in reducing ill-health from malaria through a 
Cochrane review and to compare IRS to ITNs.  
 
Local level – malaria in Papua New Guinea 
To get an overview on malaria epidemiology within the Higaturu Oil Palms plantation (HOP) 
in Oro Province in PNG, different observational study approaches were used. In 2006, we 
carried out a cross-sectional study within six company villages, which included the 
determination of parasite rates by conventional microscopy, interviews and haemoglobin 
measurements. Passive surveillance data were collected from the 13 company aid posts for 
the years 2005 and 2006. Before the start of this study, malaria diagnosis was relying on 
clinical symptoms only. Since malaria symptoms are unspecific, we introduced rapid 
diagnostic tests (RDTs) in all aid posts. Finally, entomological data were collected by human 
landing catches.  
 
Prevalence of malaria was high, with more than a third of the participants (33.5%, 95% 
confidence interval (CI): 30.1-37.0) found with a malaria positive blood slide. Overall, 
prevalence was highest in the age group 5-9 years (40.3%, 95% CI 0.32-0.49). More than 
half of the infections were caused by Plasmodium falciparum (59.5%), followed by P. vivax 
with 37.6% and P. malariae (6.6%). Haemoglobin levels were low, with a mean of 11.0 g/dl 
(95% CI 10.8-11.1) for men and 10.4 g/dl (95% CI 10.3-10.5) for women. Plasmodium 
falciparum infections were significantly associated with anaemia (Hb < 10 g/dl). At the aid 
posts, all malaria cases in 2005 and January-March 2006 were diagnosed by symptoms 
only, while from April 2006 onwards most cases were tested by rapid diagnostic tests. 
Between 2005 and 2006, 22,023 malaria cases were diagnosed at the aid posts and malaria 
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accounted for 30-40% of all clinical cases. Of the malaria cases, 13-20% were HOP 
employees. On average, an employee sick with malaria was absent for 1.8 days, resulting in 
a total of 9,313 workdays lost between 2005 and 2006. Sleeping outside of the house did not 
increase the risk for a malaria infection, neither did getting up before 7am. Anopheles 
punctulatus was the main vector founding the area. 
 
Malaria was found to be a major health burden in the Higaturu Oil Palm plantation, posing a 
high risk to company staff and their relatives, including expatriates and other non-immune 
workers. Reducing the malaria risk is a highly recommended investment for the company.  
 
Global level 
 
The health effects of IRS were summarized and quantified in the frame of a Cochrane 
review. Studies considered for the review had to be either Randomized Controlled Trials 
(RCTs), Controlled Before-and After studies (CBA), or Interrupted Time Series (ITS). They 
had to include children and adults living in malarious areas and be carried out with one of the 
World Health Organization (WHO) recommended insecticides. 
 
There was a great paucity of high-quality evidence. Only six out of 132 identified studies met 
the inclusion criteria (four RCTs, one CBA and one ITS) and not all key malariological 
outcomes were addressed within these studies. Also, the geographic spread of the included 
studies was limited.  
 
For stable malaria settings, malaria incidence was significantly reduced in children aged one 
to five years (RR 0.86, 95% CI 0.77 to 0.95), while no difference was seen for children older 
than five years. For malaria prevalence no difference was seen between the IRS and the 
control group. With regard to anaemia, the haemoglobin levels were significantly lower in the 
control group than in the IRS group (WMD 0.61 g/dl; 95% CI IRS group 9.99 to 10.02; 95% 
CI no IRS group: 9.38 to 9.40). 
 
When comparing IRS to ITNs, IRS showed a better protective effect in reducing malaria 
incidence for children aged one to five years (RR 0.88, 95% CI 0.78 to 0.98). No difference 
was seen for children older than five years. Prevalence rates were found to be equal within 
the IRS and ITN groups. No difference in haemoglobin levels was found (WMD 0.01; 95% CI 
IRS: 9.99 to 10.02; 95% CI ITN: 9.99 to 10.01). 
 
In regard to unstable malaria settings IRS was shown to significantly reduce the incidence 
rate of malaria infections with a protective efficacy ranging from 24% to 86%. IRS also 
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significantly reduced the incidence of malaria when looking separately at P.falciparum and P. 
vivax (P.falciparum: RR 0.07, 95% CI 0.02 to 0.39; P. vivax: RR 0.21, CI 95% 0.10 to 0.55).  
Different results were seen when assessing the impact of IRS on malaria prevalence. No 
effect of IRS in reducing malaria prevalence was found in India. In children aged five to 
fifteen in Pakistan, IRS reduced the risk of getting infected with P. falciparum as well as with 
P.vivax - by 90% and 68%. 
 
Conflicting results were seen comparing IRS to ITNs against malaria incidence, with one 
study showing a better protection with ITNs (RR 1.55, 95% CI 1.49 to 1.60) and one study 
detecting no difference between the two interventions.  
 
Unfortunately, the aim of the review (to quantify the health effects of IRS) could not be 
achieved. A major conclusion of this work is the urgent need for high-quality evidence from 
two or three-arm RCTs. Ideally such trials should have one IRS arm, one ITN arm and an 
arm combining both interventions at high coverage. A control arm should not be planned for 
ethical reasons. This evidence will be crucial to support the long-term aim of malaria 
elimination/eradication. 
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Zusammenfassung 
 
Zusätzlich zu einer wirksamen Behandlung im Falle einer Malaria Erkrankung stützt sich die 
Malariakontrolle auf die Bekämpfung des Vektors mit dem Gebrauch von 
insektizidbehandelten Mückennetzen (ITNs) und dem Besprühen von Wänden im Innern von 
Häusern mit Insektizid (Indoor Residual Spraying, IRS). Während die Wirksamkeit von ITNs, 
die Malaria unter verschiedensten Bedingungen zu kontrollieren, bereits ausführlich 
dokumentiert wurde, fehlt dieses Wissen noch immer für IRS. Obwohl IRS in der 
Malariakontrolle eine lange und bedeutende Rolle hat, wurde der Einfluss des Sprayens auf 
die Gesundheit noch nie richtig dokumentiert.  
 
Ziel dieser Arbeit war es, den Wissensstand der Malariakontrolle sowohl auf lokaler als auch 
auf globaler Ebene zu erweitern. Auf lokaler Ebene konnten wir neue Erkenntnisse über die 
Malaria-Bürde im Südosten von Papua Neuguinea generieren. Die Arbeit wurde innerhalb 
einer Ölpalmenplantage ausgeführt, was es uns ermöglich hat, zusammen mit dem 
Management der Firma verschiedene Möglichkeiten der Malariakontrolle anzuschauen. Auf 
globaler Ebene hatten wir das Ziel mit Hilfe einer Cochrane Review den Effekt von IRS auf 
die Malaria bedingte Morbidität zu quantifizieren und mit ITNs zu vergleichen.  
 
Lokale Ebene - Malaria in Papua Neuguinea    
 
Mit Hilfe von verschiedenen beobachtenden Studiendesigns konnte ein Überblick über die 
Malaria-Epidemiologie innerhalb der Higaturu Oil Palms Plantagen (HOP) gewonnen 
werden. In 2006 haben wir in sechs verschiedenen Firmen-Dörfern eine Querschnittsstudie 
durchgeführt, in welcher wir Daten über die Parasitenrate gesammelt, Interviews 
durchgeführt und den Hämoglobinlevel gemessen haben. In den Jahren 2005 und 2006 
wurde mithilfe von passiver Überwachung Daten von 13 Firmenkliniken gesammelt. Vor dem 
Beginn der Studie wurde Malaria anhand von klinischer Symptome diagnostiziert. Da diese 
Symptome aber sehr unspezifisch sind, haben wir Schnelltest für die Malariadiagnose  
(RDTs) eingeführt. Zu guter Letzt wurden entomologische Daten mithilfe von „human landing 
catches“ gesammelt. 
 
Die Malariaprävalenz war hoch. Insgesamt wurde bei mehr als einem Drittel der Teilnehmer 
(33.5%, 95% CI 30.1 -37.0) Malariaparasiten im Blut entdeckt. Mit einer Prävalenz von 
40.3% (95% CI 0.32-0.49) waren die 5-9 jährigen Kinder am meisten von der Malaria 
betroffen. Über die Hälfte der Infektionen wurden durch Plasmodium falciparum verursacht 
(59.5%), gefolgt von P. vivax mit 37.6% und P. malariae mit 6.6%. Die Hämoglobinlevels 
Zusammenfassung 
 
 xi 
waren tief mit einem Durchschnittswert von 11.0 g/dl (95% CI 10.8-11.1) für Männer und 
10.4g/dl (95% CI 10.3-10.5) für Frauen. Es wurde ein signifikanter Zusammenhang zwischen 
P. falciparum und Anämie (Hb < 10g/dl) gefunden. Während in den Kliniken im Jahr 2005 
und von Januar bis März im 2006 alle Malariafälle aufgrund von klinischen Symptomen 
diagnostiziert worden sind, wurden ab April 2006 RDTs benutzt. In den Kliniken wurden von 
2005 bis 2006 22'023 Malariafälle diagnostiziert, was 30-40% von allen klinischen Fällen 
ausmachte. 13-20% der Malariafälle waren Angestellte von HOP. Innerhalb den drei 
Monaten in 2006 in welchen noch keine RDTs benutzt wurden, wurden monatlich 1'220 
Malariafälle diagnostiziert. Nach der Einführung von RDTs in April wurden bis Ende 2006 
monatlich nur noch 698 Malariafälle diagnostiziert. Ein erkrankter Arbeiter fehlte 
durchschnittlich 1.8 Tage pro Malariaepisode. Dies führte in den Jahren 2005 und 2006 zu 
9'313 verlorenen Arbeitstagen für die Firma. Leute die im Freien schliefen oder vor sieben 
Uhr morgens aufstanden, hatten kein erhöhtes Risiko an Malaria zu erkranken. Anopheles 
punctulatus wurde als wichtigster Vektor in diesem Gebiet identifiziert.  
 
Malaria wurde als eine bedeutende Gesundheitsbürde für die Higaturu Oil Palm Plantage 
identifiziert, welche ein grosses Risiko sowohl für die Angestellten als auch deren 
Angehörigen, inklusive andere nicht-immune Arbeiter, darstellt. Eine Investition in die 
Reduktion des Malariarisikos wird der Firma stark empfohlen.  
 
Globales Level 
Die Auswirkungen von IRS auf die Gesundheit wurden im Rahmen einer Cochrane Review 
zusammengefasst und quantifiziert. Nur randomisierte Kontrollstudien (RCT) sowie 
kontrollierte Vor-und-Nachher-Studien (CBA) und unterbrochene Zeitstudien (interrupted 
time series, ITS) wurden für die Studie berücksichtigt. Die Studien mussten sowohl Kinder 
und Erwachsene aus einem Malariabetroffenen Gebiet beinhalten als auch mit einem 
Insektizid durchgeführt worden sein, welches von der Weltgesundheitsorganisation (WHO) 
empfohlen wird.   
 
Es wurde ein grosser Mangel an hochwertiger Evidenz festgestellt. Von 132 identifizierten 
genügten nur sechs Studien den Einschlusskriterien (vier RCTs, ein CBA und ein ITS) und 
nicht alle malariologisch-relevanten Resultate wurden angesprochen. Die geographische 
Ausbreitung der Studien war ebenfalls sehr limitiert. 
 
In den Gebieten mit stabiler Malaria wurde die Malaria-Inzidenz in ein- bis fünfjährigen 
Kindern signifikant reduziert (RR 0.86, 95% CI 0.77 to 0.95). Für Kinder über fünf Jahre 
wurde kein Effekt festgestellt. Im Bezug auf die Prävalenz wurde kein Unterschied zwischen 
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der Gruppe mit IRS und der Kontrollgruppe festgestellt. Der Hämoglobinlevel in der Gruppe 
mit IRS war signifikant tiefer im Vergleich zu der Gruppe ohne IRS (WMD 0.61 g/dl;  95% CI 
IRS group 9.99 to 10.02;  95% CI no IRS group: 9.38 to 9.40). 
 
Bei dem Vergleich von IRS mit ITNs erzielte IRS bei der Reduktion der Malaria-Inzidenz bei  
ein- bis fünfjährigen Kindern ein besseres Resultat als ITNs (RR 0.88, 95% CI 0.78 to 0.98). 
Für Kinder über fünf Jahre wurde hingegen kein Unterschied festgestellt.  Die Prävalenz-
Raten zwischen IRS und ITN Gruppen waren gleich. Es wurde kein Unterschied zwischen 
den Hämoglobinlevels gefunden (WMD 0.01;  95% CI IRS: 9.99 to 10.02;  95% CI ITN: 9.99 
to 10.01). 
 
In den Gebieten mit unstabiler Malaria reduzierte IRS die Inzidenz-Rate signifikant und 
erreichte eine  „protective efficacy“ zwischen 24% und 86%. Auch wenn man die Spezies P. 
falciparum und P.vivax separat betrachtet, wird die Inzidenz-Rate signifikant durch IRS 
reduziert (P.falciparum: RR 0.07, 95% CI 0.02 to 0.39;  P. vivax: RR 0.21, CI 95% 0.10 to 
0.55). 
 
Beim Betrachten des Einflusses auf die Prävalenz wurden unterschiedliche Resultate 
vorgefunden. In Indien wurde durch IRS keine Reduktion der Prävalenz festgestellt. In  
Pakistan hingegen wurde für ein- bis fünfjährige Kinder sowohl das Infektionsrisiko für P. 
falciparum- als auch für P. vivax um 90%, respektive 68% reduziert. 
 
Im Bezug auf die Inzidenz wurden bei dem Vergleich von IRS mit ITNs widersprüchliche 
Daten gefunden. Während eine Studie einen besseren Schutz durch ITNs aufzeigte (RR 
1.55, 95% CI 1.49 to 1.60), fand eine andere Studie keinen Unterschied zwischen den 
Interventionen.  
 
Unglücklicherweise wurde das Ziel der Review (den Effekt von IRS auf die Malaria bedingte 
Morbidität zu quantifizieren) nicht erreicht. Eine wichtige Schlussfolgerung dieser Arbeit ist, 
dass dringend qualitativ hochstehende Evidenz benötigt wird, welche durch zwei- oder drei-
armige RCTs gewonnen werden sollte. Idealerweise sollten diese Studien aus einem Arm 
mit  IRS, einem mit ITN und einem mit beiden Interventionen zusammen bestehen. Dabei 
sollte bei den Interventionen einen hohen Deckungsgrad erreicht werden. Aus ethischen 
Gründen sollte auf einen Kontrollarm verzichtet werden. Solche Evidenz wird entscheidend 
dafür sein, das langfristige Ziel der Malaria Elimination/Eradikation zu unterstützen. 
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1 Introduction 
 
1.1 Malaria: Global burden, geographical distribution and its causative organism  
 
Malaria is the pre-eminent parasitic infection in humans and about half of the world’s 
population is at risk of getting infected (Greenwood et al. 2005; WHO & UNICEF 2008). 
Obtaining exact measures on the morbidity and mortality due to malaria is difficult (de 
Savigny & Binka 2004). Frequently, data are derived from health facilities, but this source is 
often of poor quality. For example in Africa, most deaths occur at home, without patients 
having seen a health facility before their death. Also geographical and physical access, 
socioeconomic status, sex, age, belief systems, quality and availability of health services, 
can influence the decision of a patient whether to visit a health facility or not (de Savigny & 
Binka 2004; Obrist et al. 2007). But also co-infections with other diseases or indirect 
contributors of mortality such as anaemia or malnutrition complicate the estimation of the real 
burden. Nevertheless, many attempts have been made and are still ongoing to produce more 
reliable burden of disease estimate, combining epidemiological, geographical and 
demographical data (Greenwood et al. 2005). These estimates suggest that yearly between 
247 – 500 million people become ill and nearly one million people die from malaria (WHO & 
UNICEF 2008; Greenwood et al. 2008; Lewison & Srivastava 2008). This makes malaria one 
of the leading global killers, with only 13 diseases or injuries causing more deaths (World 
Health Organization 2004; Roll Back Malaria 2008b).  
 
In areas of high malaria transmission, pregnant women and children under five suffer most 
from malaria (World Health Organization 2004). Pregnant women infected with malaria have 
a higher risk of developing severe anaemia and the percentage of malaria-related maternal 
deaths range from 0.5% to 23% (Desai et al. 2007). The risk of a baby to be born with low 
birth weight (LBW) is considerable higher in women with placental malaria and LBW is 
associated with a clear increase in infant mortality (Desai et al. 2007). More than 75% of all 
deaths by malaria occur in children (Breman 2001), mainly resulting from cerebral malaria 
and anaemia. And of those who survive severe malaria, up to 20% experience neurological 
sequelae including behavioural disorders, as well as other sequelae (Sachs & Malaney 
2002). This is also hampering the economics of malaria endemic countries (for more details 
see chapter 1.6). 
 
Malaria is present in 109 countries, mainly in the tropics and subtropics (Figure 1) (WHO & 
UNICEF 2008). Malaria transmission does not occur at temperatures below 16° C or above 
33° C and at altitudes greater than 2000 m above se a level because the development of the 
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parasite within the mosquito can not take place (Cook & Zumla 2003). Sub-Saharan Africa 
bears the major disease burden and the risk of dying from malaria is considerable higher 
than in other parts of the world (WHO & UNICEF 2008). Ecology and the climate are the 
main factors defining the distribution of malaria. However, there are other factors which also 
play an important role such as the demography as well as the socio-economic and cultural 
characteristic of the population, the predominant vectors and parasites and their ability to 
mount resistance against anti-malarial drugs and insecticides, the functioning of the public 
health systems and finally the presence of control programmes.  
 
 
Figure 1: Geographical distribution of malaria in 2006 (Source: World Health Organisation: 
http://www.who.int/malaria/malariaendemiccountries.html)  
 
1.2 Malaria – the parasite 
 
Malaria is caused by protozoan parasites of the genus Plasmodium (Warrell & Gilles 2002). 
Of the four Plasmodium species that cause malaria in humans, Plasmodium falciparum is the 
most virulent one, responsible for the most deaths from malaria (Greenwood et al. 2008). P. 
vivax is less deadly, but it is also recognised to be responsible for a substantial health burden 
(Picot 2006; Genton et al. 2008; Karyana et al. 2008; Greenwood et al. 2008; Greenwood 
2008). P. ovale and P. malariae are thought to cause relatively mild infections (Mueller et al. 
2007). In some areas, for example Malaysia, a fifth species, Plasmodium knowlesi, also 
infects humans although it is primarily a parasite of the long-tailed macaque monkeys 
(Greenwood et al. 2008).  
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Malaria gets transmitted to humans when they are bitten by an infectious Anopheles 
mosquito, releasing the infective form of the parasites (sporozoites) into the human body 
(Figure 2). Within humans, the parasite enters the blood stream and then rapidly invades the 
liver, where it multiplies and transforms into merozoites. The merozoites then invade red 
blood cells. Within the blood stages, merozoites either undergo repeated cycles of 
multiplication or transform into gametocytes, which are taken up by a female Anopheles 
mosquito. Within the mosquito, the parasite undergoes further transformation and the sexual 
replication takes place. After approximately two weeks the mosquito becomes infectious for 
the humans and the cycle repeats itself (Warrell & Gilles 2002; Greenwood et al. 2008).  
 
The life cycle of Plasmodium as it was just described has some specifics for each of the four 
species. During the blood stage of an infection, P. falciparum is able to stick to the 
endothelium and hence to be sequestered in internal organs, including the brain. It further 
needs a higher environmental temperature to develop within the mosquito than P. vivax, 
which explains the wider distribution of P. vivax compared to P. falciparum. P.vivax and P. 
ovale are able to remain dormant for months within the liver through the production of 
hypnozoites, which makes their infection difficult to eliminate. The ability to remain for years 
in the blood in a very low density is a feature of Plasmodium malariae (Greenwood et al. 
2008).  
 
The length of the erythrocytic cycle varies with the different species. It takes 48 hours in P. 
falciparum and P. vivax infections and 72 hours in P. malariae infections. The characteristic 
fever therefore occurs every third, respectively fourth day (Warrell & Gilles 2002).   
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Figure 2: Life cycle of malaria-causing Plasmodium parasites in humans and the mosquito 
(Source: Greenwood et al. 2008) 
 
1.3 Malaria in PNG 
 
Papua New Guinea is characterized by its variability and complexity in culture, ecology and 
geography. This complexity is also reflected in the malaria situation. All four human pathogen 
malaria parasites are found. Plasmodium falciparum is the dominant species, followed by P. 
vivax, P. malariae and P. ovale (Muller et al. 2003).  
 
After pneumonia, malaria ranks second amongst the main diseases that cause death in 
Papua New Guinea (Genton et al. 2003) and 90% of all people are at risk (RBM Partnership 
& WHO 2000). But there is a great variation in the relative importance of malaria in different 
areas of the country. The epidemiology of malaria in PNG ranges from complete absence of 
malaria through unstable low levels of transmission with recurring epidemics, to permanently 
high levels of transmission (Schuurkamp 1992; Genton et al. 1995a; Mueller et al. 2002), 
even reaching the highest transmission levels known outside of Africa. About 46% of all 
Papua New Guineans live in an altitude zone of 0 – 600 m (Muller et al. 2003), where malaria 
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is found to be highly endemic. Variation in the malaria epidemiology is not only seen between 
different regions but also between villages and even between clusters of houses. The 
variations in endemicity are mainly due to environmental differences (Genton et al. 1995a; 
Muller et al. 2003). But there are several other factors that also play a role in the malaria 
distribution. These include primarily drug and bednet usage, nutritional factors, and also 
migration (Muller et al. 2003).  
 
PNG has a highly diverse Anopheline mosquito fauna. The group of mosquitoes which is 
mainly responsible for the transmission of malaria is the Anopheles punctulatus complex. 
This group consists of at least 11 species (Muller et al. 2003). Members that have been 
identified in PNG are A. punctulatus, A. koliensis, A. farauti s.s., A. farauti 2, A. farauti 3, A. 
farauti 4-6 and A. sp. near punctulatus (Cooper et al. 2002). The different species have a 
diverse distribution throughout the country and are known to differ significantly in their biting 
patterns (early vs. late, indoor vs outdoor biting), their larval habitats as well as in their 
vectorial capacity. These differences have an important impact on malaria control programs 
since (1) mosquito nets do not protect people so well against mosquitoes which bite before 
they go indoors, and (2) indoor residual spraying protects less against outdoor biters. 
Therefore, it might be necessary to adapt vector control programs for each region. 
1.4 Malaria control 
 
For a successful malaria control, a solid understanding of the local malaria epidemiology, as 
well as the social and economic circumstances is needed (Warrell & Gilles 2002).  
 
With targeted vector control, changes in land use, agricultural practices and quality house 
construction, malaria could be eliminated from the United States and most of Europe during 
the first half of the twentieth century (Greenwood & Mutabingwa 2002). In 1939 the highly 
effective residual insecticide dichlordiphenyltrichlorethane (DDT) was developed, which gave 
hope of eradicating malaria. With the dual strategy of DDT spraying and choloroquine 
treatment, the World Health Organization carried out the global eradication programme in the 
1950s and 1960s. It was initially very successful in many countries such as India, Sri Lanka 
and the former Soviet Union. But in highly endemic areas, above all in Africa, the eradication 
programme was never implemented and the situation remained as bad as before 
(Greenwood & Mutabingwa 2002). The high costs of the programme, resistance of many 
communities to repeated spraying of their houses and the emergence of DDT resistance led 
to programme failures. In 1969 the strategy of malaria eradication was officially abandoned. 
The malaria eradication program was a big success in that it freed over 30 countries from 
malaria and the risk of malaria was removed from about 20% of the world’ population. 
However, it clearly did not come anywhere close to eradication of the disease and hence it 
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was unfortunately considered widely to be a failure (Greenwood 2008). This led to a neglect 
of malaria research and control from the early 1970s to the late 1990s. As an example, 
between 1975 and 1996 only 3 out of 1223 new drugs were antimalarials (Greenwood & 
Mutabingwa 2002), even though in the late 1970s the method of in vitro cultivation for 
Plasmodium falciparum was developed.  
 
In 1992 the process of malaria control was re-started with the ministerial conference in 
Amsterdam. In 1998, the Roll Back Malaria partnership was launched with the aim of halving 
the deaths from malaria by 2010 (Yamey 2004). This was supported by the summit of African 
Heads of State in Abuja, Nigeria in 2000, where African leaders declared to ensure that by 
the year 2005: 
• at least 60% of those suffering from malaria have prompt access to, and are able to 
correctly use, affordable and appropriate treatment within 24 hours of the onset of 
symptoms 
• at least 60% of those at risk of malaria, particularly children under five years of age 
and pregnant women, will benefit from the most suitable combination of personal and 
community measures such as insecticide treated mosquito nets and other 
interventions and 
• at least 60% of all pregnant women who are at risk of malaria have access to 
chemoprophylaxis or presumptive intermittent treatment (Roll Back Malaria & World 
Health Organization 2000). 
 
In 2005, the target coverage was changed from 60% to 80% by 2010, even though many 
countries had not met the 2005 targets (Yamey 2004; WHO & UNICEF 2008). 
 
At present, malaria research and control is high on the donors’ agenda. The global financial 
investment into malaria control increased to over 2 billions per year in 2008, the main 
sources being the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM) as well as 
the United States President’s Malaria Initiative (PMI) and the World Bank’s Booster Program 
(World Health Organization 2008). However, the estimated global cost to control and 
eliminate malaria is much higher with an estimated average of US$ 5.9 billion needed per 
year from 2011 to 2020 (Roll Back Malaria 2008a). 
 
Since the failure of the world eradication program in the 1960s, the dominant strategy was to 
control malaria, and eradication of malaria has never been considered again until October 
2007, when Bill and Melinda Gates called for a new malaria eradication campaign. They 
claimed that new scientific advances and growing financial and political support for malaria 
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initiatives had made the goal of eradication realistic again (Anonymous 2007). This was also 
taken up by the World Health Organization (WHO), with its current objectives of reducing the 
disease burden and maintaining it at a low level, to eliminating the disease from a defined 
geographical area and, finally to eradicate the disease globally (World Health Organization 
2008). However, the feasibility of eradicating malaria has been doubted by malaria experts 
(Roberts & Enserink 2007; Greenwood 2008; Tanner & deSavigny D. 2008). There is 
consensus that elimination in stable malaria transmission settings with the existing tools is 
impossible at present, due to lacking tools, weak health systems and insufficient knowledge 
on malaria transmission heterogeneity. Even if elimination was achieved in some areas, the 
possibility of reintroduction would be a constant threat, requiring highly effective surveillance 
and monitoring systems (Greenwood 2008; Tanner & deSavigny D. 2008). Elimination is 
most likely to be achieved currently in areas of low and unstable transmission or on islands 
(Greenwood 2008).  
 
The current tools with which malaria should be controlled (and eventually eradicated) are the 
following (Roll Back Malaria 2008b): 
 
1) Early diagnosis and prompt and effective treatment of malarial illness 
Without treatment, acute mild episodes of malaria in non-immune and semi-immune people 
can progress rapidly into the severe and fatal forms of the disease. Therefore, identifying 
potential malaria cases early and treating them promptly with an efficacious drug remains the 
first and foremost intervention to reduce disease and death from malaria. By eliminating 
parasite reservoirs in the general population and by decreasing the duration of illness, 
prompt diagnosis and treatment also helps to reduce malaria transmission (Alilio et al. 2004).  
 
Microscopy is the most widely used routine method for malaria diagnosis and is considered 
as the gold standard (Shrinivasan et al. 2000). It enables to specify and quantify the 
parasites seen in thick and thin blood smears. But, it requires a special expertise and an 
organized health system infrastructure (Duffy & Fried 2005; Bell et al. 2006). In many 
countries malaria diagnosis is purely made on a symptomatic basis as the laboratory 
equipment is insufficient (Hommel 2002). This leads to a large over-treatment, as symptoms 
of malaria are non-specific and similar to those of other infections like influenza, pneumonia, 
viral hepatitis or typhoid fever (Hommel 2002). It also leads to the under-treatment of other 
potentially fatal conditions, such as pneumonia.  
 
A potential alternative to microscopy is the use of rapid diagnostic tests (RDTs). RDTs have 
the advantage to be quick, easy to perform and interpret and recent reviews have shown, 
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that their performance is comparable to that of expert microscopy (WHO 2000; Moody 2002; 
Soto et al. 2004; D'Acremont et al. 2009).  
 
Current guidelines recommend that all fever episodes in African children should be treated 
presumptively with antimalarial drugs (D'Acremont et al. 2009). However, this is currently 
debated (D'Acremont et al. 2009; English et al. 2009) and there is still a long way to go 
towards universal testing of all fever episodes in malaria-endemic zones.  
 
2) Vector control interventions 
Indoor Residual Spraying (IRS): IRS has a long and distinguished history in malaria 
control. Using mainly DDT, malaria was eliminated or greatly reduced as a public health 
problem in Asia, Russia, Europe, and Latin America (Shiff 2002;  Lengeler & Sharp 2003;  
Roberts et al. 2004). IRS continues to be used in many parts of the world, with the services 
provided by the public health system or by a commercial company (usually for the benefit of 
its employees). There is no IRS programme known to us in which beneficiaries were 
expected to contribute financially. A historical review of IRS in Southern Africa investigated 
the malaria situation before and after the introduction of IRS in South Africa, Swaziland, 
Namibia, Zimbabwe, and Mozambique, where it continues to protect 13 million people 
(Mabaso et al. 2004). Immediately after the implementation of control operations, spectacular 
reductions in malaria and vector densities were recorded, malaria endemicity was reduced, 
and in certain instances the intervention led to local elimination. Another historical paper 
reviewed the health impacts of 36 successful IRS programmes in 19 countries throughout 
sub-Saharan Africa (Kouznetsov 1977). The analyses compared parasite rates and other 
malariological outcomes before and after the implementation of IRS in each of the five major 
eco-epidemiological zones.  
 
IRS operates both through repelling mosquitoes from entering houses and by killing female 
mosquitoes that are resting inside houses after having taken a blood meal. This implies that 
IRS is most effective against mosquito species that are resting indoors (so called endophilic 
mosquitoes). Spraying needs to be carried out between once and three times per year;  the 
timing depends on the insecticide and the seasonality of transmission in a given setting. 
Reviewing the advantages and disadvantages of each insecticide is beyond the scope of this 
review and can be found in Najera (2001). IRS has the advantage of being able to make use 
of a much wider range of insecticide products in comparison to Insecticide-Treated Nets 
(ITNs) for which pyrethroids are the only class of insecticide currently used. The World 
Health Organization recommends a number of insecticides for IRS: DDT wettable powder 
(WP);  malathion WP;  fenitrothion WP;  pirimiphos-methyl WP and emulsifiable concentrate 
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(EC); bendiocarb WP; propoxur WP; alpha-cypermethrin WP & SC; cyfluthrin WP; 
deltamethrin WP; etofenprox WP; and lambda-cyhalothrin WP (WHOPES 2007). This range 
of insecticides has important implications for the management of insecticide resistance and 
hence long-term sustainability (pyrethroid resistance has already been reported in many 
parts of tropical Africa and other parts of the world among populations of the major malaria 
vectors).  
 
Insecticide-treated nets (ITN): Mosquito nets represent a physical barrier between humans 
and mosquitoes. Insecticides have either a repellent effect or kill the mosquito on contact (or 
both). Thus, mosquitoes are prevented from biting people and are killed if they try to do so 
(Lengeler & Sharp 2003). ITNs have been shown to be very effective in controlling malaria in 
many different settings (Lengeler 2004). The use of ITNs has led to a reduction of up to 50 % 
in the number of fever cases in children in Asia, Africa and Latin America. The anaemia 
status of children and pregnant women in Africa could also be improved significantly. Most 
importantly, ITNs could be shown to be very effective in reducing child mortality rates. 
Overall, ITNs showed a 18% protective efficacy against all-cause child mortality (Lengeler 
2004). When coverage exceeded 50%, ITNs could be shown not only to be effective for the 
people sleeping under nets but also in reducing morbidity and mortality for people sleeping 
within a 300m distance of the treated net (Binka et al. 1998;  Hawley et al. 2003). Currently, 
pyrethroids are the only class of insecticides being available for impregnating bed nets and 
research on new insecticides is urgently needed.  
 
3) Malaria prophylaxis and intermittent preventive treatment during pregnancy 
For pregnant women and their newborn children, malaria infections with P. falciparum or P. 
vivax pose a substantial risk. In areas of low transmission, malaria can result in stillbirths, 
spontaneous abortions, or maternal deaths. In highly endemic areas, malaria infections can 
cause placental parasitaemia and contribute to maternal anaemia, both of which may lead to 
low birth weight (LBW) and an increased risk of death in the newborn. It is estimated that 5-
12% of all LBW are due to malaria in pregnancy (Newman et al. 2003). 
 
These risks can be lowered with effective prevention of malaria, with chemoprophylaxis on a 
weekly base being the method of choice. But this method faces problems such as parasite 
drug resistance, contra-indications of certain drugs and poor patient compliance. In the 
search of an alternative, intermittent treatment during pregnancy (IPTp) was proposed. It 
involves the administration of a full curative-treatment dose of an effective antimalarial drug 
at predefined intervals during pregnancy. It was suggested as a simple and cost-effective 
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method in highly malarious areas (Greenwood 2004; Garner & Gulmezoglu 2006) and it is 
now policy in a number of endemic countries.  
 
4) Surveillance, prediction of, and rapid response to epidemics 
Among susceptible populations with low immunity, epidemics often lead to great morbidity 
and cause high fatality rates in all age groups (Kiszewski & Teklehaimanot 2004;  Mueller et 
al. 2009). Therefore, it is paramount to be able to predict epidemics and ensure epidemic 
preparedness at all levels. For this purpose, it is necessary to establish an early warning 
system (e.g. based on meteorological data and population movements) which triggers the 
chain of events leading to an explosive increase in the number of cases. In parallel, countries 
need to establish emergency- preparedness systems that allow them to react promptly with 
vector control and treatment activities (Najera 1999).  
 
Malaria vaccine 
So far, no vaccine against malaria is available. However, promising results concerning the 
malaria vaccine RTS,S were published recently from three trials (Aponte et al. 2007.; Bejon 
et al. 2008; Abdulla et al. 2008). In these phase IIb randomized, controlled and double-blind 
trials, a protective efficacy against P. falciparum infections of 56% for infants was found 
(Bejon et al. 2008). The vaccine was also found to be safe and feasible for integration into 
the WHO Expanded Program on Immunization (EPI) (Bejon et al. 2008; Abdulla et al. 2008). 
The vaccine is now going to be tested within a large, multi-country phase III trial, giving hope 
that in future time it might be part of an integrated control strategy.   
1.5 Malaria control in Papua New Guinea (PNG) 
 
The first known attempt to control malaria in Papua New Guinea (PNG) was carried out as 
early as 1901 on the north coast by mass treating (immigrant) people with quinine. After the 
identification of the vectors, local larval control measures were undertaken. However, this 
was largely done in urban areas and malaria in the indigenous population was regarded as 
largely beyond control (Spencer 1992). 
 
During the Second World War, much information on malaria epidemiology and parasitology 
was collected by the Australian and American military. They implemented larval control 
measures by draining swamp areas, introducing Gambusia affinis fish and by chemical 
applications. In 1943, DDT (dichlorodiphenyltrichloroethane) became available and was 
widely used during the last phase of the war (Spencer 1992).   
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During the world malaria eradication period of the World Health Organization (1957-1968), a 
plan was formulated for an eradication campaign using dieldrin to cover the whole of PNG 
progressively over a period of 14 years. However, in 1959 the promoters changed the 
insecticide to DDT to overcome the short residual effect of dieldrin. While successes were 
achieved, it became evident that eradication with DDT and mass drug administration alone 
wouldn’t be possible. In 1969, control programs aiming at the reduction of malaria incidence 
replaced eradication. The insecticide was changed to a mix of Malathion and DDT, since 
bedbugs became resistant to DDT, which was worrying the local inhabitants. Another 
problem was the damage of the sago-palm roofing by the moth larvae Herculia nigrivitta 
following DDT spraying. The feeding habits of these larvae protected them from DDT, 
whereas all their predators were killed by the insecticide. 
  
Furthermore, not all control measures were carried out carefully and had success, leading to 
a lower trust of the public and morale within the control service (Spencer 1992). Outdoor 
activities such as sago making, gardening, social gatherings and cooking were identified to 
be associated with being at risk of malaria and were considered to hamper control. By 1978 
the malaria control strategy was changed again. The new aims were 1) to reduce malaria 
mortality and mortality, 2) to reduce the effects of the disease on socioeconomic 
development and 3) achieve elimination wherever feasible.  
 
Overall, DDT was sprayed for approximately 30 years and various modifications were tried 
such as shortening of the period between spray rounds, mixing of dieldrin with DDT, 
distribution of pyrimethaminized salt, or additional mass drug administration. However, 
spraying was never able to completely interrupt the transmission of malaria in areas with a 
high degree of malaria endemicity (Spencer 1992). After the cessation of vector control in 
1984, easy access to antimalarial drugs, especially chloroquine, became the mainstay of 
malaria control (Muller et al. 2003). Mosquito nets were also used for protection and some of 
the first studies worldwide on ITNs were carried out in PNG, showing effects on mosquito 
population as well as and the prevalence and incidence of P. falciparum infections in children 
(Graves et al. 1987; Charlwood & Graves 1987; Muller et al. 2003). 
 
As a result of control measures, marked changes in the epidemiology of malaria occurred 
during the last 30 years (Cattani et al. 1986; Muller et al. 2003; Mueller et al. 2005). Before 
the start of the extensive vector control programmes in 1957, Plasmodium vivax was the 
predominant species followed by P. falciparum and P. malariae (Cattani et al. 1986; Mueller 
et al. 2005). Nowadays, P. falciparum is predominant everywhere, in areas covered by the 
control programme and in areas not covered (Cattani et al. 1986; Genton et al. 1995b). The 
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relative increase of P. falciparum is thought to have occurred as an immediate consequence 
of the cessation of spraying and also due to the spread of drug resistance. P. falciparum 
resistance to Chloroquine is very common in PNG. It was first noted in 1976 and there was a 
great reduction in the effectiveness of chloroquine by the early 1990s. P. vivax resistance is 
also present, but to a much lesser extend (Muller et al. 2003). Control measures might also 
have affected the immune status of the population and caused a shift towards older ages of 
peak prevalence. However, since the cessation of vector control the peak prevalence has 
shifted back to younger children (Mueller et al. 2005).  
 
Currently, PNG aims to halve the number of deaths and illness caused by malaria between 
2001 and 2010. Following strategies were implemented by the National Malaria Control 
Programme (NMCP): 1) improvement of diagnosis and treatment, 2) implementation of 
vector control through ITNs, IRS, and – where feasible – environmental modification and 3) 
information, education and communication. For the vector control the aim is to have by 2010 
80% of the population living in endemic areas protected by an ITN, and in the highland 
regions (prone to epidemics) IRS being conducted annually (WHO & UNICEF 2005). Targets 
were difficult to achieve before 2003 because of financial constraints. Having received funds 
from the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) in 2003, the targets 
of the NMCP were adjusted for 2008: 1) more than 80% of the population in malaria-endemic 
areas should be consistently using LLINs, 2) over 70% of suspected malaria cases should be 
laboratory-confirmed by rapid diagnostic tests or microscopy, 3) the case rate should be 
reduced from 504/100,000 in 2001 to 300/100,000 and 4) the mortality rate should be 
reduced from 12.8/100,000 in 2001 to 7/100,000. However, until 2007 only 53,500 treated 
nets were delivered, resulting in a coverage of 23.5%, which is still far away of the target of 
80%. Close to 25,000 people were protected by IRS (WHO & UNICEF 2008). 
 
1.6 Malaria control within the private sector 
 
Malaria represents not only a huge health but also a major economic burden. In Africa alone, 
the estimated direct and indirect costs of malaria exceed US$ 12 billion annually (Breman et 
al. 2004). Malaria negatively influences economic growth, reducing it for example by 1.3% 
annually in endemic countries between 1965 and 1990. In 1995, the average gross domestic 
product in non-malarious countries was five times higher than in countries affected with 
malaria (Gallup & Sachs 2001).  
 
Apart from households, malaria also impacts on private sector companies. The most 
immediate effect of malaria on a company is its impact on the workforce and the resulting 
cost of caring for sick employees. Employees who are sick with malaria are not working 
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efficiently and are likely to take time off to recover. In a worst case, employees die and 
replacements need to be recruited and trained (Global Health Initiative 2006).  
A survey of the World Economic Forum (WEF) of over 8000 business leaders from over 100 
countries showed that about three-quarter of them perceived malaria as having an impact on 
their business, and that about 40% perceived this impact to be severe. It also showed that 
several major businesses had already taken action against malaria (Global Health Initiative 
2006). Within the Global Malaria Action Plan, RBM recognises the private sector as an 
important partner in scaling up malaria interventions (Roll Back Malaria 2008b). However, 
even though some successful experiences of malaria control by private companies exist, the 
literature available on impact and effectiveness is scarce. Yet, in recent years, new initiatives 
such as the Global Business Coalition (http://www.gbcimpact.org) as well as the Global 
Health Initiative of the World Economic Forum (http://www.weforum.org/en/initiatives/ 
globalhealth/index.htm) were formed to support and link companies in their fight against 
malaria. Currently, a review on the engagement and successes of the private sector in 
malaria control is being carried out at the World Economic Forum (Achoki T., personal 
communication).   
1.7 Systematic reviews and the Cochrane Collaboration 
 
Annually, over two million articles are published in the biomedical literature in over 20’000 
journals, leaving policy makers, health care providers and researchers with an 
unmanageable amount of information. Systematic reviews summarise this overwhelming 
amount of facts and ascertain whether scientific findings are convincing and can be 
generalised across populations, settings, and treatment variations (Mulrow 1994; Green 
2005). Systematic reviews seek to comprehensively identify all literature on a given topic and 
review all the evidence is a sound way. Systematic reviews can include a meta-analysis, a 
statistical approach for merging the results of several studies into a single estimate if certain 
statistical conditions are met (mainly the homogeneity of the results). This is in contrast to the 
term “review” which is just the general term for attempts to consolidate the results and 
conclusions from a number of publications (Sackett et al. 1996; Green 2005).  
 
The Cochrane Collaboration (CC) holds a very prominent role within the health sector in 
producing systematic reviews (www.cochrane.org). The CC was formally formed in 1993 and 
named after the person who inspired it, Archie Cochrane (a British public health researcher 
1909-1988). The CC is an international not-for-profit organisation aiming to improve decision 
making by preparing, maintaining and promoting systematic reviews of the effects of 
healthcare interventions (Jadad et al. 1998; Clarke 2002). It is financially supported by over 
650 organisations, including health service providers, research funding agencies, 
departments of health, international organizations, universities and industry (Clarke 2002). 
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Over 15,000 people, mainly review authors, are involved in about 100 countries. Authors 
work within one of the 51 Cochrane review groups, which provide editorial support, 
administration and infrastructure. Cochrane Centres provide training, support and 
methodological advice to the review groups. The Cochrane collaboration includes 11 
methods groups, which are dealing with topics such as applicability, reporting bias, statistics, 
and health economics. In addition, a consumer network exists, helping to promote the 
interests of users of health care. The main instrument to disseminate the work of the 
Cochrane collaboration is the Cochrane Library, a database of reviews and other resources 
available either on a CD-ROM or on the internet (Clarke 2002; Clarke 2007). 
 
Cochrane reviews all have the same format and are written in a highly structured manner 
(White 2002; Higgins & Green 2008). Unlike other reviews, the Cochrane reviews are 
reviewed very extensively. The Cochrane editorial group is involved at the beginning and a 
proposal has to be written and accepted by the Cochrane review group. Cochrane reviews 
aim to search comprehensively for all evidence available on a particular topic. For this, an 
extensive search has to be carried out, including grey and unpublished literature, irrespective 
of the language. In a second step, a quality appraisal of all identified studies has to be done. 
Once the review is finished and accepted by the Cochrane group, it will be published 
electronically within the Cochrane library.  
 
Today, Cochrane reviews of interventions are considered to be the gold standard for 
assessing the effectiveness of health care interventions. This is also expressed by the rising 
number of reviews written: in 1995, 36 full reviews were completed, rising to 2000 reviews in 
2004 (Clarke 2007) and 5676 reviews in January 2009.  
 
Rationale for the current PhD thesis 
 
Despite the fact that Papua New Guinea suffers heavily under the burden of malaria, 
research on malaria control is largely focused on Africa. Furthermore, it is known that malaria 
is not only a health, but also an economic burden. Several studies on the epidemiology of 
malaria were carried out within the research areas of the Institute of Medical Research e.g. 
around Madang and the Wosera area, whereas other areas of PNG were neglected. To the 
best of our knowledge, no data is published to-date on the malaria epidemiology within the 
Popondetta area, Oro province. Furthermore, there is an urgent need for more studies 
assessing the health as well as the economic risk posed by malaria to companies based in 
endemic settings and the possibility for such companies to initiate control measures.  
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In a second part compile all available evidence of the effectiveness of IRS in reducing ill-
health from malaria, one of the malaria control tools used in PNG. While the effectiveness of 
ITNs has already been comprehensively summarised in two Cochrane reviews (one for the 
general population and one for pregnant women (Lengeler 2004; Gamble et al. 2004), no 
such systematic assessment has been done for IRS. Two reviews outlined the cost and 
health effects of IRS (Curtis & Mnzava 2001; Lengeler & Sharp 2003), but neither was 
conducted systematically or assessed the methodological quality of the included studies. 
Since ITNs and IRS are in many ways similar interventions, more information is needed 
urgently on their comparative impact. To this effect we conducted a Cochrane review on IRS, 
following a similar methodology to the one on ITNs. 
1 - Introduction 
 
 16 
1.8 References 
 
Abdulla, S., Oberholzer, R., Juma, O., Kubhoja, S., Machera, F., Membi, C., Omari, S., 
Urassa, A., Mshinda, H., Jumanne, A., Salim, N., Shomari, M., Aebi, T., Schellenberg, 
D. M., Carter, T., Villafana, T., Demoitie, M. A., Dubois, M. C., Leach, A., Lievens, M., 
Vekemans, J., Cohen, J., Ballou, W. R., & Tanner, M. 2008, "Safety and 
immunogenicity of RTS,S/AS02D malaria vaccine in infants", N.Engl.J Med, vol. 359, 
no. 24, pp. 2533-2544. 
Alilio, M. S., Kitua, A., Njunwa, K., Medina, M., Ronn, A. M., Mhina, J., Msuya, F., Mahundi, 
J., Depinay, J. M., Whyte, S., Krasnik, A., & Bygbjerg, I. C. 2004, "Malaria control at 
the district level in Africa: the case of the muheza district in northeastern Tanzania", 
Am J Trop Med Hyg, vol. 71, no. 2 Suppl, pp. 205-213. 
Aponte, J. J., Aide, P., Renom, M., Mandomando, I., Bassat, Q., Sacarlal, J., Manaca, M. N., 
Lafuente, S., Barbosa, A., Leach, A., Lievens, M., Vekemans, J., Sigauque, B., 
Dubois, M. C., Demoitiθ, M. A., Sillman, M., Savarese, B., McNeil, J. G., Macete, E., 
Ballou, W. R., Cohen, J., & Alonso, P. L. 2007 "Safety of the RTS,S/AS02D candidate 
malaria vaccine in infants living in a highly endemic area of Mozambique: a double 
blind randomised controlled phase I/IIb trial", The Lancet, vol. 370, no. 9598, pp. 
1543-1551.   
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, 
T., Gould, J., Dubois, M. C., Demoitie, M. A., Stallaert, J. F., Vansadia, P., Carter, T., 
Njuguna, P., Awuondo, K. O., Malabeja, A., Abdul, O., Gesase, S., Mturi, N., 
Drakeley, C. J., Savarese, B., Villafana, T., Ballou, W. R., Cohen, J., Riley, E. M., 
Lemnge, M. M., Marsh, K., & von, Seidlein L. 2008, "Efficacy of RTS,S/AS01E 
vaccine against malaria in children 5 to 17 months of age", N.Engl.J Med, vol. 359, 
no. 24, pp. 2521-2532. 
Bell, D., Wongsrichanalai, C., & Barnwell, J. W. 2006, "Ensuring quality and access for 
malaria diagnosis: how can it be achieved?", Nat.Rev.Microbiol., vol. 4, no. 9, pp. 
682-695. 
Binka, F. N., Indome, F., & Smith, T. 1998, "Impact of spatial distribution of permethrin-
impregnated bed nets on child mortality in rural northern Ghana", Am J Trop Med 
Hyg, vol. 59, no. 1, pp. 80-85. 
Breman, J. G. 2001, "The ears of the hippopotamus: manifestations, determinants, and 
estimates of the malaria burden", Am J Trop Med Hyg, vol. 64, no. 1-2 Suppl, pp. 1-
11. 
Breman, J. G., Alilio, M. S., & Mills, A. 2004, "Conquering the intolerable burden of malaria: 
what's new, what's needed: a summary", Am J Trop Med Hyg, vol. 71, no. 2 Suppl, 
pp. 1-15. 
Cattani, J. A., Moir, J. S., Gibson, F. D., Ginny, M., Paino, J., Davidson, W., & Alpers, M. P. 
1986, "Small-area variations in the epidemiology of malaria in Madang Province", 
P.N.G.Med J, vol. 29, no. 1, pp. 11-17. 
Charlwood, J. D. & Graves, P. M. 1987, "The effect of permethrin-impregnated bednets on a 
population of Anopheles farauti in coastal Papua New Guinea", Med Vet.Entomol., 
vol. 1, no. 3, pp. 319-327. 
1 - Introduction 
 
 17 
Clarke, M. 2002, "The Cochrane Collaboration: providing and obtaining the best evidence 
about the effects of health care", Eval.Health Prof., vol. 25, no. 1, pp. 8-11. 
Clarke, M. 2007, "The Cochrane Collaboration and the Cochrane Library", Otolaryngol.Head 
Neck Surg., vol. 137, no. 4 Suppl, p. S52-S54. 
Cook, G. C. & Zumla, A. 2003, Manson's Tropical Diseases, 21 edn, Elsevier Science 
Limited. 
Cooper, R. D., Waterson, D. G., Frances, S. P., Beebe, N. W., & Sweeney, A. W. 2002, 
"Speciation and distribution of the members of the Anopheles punctulatus (Diptera: 
Culicidae) group in Papua New Guinea", J Med Entomol., vol. 39, no. 1, pp. 16-27. 
Curtis, C. & Mnzava, A. Treated nets vs house spraying. Bull World Health Organ 79[7]. 
2001.  
D'Acremont, V., Lengeler, C., Mshinda, H., Mtasiwa, D., Tanner, M., & Genton, B. 2009, 
"Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed 
Diagnosis and Treatment in African Children with Fever", PLoS.Med, vol. 6, no. 1, p. 
e252. 
de Savigny, D. & Binka, F. 2004, "Monitoring future impact on malaria burden in sub-saharan 
Africa", Am J Trop Med Hyg, vol. 71, no. 2 Suppl, pp. 224-231. 
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. 
D. 2007, "Epidemiology and burden of malaria in pregnancy", Lancet Infect Dis, vol. 
7, no. 2, pp. 93-104. 
Duffy, P. & Fried, M. 2005, "Malaria: new diagnostics for an old problem", Am J Trop Med 
Hyg, vol. 73, no. 3, pp. 482-483. 
English, M., Reyburn, H., Goodman, C., & Snow, R. W. 2009, "Abandoning Presumptive 
Antimalarial Treatment for Febrile Children Aged Less Than Five Years-A Case of 
Running Before We Can Walk?", PLoS.Med, vol. 6, no. 1, p. e15. 
Gallup, J. L. & Sachs, J. D. 2001, "The economic burden of malaria", Am J Trop Med Hyg, 
vol. 64, no. 1-2 Suppl, pp. 85-96. 
Gamble, C., Ekwaru, J. P., & ter Kuile, F. O. 2006, "Insecticide-treated nets for preventing 
malaria in pregnancy", Cochrane.Database.Syst.Rev. no. 2, p. CD003755. 
Garner, P. & Gulmezoglu, A. M. 2006, "Drugs for preventing malaria in pregnant women", 
Cochrane.Database.Syst.Rev. no. 4, p. CD000169. 
Genton, B., al-Yaman, F., Beck, H. P., Hii, J., Mellor, S., Narara, A., Gibson, N., Smith, T., & 
Alpers, M. P. 1995a, "The epidemiology of malaria in the Wosera area, East Sepik 
Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric 
indices and immunity", Ann.Trop Med Parasitol., vol. 89, no. 4, pp. 359-376. 
Genton, B., al-Yaman, F., Beck, H. P., Hii, J., Mellor, S., Rare, L., Ginny, M., Smith, T., & 
Alpers, M. P. 1995b, "The epidemiology of malaria in the Wosera area, East Sepik 
Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and 
morbidity", Ann.Trop Med Parasitol., vol. 89, no. 4, pp. 377-390. 
Genton, B., Anders, R. F., Alpers, M. P., & Reeder, J. C. 2003, "The malaria vaccine 
development program in Papua New Guinea", Trends Parasitol., vol. 19, no. 6, pp. 
264-270. 
1 - Introduction 
 
 18 
Genton, B., D'Acremont, V., Rare, L., Baea, K., Reeder, J. C., Alpers, M. P., & Muller, I. 
2008, "Plasmodium vivax and mixed infections are associated with severe malaria in 
children: a prospective cohort study from Papua New Guinea", PLoS.Med, vol. 5, no. 
6, p. e127. 
Global Health Initiative. Business and Malaria: A Neglected Threat?  2006. Geneva, World 
Economic Forum.  
Graves, P. M., Brabin, B. J., Charlwood, J. D., Burkot, T. R., Cattani, J. A., Ginny, M., Paino, 
J., Gibson, F. D., & Alpers, M. P. 1987, "Reduction in incidence and prevalence of 
Plasmodium falciparum in under-5-year-old children by permethrin impregnation of 
mosquito nets", Bull World Health Organ, vol. 65, no. 6, pp. 869-877. 
Green, S. 2005, "Systematic reviews and meta-analysis", Singapore Med J, vol. 46, no. 6, 
pp. 270-273. 
Greenwood, B. 2008, "Can malaria be eliminated?", Trans R Soc Trop Med Hyg. 103 Suppl 
1: S2-5S, Epub 
Greenwood, B. 2004, "The use of anti-malarial drugs to prevent malaria in the population of 
malaria-endemic areas", Am J Trop Med Hyg, vol. 70, no. 1, pp. 1-7. 
Greenwood, B. & Mutabingwa, T. 2002, "Malaria in 2002", Nature, vol. 415, no. 6872, pp. 
670-672. 
Greenwood, B. M., Bojang, K., Whitty, C. J., & Targett, G. A. 2005, "Malaria", Lancet, vol. 
365, no. 9469, pp. 1487-1498. 
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H., Alonso, P. L., Collins, F. H., & 
Duffy, P. E. 2008, "Malaria: progress, perils, and prospects for eradication", J 
Clin.Invest, vol. 118, no. 4, pp. 1266-1276. 
Hawley, W. A., Phillips-Howard, P. A., ter Kuile, F. O., Terlouw, D. J., Vulule, J. M., Ombok, 
M., Nahlen, B. L., Gimnig, J. E., Kariuki, S. K., Kolczak, M. S., & Hightower, A. W. 
2003, "Community-wide effects of permethrin-treated bed nets on child mortality and 
malaria morbidity in western Kenya", Am J Trop Med Hyg, vol. 68, no. 4 Suppl, pp. 
121-127. 
Higgins, J. & Green, S. 2008, Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.0.1 [updated September 2008] The Cochrane Collaboration. Available from 
www.cochrane-handbook.com. 
Hommel, M. 2002, "Diagnostic methods in malaria," in Essential Malariology, 4 edn, Warrell 
and Gilles, ed., Arnold, London, pp. 35-39. 
Jadad, A. R., Cook, D. J., Jones, A., Klassen, T. P., Tugwell, P., Moher, M., & Moher, D. 
1998, "Methodology and reports of systematic reviews and meta-analyses: a 
comparison of Cochrane reviews with articles published in paper-based journals", 
JAMA, vol. 280, no. 3, pp. 278-280. 
Karyana, M., Burdarm, L., Yeung, S., Kenangalem, E., Wariker, N., Maristela, R., Umana, K. 
G., Vemuri, R., Okoseray, M. J., Penttinen, P. M., Ebsworth, P., Sugiarto, P., Anstey, 
N. M., Tjitra, E., & Price, R. N. 2008, "Malaria morbidity in Papua Indonesia, an area 
with multidrug resistant Plasmodium vivax and Plasmodium falciparum", Malar.J, vol. 
7, p. 148. 
1 - Introduction 
 
 19 
Kiszewski, A. E. & Teklehaimanot, A. 2004, "A review of the clinical and epidemiologic 
burdens of epidemic malaria", Am J Trop Med Hyg, vol. 71, no. 2 Suppl, pp. 128-135. 
Kouznetsov, R. L. 1977, "Malaria control by application of indoor spraying of residual 
insecticides in tropical Africa and its impact on community health", Trop Doct., vol. 7, 
no. 2, pp. 81-91. 
Lengeler, C. 2004, "Insecticide-treated bed nets and curtains for preventing malaria", 
Cochrane.Database.Syst.Rev. no. 2, p. CD000363. 
Lengeler, C. & Sharp, B. 2003, "Indoor Residual Spraying and Insecticide-Treated Nets," in 
Reducing Malaria's Burden, Evidence of Effectiveness for Decision Makers, C. 
Murphy et al., eds., Global Health Council, Washington, pp. 17-24. 
Lewison, G. & Srivastava, D. 2008, "Malaria research, 1980-2004, and the burden of 
disease", Acta Trop, vol. 106, no. 2, pp. 96-103. 
Mabaso, M. L., Sharp, B., & Lengeler, C. 2004, "Historical review of malarial control in 
southern African with emphasis on the use of indoor residual house-spraying", Trop 
Med Int.Health, vol. 9, no. 8, pp. 846-856. 
Moody, A. 2002, "Rapid diagnostic tests for malaria parasites", Clin.Microbiol.Rev., vol. 15, 
no. 1, pp. 66-78. 
Mueller, D. H., Abeku, T. A., Okia, M., Rapuoda, B., & Cox, J. 2009, "Costs of early detection 
systems for epidemic malaria in highland areas of Kenya and Uganda", Malar.J, vol. 
8, no. 1, p. 17. 
Mueller, I., Taime, J., Ibam, E., Kundi, J., Lagog, M., Bockarie, M., & Reeder, J. C. 2002, 
"Complex patterns of malaria epidemiology in the highlands region of Papua New 
Guinea", P.N.G.Med J, vol. 45, no. 3-4, pp. 200-205. 
Mueller, I., Tulloch, J. L., Marfurt, J., Hide, R., & Reeder, J. C. 2005, "Malaria control in 
Papua New Guinea results in complex epidemiological changes", P.N.G.Med J, vol. 
48, no. 3-4, pp. 151-157. 
Mueller, I., Zimmerman, P. A., & Reeder, J. C. 2007, "Plasmodium malariae and Plasmodium 
ovale--the "bashful" malaria parasites", Trends Parasitol., vol. 23, no. 6, pp. 278-283. 
Muller, I., Bockarie, M., Alpers, M., & Smith, T. 2003, "The epidemiology of malaria in Papua 
New Guinea", Trends Parasitol., vol. 19, no. 6, pp. 253-259. 
Mulrow, C. D. 1994, "Rationale for systematic reviews", BMJ, vol. 309, no. 6954, pp. 597-
599. 
Najera, J. A. 1999, "Prevention and control of malaria epidemics", Parassitologia, vol. 41, no. 
1-3, pp. 339-347. 
Najera, J. A. 2001, Malaria vector control: insecticides for indoor residual spraying, World 
Health Organization, Geneva, WHO/CDS/WHOPES/2001.3. 
Newman, R. D., Parise, M. E., Slutsker, L., Nahlen, B., & Steketee, R. W. 2003, "Safety, 
efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: 
implications for prevention programmes in Plasmodium falciparum-endemic sub-
Saharan Africa", Trop Med Int Health, vol. 8, no. 6, pp. 488-506. 
1 - Introduction 
 
 20 
Obrist, B., Iteba, N., Lengeler, C., Makemba, A., Mshana, C., Nathan, R., Alba, S., Dillip, A., 
Hetzel, M. W., Mayumana, I., Schulze, A., & Mshinda, H. 2007, "Access to health 
care in contexts of livelihood insecurity: a framework for analysis and action", 
PLoS.Med, vol. 4, no. 10, pp. 1584-1588. 
Picot, S. 2006, "[Is Plasmodium vivax still a paradigm for uncomplicated malaria?]", Med Mal 
Infect, vol. 36, no. 8, pp. 406-413. 
RBM Partnership & WHO 2000, RBM Action at Country Level: Country Updates, World 
Health Organisation (WHO/CDS/RBM/2000.24), Geneva. 
Roberts, D., Curtis, C., Tren, R., Sharp, B., Shiff, C., & Bate, R. 2004, "Malaria control and 
public health", Emerg Infect Dis, vol. 10, no. 6, pp. 1170-1171. 
Roberts, L. & Enserink, M. 2007, "Malaria. Did they really say ... eradication?", Science, vol. 
318, no. 5856, pp. 1544-1545. 
Roll Back Malaria 2008a, Global malaria action plan: for a malaria free world. 
Roll Back Malaria 2008b, Key Facts, Figures and Strategies: The Global Malaria Action Plan, 
Roll Back Malaria Partnership. 
Roll Back Malaria & World Health Organization 2000, The African Summit on Roll Back 
Malaria, Abuja, 25 April 2000, World Health Organization (WHO/CDS/RBM/2000.17), 
Geneva. 
Sachs, J. & Malaney, P. 2002, "The economic and social burden of malaria", Nature, vol. 
415, no. 6872, pp. 680-685. 
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. 
1996, "Evidence based medicine: what it is and what it isn't", BMJ, vol. 312, no. 7023, 
pp. 71-72. 
Schuurkamp, G. J. 1992, The Epidemiology of Malaria and Filariasis in the Ok Tedi Region 
of Western Province, Papua New Guinea, University of Papua New Guinea. 
Shiff, C. 2002, "Integrated approach to malaria control", Clin.Microbiol.Rev., vol. 15, no. 2, 
pp. 278-293. 
Soto, T. A., Solari, Z. L., Mendoza, R. D., Llanos-Cuentas, A., & Magill, A. 2004, "Evaluation 
of the rapid diagnostic test OptiMAL for diagnosis of malaria due to Plasmodium 
vivax", Braz.J Infect Dis, vol. 8, no. 2, pp. 151-155. 
Spencer, M. 1992, "The history of malaria control in the southwest Pacific region, with 
particular reference to Papua New Guinea and the Solomon Islands", P.N.G.Med J, 
vol. 35, no. 1, pp. 33-66. 
Srinivasan, S., Moody, A. H., & Chiodini, P. L. 2000, "Comparison of blood-film microscopy, 
the OptiMAL dipstick, Rhodamine-123 fluorescence staining and PCR, for monitoring 
antimalarial treatment", Ann.Trop Med Parasitol., vol. 94, no. 3, pp. 227-232. 
Tanner, M. & deSavigny D. 2008, "Malaria eradication back on the table", Bull World Health 
Organ, vol. 86, no. 2, p. 82. 
The Lancet 2007 Anonymous, "Is malaria eradication possible?", Lancet, vol. 370, no. 9597, 
p. 1459. 
1 - Introduction 
 
 21 
Warrell, D. A. & Gilles, H. M. 2002, Essential Malariology, 4 edn, Oxford University Press. 
White, P. J. 2002, "Evidence-based medicine for consumers: a role for the Cochrane 
Collaboration", J Med Libr.Assoc., vol. 90, no. 2, pp. 218-222. 
WHO 2000, New perspectives: Malaria diagnosis, World Health Organization, Geneva. 
WHO & UNICEF 2005, World Malaria Report 2005, Geneva, World Health Organization. 
WHO & UNICEF 2008, World Malaria Report 2008, Geneva, World Health Organization. 
WHOPES 2007, WHO recommended insecticides for indoor residual spraying against 
malaria vectors, www.who.int/malaria/cmc_upload/0/000/012/604/IRSInsecticides.htm 
(accessed 12 May 2007). 
World Health Organization 2008, Global malaria control and elimination: report of a technical 
review, World Health Organization, Geneva. 
World Health Organization 2004, The Global Burden Of Disease 2004 Update. 
Yamey, G. 2004, "Roll Back Malaria: a failing global health campaign", BMJ, vol. 328, no. 
7448, pp. 1086-1087. 
 
  22 
2 – Aims and objectives 
 
 23 
2 Aims and objectives 
 
 
Note: the intention of this work was to assess the benefits and costs of an integrated malaria 
control program in a large oil palm plantation in Papua New Guinea, focusing on house 
screening. The work was to be implemented within the Higaturu Oil Palm Plantations 
(HOPPL), a company of the Commonwealth Development Corporation (CDC). Unfortunately, 
in 2006, HOPPL was sold to Cargill Corp. Following this change of leadership, HOP set new 
priorities and beginning of April 2007 the company decided to terminate the house screening 
intervention that was to be the core of this project.  
 
Hence, the revised objectives of the present PhD thesis were as follows:  
 
1. To provide an overview of the malaria epidemiology within a commercial oil palm 
plantation in the Oro Province (Papua New Guinea) and to quantify the burden of malaria 
and its implication for the company. 
  
2. To systematically review the impact of indoor residual spraying (IRS) on key malariological 
parameters and to compare the relative impacts of IRS and ITNs in the frame of a Cochrane 
review. 
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3.1 Abstract  
 
Background 
 
For companies operating in malaria endemic countries, malaria represents a substantial risk 
to workers and their dependants, and can lead to significantly reduced worker productivity. 
This study provides an overview of the malaria epidemiology within an oil palm plantation in 
Popondetta, south-eastern Papua New Guinea, its implication for the company with its 
employees and their families and the potential for control. 
 
Methods 
 
In 2006, we carried out a cross-sectional study within six company villages, which included 
the determination of parasite rates by conventional microscopy, interviews and haemoglobin 
measurements. Passive surveillance data were collected from the 13 company aid posts for 
the years 2005 and 2006.  
 
Results 
 
Malaria prevalence was found to be high: all-age prevalence was 33.5% (95% CI 30.1-37.0) 
in 723 individuals. Plasmodium falciparum was the dominant species, followed by 
Plasmodium vivax and Plasmodium malariae. Children between five and nine years of age 
were most affected (40.3%, 95% CI 0.32-0.49). Haemoglobin levels were found to be low;  
11.0 g/dl (95% CI 10.8-11.1) for men and 10.4 g/dl (95% CI 10.3-10.5) for women, 
respectively. Plasmodium falciparum infections were significantly associated with anaemia 
(Hb < 10 g/dl). At the aid posts, all malaria cases in 2005 and January-March 2006 were 
diagnosed by symptoms only, while from April 2006 onwards most cases were tested by 
rapid diagnostic tests. Between 2005 and 2006, 22,023 malaria cases were diagnosed at the 
aid posts and malaria accounted for 30-40% of all clinical cases. Of the malaria cases, 13-
20% were HOP employees. On average, an employee sick with malaria was absent for 1.8 
days, resulting in a total of 9,313 workdays lost between 2005 and 2006. Sleeping outside of 
the house did not increase the risk of a malaria infection, neither did getting up before 7am. 
 
Conclusions 
 
Malaria was found to be a major health burden in the Higaturu Oil Palm plantation, posing a 
high risk for company staff and their relatives, including expatriates and other non-immune 
workers. Reducing the malaria risk is a highly recommended investment for the company.
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3.2 Background  
 
Papua New Guinea (PNG) is characterized by its variability and complexity in culture, 
ecology and geography. This complexity is also reflected in the malaria situation (Muller et al. 
2003). Malaria ranks first amongst the diseases causing illness and death in Papua New 
Guinea (WHO & UNICEF 2005), although there is a great variation in the relative importance 
of malaria for people in different areas. The epidemiology of malaria in PNG ranges from 
complete absence of malaria, through unstable low levels of transmission with recurring 
epidemics, to permanently high levels of transmission (Genton et al. 1995; Mueller et al. 
2002), even reaching the highest transmission levels known outside of Africa. About 46% of 
all Papua New Guineans live in an altitude zone of 0 – 600 m above sea level (Muller et al. 
2003), where malaria is highly endemic.   
 
Malaria represents not only a health, but also an economic burden. In Africa alone, the 
estimated direct and indirect costs of malaria exceed US$ 12 billion annually (Breman et al. 
2004). Malaria negatively influences economic growth, reducing it for example by 1.3% 
annually in endemic countries between 1965 and 1990. In 1995, the average gross domestic 
product in non-malarious countries was five times higher than in countries affected with 
malaria (Gallup & Sachs 2001). The most immediate effect of malaria on a company is its 
impact on the workforce and the resulting cost of caring for sick employees. Employees sick 
with malaria are not working efficiently and are likely to take time off to recover. In a worst 
case, employees die and replacements need to be recruited and trained (Global Health 
Initiative 2006).  
 
In PNG, oil palm is a major agro-industry. In 2001, over 100,000 hectares of oil palms were 
planted. Since 2000, palm oil has been the most important agricultural export industry in 
PNG, with nearly 400,000 tons exported in 2002, amounting to approximately 136 million 
USD (Koczberski et al. 2001; FAO 2008). Commercial plantations such as oil palm 
plantations offer suitable environmental conditions for Anopheles mosquitoes breeding and 
people living and working in such plantations are thus likely to be at high risk for malaria 
(Chang et al. 1997). However, such plantations also provide relatively good housing and 
infrastructure for their workers, making it relatively easy to deploy screening or indoor 
residual spraying, and improvement in case management.  
 
Higaturu Oil Palms plantations (HOP) is one of the major employers in Oro Province (south-
east PNG). It provides housing for its employees and their dependants within the plantation. 
HOP is located in the area around Popondetta, the capital of Oro province, on a coastal plain 
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at the foot of the Owen-Stanley range. So far, and to the best of our knowledge, no data 
have ever been collected on the epidemiology of malaria for this part of the country. 
Therefore, this study aims to provide (1) an overview of the malaria epidemiology in Oro 
province, and (2) to quantify the problem of malaria within a commercial oil palm plantation, 
its implications for the company and the potential for control. Few such studies have been 
carried out and this economic risk (in addition to the health risk) urgently requires to be better 
quantified. 
 
3.3 Methods 
 
Study site 
 
The study was conducted within the oil palm plantations of CTP (PNG) Ltd. (trading as 
Higaturu Oil Palms - HOP), close to Popondetta, the capital of Oro Province in Papua New 
Guinea. HOP processes palm fruits from an area of about 22,997 hectares. The company 
owns 8,997 hectares which are divided into five estates (namely Javuni, Sumbiripa, Ambogo, 
Mamba and Embi). Smallholders own another 14,000 hectares. While the smallholders are 
responsible for maintaining and harvesting the palms, Higaturu buys their fruits and 
processes them into palm oil and palm kernel oil.  
People living in the 14 villages within the plantation consist of HOP employees and their 
dependants, for whom housing is provided by the company. Every village is equipped with a 
small health centre, staffed with one Community Health Worker or nursing officer. A bigger 
health centre with a laboratory is situated in Siroga village, which is easily accessible by car 
or foot.   
 
The cross-sectional study took place in six villages (namely Epa, Irigi, Sumbiripa, Irihambo, 
Javuni and Moale), located within three of the five estates. Two of the estates (Mamba and 
Embi) were excluded as they were difficult to reach due to their geographical distance. 
Mamba estate is located in the mountains and hence is not ecologically comparable to the 
other estates. For the passive surveillance system, all aid posts were included.  
 
Ecologically the study villages are very similar to each other, all being surrounded by oil 
palms. Within the study area, rainfall usually shows some seasonality with a wet season from 
November to April and a drier season from May/June to October. During our study period the 
average rainfall was 189 mm, with 243 mm in April and 135 mm in May (Figure 1). 
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Figure 1: Average monthly rainfall within the study area from 2004 to 2006.  
 
A company village consists of 100 houses of which 87-98% are so-called “labour houses”, 
wooden two-bedroom houses with a cooking place outside on the veranda and its own 
ablution block and toilet next to the house (Figure 2).  
 
 
Figure 2: A typical worker’s house. 
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Cross-sectional parasitology surveys 
 
The cross-sectional surveys were conducted between April and May 2006. Every village was 
visited once. Households to be included were selected by random sampling from the existing 
list of houses provided by the company.  
 
Inclusion/exclusion criteria. Every person living within the selected villages and households 
was eligible for the study. Consent procedures are described below. Persons ill at the time of 
the survey, as well as visitors to the household who had lived less than four weeks in the 
village, were excluded from the study.  
 
Measurements. From each participant we measured the axillary temperature with an 
electronic thermometer. At the same time, a questionnaire was administered on the use of 
bed nets, the history of malaria sickness in the previous two weeks, the use of anti-malarial 
drugs and health facility attendance, travel behaviour, evening leisure activities and sleeping 
habits (outside or inside their house). The interview was performed in English or Melanesian 
pidgin by bilingual interviewers. At the same time as the interview, a blood slide including a 
thick and a thin film was prepared. Thin blood films were fixed with methanol. All smears 
were stained with 2.5% buffered Giemsa (pH 7.2) for 35 minutes and examined afterwards 
microscopically for 100 fields under oil immersion (x 1000 magnification) before being 
declared negative. In positive films, parasite species were identified and densities recorded 
as the number of parasites/200 white blood cells (WBC). Densities were converted to the 
number of parasites/µl of blood assuming 8,000 WBC/µl.  
 
Haemoglobin levels were measured from the same finger prick as from the blood slide, using 
a HaemoCue machine (HemoCue B-Hemoglobin, Angholm, Sweden). From each individual 
the spleen size was determined according to Hackett’s grading by a local nurse. 
 
Routine data assessment 
 
Malaria incidence data routinely collected by the health staff of the HOP aid posts were 
available from January 2005 to December 2006. Until April 2006, all patients presenting with 
fever were considered as malaria cases. In April 2006 Rapid Diagnostic Tests (RDTs, ICT 
Malaria Combo Cassette, R&R Marketing, South Africa) were introduced in all aid posts 
within the Higaturu Oil Palm estates. Before the introduction of the RDTS, a three-day 
training course on the theory and usage of the RDTs was provided to every member of the 
health staff of HOP. After the introduction of RDTs, patients were classified as having malaria 
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only if the RDT result was positive. Compared to microscopy the RDT sensitivity was 89%, 
which is excellent.    
 
For every patient visiting a HOP aid post, the date of the visit, data of joining the company 
(employee, dependant or outsider) and the diagnosis were collected.  
In 2006, for an ad hoc sample of employees, the numbers of days missing from work due to 
malaria were recorded.  
 
Data entry and analysis 
 
The data from the questionnaires were entered in an Access 2002 database (Microsoft 
Corp., Redmond, US). To check for data entry mistakes, the entered data were checked and 
corrected by one person, while a second person was reading out the entries of the original 
questionnaires. The blood slides were read twice by two different microscopists and the 
results entered into two different Excel databases (Microsoft Corp., Redmond, US). A Kappa 
test for checking for consistency between the two datasets showed an expected agreement 
of 78.4% (k=0.43). In case one microscopist only found few parasites (< 3 
parasites/200WBC) and the other none, the slides were considered to be positive. Slide 
results were excluded from the analysis if one microscopist found a high parasites density 
(>12 parasites/200 WBC) and the second one found none. Differences in categorical 
variables were tested using the Pearson chi-square test. Differences were regarded as 
significant if the p-value of the test statistic was ≤5%. 
 
Changes of haemoglobin values were calculated using linear regression, adjusting for age, 
gender and mosquito net use. Difference between males and females in haemoglobin levels 
were tested with Wilcoxon test, as the Bartlett’s test for the differences in the variance was 
significant. Participants were classified as having anaemia if haemoglobin levels were under 
10 g/dl. For obtaining odds ratios, relevant variables (age, sex, village, sleep outside on the 
veranda, sleep outside in a shelter, sleeping under a bed net, work and getting up before 
7am) were added one-by-one in the model and a likelihood ratio tests was performed to test 
for significance.    
Work days lost for the company were calculated by taking the arithmetic mean of the days 
not worked per employee due to malaria.  
 
Unfortunately, it was not possible to get the results of RDT testing from all the clinics 
because these statistics were not available to us. In order to have at least an estimate of 
testing positivity rate, a sample of 90 successive patients in one clinic (Siroga) who were 
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clinically diagnosed with malaria were also tested with a RDT in order to calculate the RDT 
positivity rate.  
 
All statistical analyses were performed in Intercooled Stata 9 (StataCorp, Texas, US). 
 
Informed consent 
 
The community was informed about the aims and the methods of the study before the start of 
the data recording and sample collection by the company health care workers. Consent was 
then sought individually from all study participants or their guardians. This was done by 
explaining again the aim and procedure of the study at the beginning of the interview. A 
signature of each participant on their understanding and willingness to participate was then 
collected. All enrolled individuals retained their right to withdraw from the study at any stage. 
 
The survey methodology was approved by the PNG Medical Research Advisory Committee 
(approval number MRAC No. 06.07).  
 
3.4 Results  
 
Cross-sectional survey: general description 
 
A total of 843 individuals were included in the survey (Table 1). The study participants 
consisted of 423 (50.2%) females and 419 (49.8%) males and were grouped into the 
following five age categories: 0-4, 5-9, 10-19, 20-39 and >40 years. There was a big excess 
of individuals aged 20-39 years (40.9% of the participants), which were made up largely of 
workers, as expected in this population. Over half of the participants (57.1%) came from Oro 
province, and overall 81.7% of the people had an Oro, a Morobe or a mixed Oro/Morobe 
origin. 28.2% (238/843) of the interviewee were permanently employed by the company and 
of those, 89.4% (211/236) were working within the field department. Employees within the 
field department work in the plantations, mainly harvesting ripe palm fruits. Only 6.8% 
(57/843), of the participants were hired as casuals, of whom 87.7% (50/57) were women. 
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Table 1: Description of cross-sectional survey participants 
Variable  N (%) Male Female 
Sex Male 423 (50.2)   
 Female 419 (49.8)   
 Total 842   
Age 0-4 169 (20.1) 89 (21.1) 79 (18.9) 
 5-9 148(17.6) 76 (18.0) 72 (17.2) 
 10-19 117 (13.9) 47 (11.1) 70 (16.7) 
 20-39 344 (40.9) 167 (39.6) 177 (42.2) 
 >40 64 (7.6) 43 (10.2) 21 (5.0) 
 Total 842 422 419 
Origin Oro 480 (57.1) 218 (51.8) 261 (62.4) 
 Morobe 160 (19.1) 97 (23.0) 63 (15.1) 
 Oro/Morobe 46 (5.5) 24 (5.7) 22 (5.3) 
 Other provinces 157(18.3) 82(19.5) 72(17.2) 
 Total 840 421 418 
Work Permanent 238 (28.2) 205 (86.1) 33 (13.9) 
 Casual 57 (6.8) 7 (12.3) 50 (87.7) 
 Not working 548 (65.0) 211 (38.6) 336 (61.4) 
 Total 843 423 419 
Work department  Field 211 (89.4) 178 (87.7) 33 (100.0) 
 Security 12 (5.1) 12 (5.9) 0 (0.0) 
 Transport 7 (3.0) 7 (3.5) 0 (0.0) 
 Mill 4 (1.7) 4 (2.0) 0 (0.0) 
 Growers 1 (0.4) 1 (0.5) 0 (0.0) 
 HR 1 (0.4) 1 (0.5) 0 (0.0) 
 Finance 0 (0.0) 0 (0.0) 0 (0.0) 
 Total 236 203 33 
Work casual Collect mama 
lusfrut 
22 (38.6) 0 22 (44.0) 
 Weeding 13 (22.8) 1 (14.3) 12 (24.0) 
 Empty Fruit 
Bunch (EFB) 
distribution 
8 (14.0) 1 (14.3) 7 (14.0) 
 Fertilizer 
application 
6 (10.5) 0 (0.0) 6 (12.0) 
 Harvest helper 3 (5.3) 2 (28.6) 1 (2.0) 
 Other 5 (8.8) 3 (42.9) 2 (4.0) 
 Total 57 7 50 
 
Population movement was low with only 7.9% (66/839) individuals reporting to have been 
travelling within the last four weeks. 70.9% of 839 participants slept under a mosquito net the 
previous night. However, many people reported, that the treatment status of their nets was 
poor, with many of the nets not having been retreated within one year of usage.    
  
Parasitological results 
 
A total of 723 blood slides were collected, of which 242 were positive for malaria (33.5%, 
95% confidence interval [CI]: 30.1-37.0). This result documents the high level of endemicity 
in this area. Between the three estates, the malaria prevalence differed significantly (χ2= 
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24.85, 2 df, p<0.001), ranging from 20.3% (95% [CI] 0.14-0.26) in Ambogo to 43.1% (0.37-
0.49) in Sumbiripa (Table 2). At village level, the malaria prevalence ranged from 17.7% 
(95% CI 0.09-0.27) in Epa to 44.6% (95% CI 0.36-0.53) in Sumbiripa village (χ2= 25.80, 5 df, 
p<0.001) (Table 2). There was no significant difference between prevalence among males 
and females (χ2=0.10, 1 df, p=0.319). Overall, prevalence was highest in the age group 5-9 
years (40.3%, 95% CI 0.32-0.49) (Figure 3). The same pattern was seen with P. falciparum 
infections, with 27.9% (95% CI 0.20-0.36) of the 5 to 9 years old children infected (Figure 4). 
For P. vivax, no difference between the age-groups was found (Figure 4). 
 
Table 2: Malaria prevalence and bed net usage, by estates and by villages (cross-sectional 
survey). 
Estate Number 
examined 
Prevalence 
 all species 
n infected; % 
(CI 95%) 
Prevalence 
P. falciparum 
n infected; % 
(CI 95%) 
Prevalence  
P. vivax 
n infected; % 
(CI 95%) 
Bed net 
usage 
(%) 
Ambogo 177 36;  20.3 
(0.14-0.26) 
28;  15.8 
(0.10-0.21) 
6;  3.4 
(0.01-0.06) 
84.3 
Sangara 279 91;  32.6 
(0.27-0.38) 
56;  20.0 
(0.15-0.25) 
35;  12.5 
(0.09-0.16) 
69.7 
Sumbiripa 267 115;  43.1 
(0.37-0.49) 
60;  22.5 
(0.17-0.27) 
50;  18.7 
(0.14-0.23) 
63.3 
Village      
Epa 68 12;  17.7 
(0.09-0.27) 
9;  13.2 
(0.05-0.21) 
2;  2.9 
(-0.01-0.07) 
97.5 
Irigi 109 24;  22.0 
(0.14-0.30) 
19;  17.4 
(0.10-0.25) 
4;  3.7 
(0.00-0.07) 
75.8 
Moale 154 48;  31.2 
(0.24-0.38) 
28;  18.1 
(0.12-0.24) 
23;  14.8 
(0.09-0.20) 
65.6 
Javuni 125 43;  34.4 
(0.26-0.43) 
28;  22.4 
(0.15-0.30) 
12;  9.6 
(0.04-0.15) 
75.0 
Irihambo 137 57;  41.6 
(0.33-0.50) 
33;  24.1 
(0.17-0.31) 
21;  15.3 
(0.09-0.21) 
57.6 
Sumbiripa 130 58;  44.6 
(0.36-0.53) 
27;  20.8 
(0.14-0.28) 
29;  22.3 
(0.15-0.29) 
68.9 
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Figure 3: Malaria prevalence (all species) by age group, with 95% confidence intervals 
 
 
Figure 4: Malaria prevalence by species and age group, with 95% confidence intervals. 
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With 59.5% (144/242) of all positives, P. falciparum was the dominant species, followed by P. 
vivax (91/242, 37.6%) and P. malariae (16/242, 6.6%). No Plasmodium ovale was found. A 
high number of the positive slides (26/242, 10.7%) were mixed infections. The parasite 
densities of the infections were low, with 91.1% (194/213) of the slides having <500 
parasites/µl. No difference in parasite densities between age groups was found (χ2= 20.18, 
12 df, p=0.064). When investigating differences by species, 11.1% (14/144) of P. falciparum 
infections were >500 parasites/µl, compared to 4.4% (4/91) of the P. vivax infections 
(significant difference χ2= 10.48, 2 df, p=0.005).  
 
Reported malaria episodes and spleen rates 
 
25 participants presented with fever at the survey and a quarter (26.1%) of the 842 
participants reported having had malaria during the past two weeks. No correlation between 
measured or reported fever and malaria parasitaemia was found: eight of the 20 (40.0%) 
people presenting with fever and having a blood slide taken, had a positive blood slide (χ2= 
0.41, 1 df, p=0.521). Of the participants with reported fever during the last two weeks and 
having a malaria slide taken, only 37.6% (70/186) had a positive slide (χ2= 1.86, 1 df, 
p=0.173).  
 
Almost everybody who reported having had malaria within the last two weeks visited a health 
centre (99.5%) and took anti-malarials (96.2%). 
 
Overall, 59.7% of the participants had an enlarged spleen with an average size of 3.2 on the 
Hackett scale, but no association with a current malaria infection was seen, neither at 
individual (χ2= 0.78, 1 df, p=0.377) nor at village level. Looking at age groups, the average 
Hackett score was lowest for the youngest age group (0-4 years) with 2.4, and it rose with 
age to 3.8 for the oldest age group (>40 years). Despite the fact that this was reported 
differently by Genton et al. within the Wosera (Genton et al. 1995), a high rate of enlarged 
spleens in adults is a particular feature of malaria in PNG. Often, enlarged spleens in adults 
are linked to hyperreactive malarial splenomegaly (Muller et al. 2003). Though usually 
present within mid altitude zones (Muller et al. 2003), this syndrome might also occur within 
this study area. 
Haemoglobin levels were low with a significantly higher level for men (11.0 g/dl, 95% CI 10.8-
11.1) than for women (10.4 g/dl, 95% CI 10.3-10.5) (χ2= 24.73, 1 df, p<0.001). In children 
aged 5-9 years, the haemoglobin levels were significantly decreased with a malaria infection: 
by 1.0 g/dl (95% CI -1.43 – -0.47, p<0.001) for any species and 1.2 g/dl (95% CI -1.66 - -
0.63, p<0.001) for P. falciparum infections. A significant association between P. falciparum 
and anaemia was found (χ2= 4.41, 1 df, p=0.036). 
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Behavioural aspects 
 
There was no difference between employees and dependants in the risk of getting infected 
with malaria (Table 3). Neither were sleeping outside during the night (on the veranda or on a 
shelter) nor getting up before 7am associated with a higher risk of a malaria infection. On an 
individual level, sleeping under a bed net showed no protection against malaria (OR 1.2, 
95% CI 0.8-1.7). However, there was a clear trend towards less malaria with higher bed net 
coverage between villages (Table 2). For every percentage increase in net coverage, the 
odds of malaria cases decreased by 3% (OR 0.97, 95% CI 0.96-0.99).  
 
Table: 3 Risk factors for getting a malaria infection (cross-sectional survey). 
Variable Total 
(n) 
Infected (%) Odds 
ratio 
CI 95% p-value 
(LRT) 
Village      
Moale 154 48 (31.2) 1  0.00 
Epa 68 12 (17.7) 0.5 0.2-1.0 0.00 
Irigi 109 24 (22.0) 0.6 0.3-1.1  
Javuni 125 43 (34.4) 1.1 0.7-1.9  
Irihambo 137 57 (41.6) 1.5 0.8-2.6  
Sumbiripa 130 58 (44.6) 1.2 1.1-3.2  
Sex   0.9 0.6-1.3 0.51 
Age      
0-4 130 37 (28.5) 1  0.14 
5-9 129 52 (40.3) 1.9 1.1-3.2  
10-19 101 32 (31.7) 1.1 0.6-2.0  
20-39 306 103 (33.7) 1.2 0.6-2.3  
>40 56 18 (32.1) 1.0 0.4-2.4  
Work  permanent (vs not 
working (=dependants)) 
215 74 (34.4) 1.0 0.5-1.8 1.00 
Work casual (vs not working 
(=dependants)) 
50 18 (36.0) 1.0 0.5-2.1  
Sleep under a bed net (yes vs 
no) 
507 160 (31.6) 1.2 0.8-1.7 0.39 
Sleep on veranda (yes vs no) 136 44 (32.4) 1.1 0.4-1.3 0.56 
Sleep in a shelter (yes vs no) 63 25 (39.7) 0.7 0.4-1.3 0.25 
Get up before 7am (vs getting 
up after 7am) 
538 181 (33.6) 0.9 0.8-1.1 0.51 
 
Incidence of routinely diagnosed malaria infections 
 
Malaria was the most common disease diagnosed by HOP health staff in 2005 and 2006. In 
2005 all malaria patients seen at the aid posts were diagnosed by clinical symptoms only. Of 
all patients seen at the 13 HOP aid posts in 2005, 39% (12,083/30,864) were diagnosed with 
malaria. Of the 12,083 malaria patients, 26% (3159/12083) were employees. On average, 
1007 patients were diagnosed with malaria every month at the 13 aid posts. Malaria cases 
were found to be evenly distributed throughout the year 2005 (Figure 5), hence showing no 
seasonality.  
   38 
In 2006, fewer patients were diagnosed with malaria than in 2005, especially after the 
introduction of RDTs in April. The RDT positivity rate, calculated for a sample of 90 patients, 
was found to be 48%. Overall, 9,940 patients were sick with malaria, still representing 29% 
(9,940/34,216) of all diagnosis made at the aid posts. 20% (2,015/9,940) of the malaria 
patients were employees. The malaria burden was highest in the beginning of the year, and 
then, after the introduction of RDTs in April a sharp decline until August was seen. During the 
three months in 2006 before the introduction of RDTs, 1,220 malaria cases were clinically 
diagnosed every month, of which 17% (211/1,220) were employees. After the introduction of 
RDTs in April and until the end of 2006, the monthly average of overall malaria cases 
decreased to 698. 153 (22%) of these malaria cases were employees. Malaria cases showed 
a seasonal peak in October, which did not reach the level of 2005, before RDT introduction 
(Figure 5). 
 
 
Figure 5: Monthly routine malaria incidence data from 2005 to 2006. 
 
Days lost for the company  
 
According to HOP administration, an employee sick with malaria was absent from work for 
an average of 1.8 days. Since 3,159 employees were sick with malaria in 2005 and 2,015 
employees in 2006, this resulted in 5,686 lost days in 2005 and 3,627 lost days in 2006.    
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3.5 Discussion  
 
To our knowledge, this work presents one of the few publications on the impact of malaria 
within an agro-industrial operation in endemic countries and the first one in PNG. 
Furthermore, it provides for the first time malariological information for the region around 
Popondetta, south-east PNG.  
Clearly, malaria was found to be a major health problem within the CTP Plantation. The 
overall prevalence rate of 33.5% found among workers and their families is high. 
Furthermore, children and adults are both affected and this suggests there is little acquired 
immunity. This level of endemicity is similar to that found in other surveys done in the 
lowlands of PNG outside agro-industrial operations. Genton et al. (1995) and Cattani et al.  
(1986) found prevalence rates of 60% in the Wosera (East Sepik) and 35.0% to 42.7% 
surrounding Madang, respectively. The prevalence data of Genton et al. and Cattani et al.  
have been collected between 10 and 20 years ago and it is likely that the overall rate of 
transmission has decreased since. Furthermore, an oil palm plantation represents an artificial 
environment with its own ecosystem, which is likely to have a different transmission rate than 
a natural habitat. Comparisons with other oil palm plantations within PNG on the same 
altitudes would have been interesting, but such data are not available. Given the particular 
malaria epidemiology of PNG, which is by far the highest in the region, comparison with other 
Asian and Pacific countries is meaningless. 
 
HOP offers housing to their employees within the geographical boundaries of the plantation. 
This special setting, with only employees and their dependants being allowed to live within 
the plantation, resulted in 40% of the participants being aged between 20 and 39. This is 
clearly not representative for the general population of the country and hence caution needs 
to be exerted when generalizing our results to the rest of the population.  
 
Ripe palm fruits are collected by company trucks, creating deep wheel tracks on the ground. 
With enough rainfall such tracks present perfect breeding sites for Anopheles punctulatus 
(Cooper et al. 2002), which were found by human landing catches within the study area 
(Cooper R.D. personal communication). Though we conducted only one cross-sectional 
survey, the age peak for malaria infections (5-9 years old) was found to be characteristic for 
a highly endemic area (Genton et al. 1995; Muller et al. 2003). Such an intense malaria 
transmission can pose a high risk for all residents, especially for expatriates and other non-
immune workers (for example coming from the cooler highlands). In one of the few 
documented examples, a large joint venture in Mozambique lost 13 expatriate employees 
due to malaria within two years (Sachs & Malaney 2002). Undoubtedly, malaria endemicity 
weighs down the attractiveness of industrial or agro-industrial sites.  
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Almost everybody who was feeling sick with presumptive malaria within the last two weeks 
had visited a health centre and received anti-malarials. This finding was not surprising, as 
employees and their dependants have free and ready health services provided by the 
company. This good access to treatment explains that we have not come across of any 
reported deaths from malaria.   
 
In 2005, with the exception of one clinic, all malaria cases were diagnosed purely on a 
symptomatic basis. Unfortunately, symptoms of malaria are non-specific and many other 
diseases can present with the same clinical picture, including harmful diseases such as 
dengue, HIV or hepatitis B. But also many harmless viral infections present similar to a 
malaria infection. Thus, a purely symptomatic diagnosis of malaria can lead to a vast over-
diagnosis of malaria cases (Font et al. 2001; Greenwood et al. 2005; Wang et al. 2006). This 
was illustrated by the fact that after the introduction of RDTs in April 2006 the number of 
reported malaria cases decreased steadily. But even with systematic testing with RDTs, still 
about 10,000 patients were diagnosed with malaria in 2006.  This high level of morbidity 
represents a considerable cost of treatment (estimated cost per treatment: USD 0.18) and a 
substantial loss of productivity. These episodes resulted in 5686 lost days for the company in 
2005, amounting to lost wages of over USD 60,000 (King G., personal communication). In 
2006, the company lost 3627 working days due to malaria. The costs associated with malaria 
illness will increase significantly as PNG moves towards introducing the significantly more 
expensive Coartem® (artemether-lumefantrine) as the national first-line treatment. 
 
More than half of the infections were caused by P. falciparum (57.4%), followed by P. vivax 
with 36.2%. Plasmodium falciparum infections are well known for their impact on morbidity 
and mortality, but also P. vivax infections are considered to be responsible for a substantial 
health burden (Greenwood et al. 2005; Picot 2006; Genton et al. 2008; Karyana et al. 2008). 
For an oil palm plantation, where approximately 60-75% of the employees do a physically 
strenuous work, a healthy workforce is crucial for a high productivity. The negative impact of 
malaria is also demonstrated by the low average haemoglobin level, which is a further drain 
on the energy of workers.  
 
Virtually all inhabitants within the study area live within so-called “labour houses” (Figure 2), 
wooden two-bedroom houses, in which room temperatures can get very high, including at 
night. As a result, people sometimes sleep outside on their veranda or in a self-built shelter, 
where they are fully exposed to biting mosquitoes. Surprisingly, sleeping on a veranda or 
sleeping on a shelter was not found to be a risk-factor for a malaria infection. The most likely 
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explanation for this finding is that the mosquitoes prevalent within the plantation, Anopheles 
punctulatus (RD Cooper, personal communication) are exo- but also endophagic (Charlwood 
et al. 1986) and can easily enter and bite occupants inside the non mosquito-proofed 
houses. 
The two main tools to prevent malaria infections are insecticide-treated mosquito nets (ITNs) 
and indoor residual spraying (IRS). Within HOP, nets are sold for half their commercial price, 
which explains the high usage rate of 70%. On an individual level no significant protection 
against malaria could be detected but this is expected in a situation with a homogeneously 
high level of net use. The village comparison showed a trend of decreasing number of 
malaria infections with increasing bed net level, confirming that the nets actually do have an 
impact. Unfortunately, the insecticide re- treatment level of the nets was poor since most nets 
were not retreated after 2004. Therefore, the introduction of LLINS, which are designed to 
maintain their efficacy against mosquitoes for at least three years without any re-treatment 
necessary, would be highly recommended (WHO Global Malaria Programme 2008). The 
high level of net protection also suggests that endemicity would be even higher if there was 
no protection.  
Indoor residual spraying requires 1) an adequate knowledge of vector behaviour and 
occurrence, and (2) a highly structured programme including well-trained personnel, properly 
used insecticides, good logistics and scheduling and a high level of sustained financing 
(Lengeler & Sharp 2003). These terms would clearly be doable by a commercial oil palm 
plantation and thus, IRS would also be a feasible option for malaria control in the HOP 
setting. With housing provided by the plantation, upgrading the housing conditions including 
house screening would be a more long-term solution of malaria control. This approach has 
already shown great success within military barracks in Pakistan and India, reducing the 
malaria incidence up to 72% (Lindsay et al. 2002). 
 
3.6 Conclusions  
 
Malaria was found to be a major health burden to the Higaturu Oil Palms, posing a high risk 
for all inhabitants, indigenous workers as well as non-immune workers. Detrimental effect 
included direct cost of treatment, days away from work and reduced physical ability. These 
losses are substantial enough to warrant the implementation of energetic and long-lasting 
malaria control measures. 
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4.1 Abstract 
 
Understanding malaria transmission in Papua New Guinea (PNG) requires exact knowledge 
on what Anopheles species are transmitting malaria and is complicated by the cryptic 
species status of many of these mosquitoes. To identify the malaria vectors in PNG we 
studied Anopheles specimens from 232 collection localities around human habitation 
throughout PNG (using CO2 baited light traps and human bait collections). A total of 22,970 
mosquitoes were individually assessed using a Plasmodium sporozoite enzyme-linked 
immunosorbent assays to identify Plasmodium falciparum, Plasmodium vivax and 
Plasmodium malariae sporozoite proteins. All mosquitoes were identified to species by 
morphology and/or PCR. Based on distribution, abundance and their ability to develop 
sporozoites, we identified 5 species as major vectors of malaria in PNG these included: 
Anopheles farauti s.s, Anopheles hinesorum (incriminated here for the first time), Anopheles 
farauti 4, Anopheles koliensis and Anopheles punctulatus. Anopheles longirostris and 
Anopheles bancroftii were also incriminated in this study. Surprisingly, An. longirostris 
showed a high incidence of infections in some areas. A newly identified taxon within the 
Punctulatus Group, tentatively called An. farauti 8, was also found positive for sporozoite 
protein. These latter three species, along with Anopheles karwari and Anopheles subpictus, 
incriminated in other studies, appear to be only minor vectors, while Anopheles farauti 6 
appears to be the major vector in the highland river valleys (>1500m). The 9 remaining 
Anopheles species found in PNG have been little studied and their bionomics are unknown;  
most appear to be uncommon with limited distribution and their possible role in malaria 
transmission has yet to be determined.  
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4.2 Introduction 
 
Identification of malaria vectors and their role in transmission is a prerequisite to establishing 
why areas are malarious and how transmission can be interrupted (Pampana, 1969). The 
recent advent of molecular biology and polymerase chain reaction (PCR) has enabled 
species identification issues associated with isomorphic species complexes to be resolved 
and now entomological parameters can be reliably ascribed to accurately identified 
specimens. 
 
In Papua New Guinea (PNG) the members of the Punctulatus Group, which originally 
included Anopheles farauti s.s., Anopheles koliensis and Anopheles punctulatus, have until 
recently been considered the major vectors of malaria and were regularly found infected with 
sporozoites (Peters and Standfast, 1960; Burkot et al., 1987). With the application of 
allozyme electrophoresis, DNA hybridisation and PCR identification techniques this group, 
which includes the Farauti Complex, is now known to consist of 11 species in PNG (Foley et 
al., 1993; Cooper et al., 2002; Bower et al., 2008), of these An. punctulatus, An. koliensis, 
An. farauti s.s., An. farauti 4 have been incriminated as vectors (Cooper and Frances 2002;  
Benet et al., 2004) based on spatially limited studies from one or two localities. Outside of the 
Punctulatus Group four species have been incriminated: Anopheles karwari, Anopheles 
subpictus, Anopheles bancroftii and Anopheles longirostris (Afifi et al., 1980; Hii et al., 2000). 
Thus of the 20 species currently recognised in PNG, eight have been found to harbour 
sporozoites, the other 12 have been little studied or received scant attention either because 
they are uncommon species with limited distributions or they appear to have little or no 
association with humans. 
 
Much of the recent work on the identification of malaria vectors in PNG has been restricted to 
the Maprik and Madang regions on the north coast of PNG (Afifi et al., 1980; Burkot et al., 
1987; Hii et al., 2000; Benet et al., 2004). During the 1990’s a series of surveys were 
conducted to identify the anophelines and to map their distribution throughout PNG (Cooper 
and Frances, 2002; Cooper et al., 2002; Cooper et al., 2006). These surveys resulted in 
collections being made from 793 localities across PNG and constitute the most extensive 
and comprehensive distribution study on anophelines in that country.  Using species-specific 
genomic DNA probes (Cooper et al., 1991; Beebe et al., 1994, 1996) and a complementary 
PCR diagnostic technique (Beebe and Saul, 1995) these surveys have now established the 
range of the anopheline fauna throughout PNG. Specimens collected in these surveys were 
processed by enzyme-linked immunosorbent assay to identify the vector species across their 
entire range, the results of this study are reported here.  
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4.3 Material and methods 
 
Surveys were made throughout the main island of PNG, the climate and topography of which 
is described in Cooper et al. (2002). From the original 793 collection sites (Cooper et al., 
2002, 2006) only those where adult collections were made within 500 m of human habitation 
were used in this study. This represented 232 trap nights using CO2 baited light traps (Rohe 
and Fall 1979) and by 26 human landing collections (in most cases from 1900 to 2200 h) as 
described in Cooper et al. (2002, 2006). In the field, specimens were initially identified by 
morphology and then preserved either in liquid nitrogen or desiccated on silica gel. In the 
laboratory the head and thorax were removed from all specimens belonging to the 
Punctulatus Group and this material was assayed for sporozoite protein, the abdomens were 
used for species identification. This was done using polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP) analysis of the internal transcribed spacer region 
2 (ITS2) of the ribosomal DNA using the methods and primers of Beebe and Saul (1995), 
while Msp1 digestion of the ITS1 resolved An. farauti 8 from An. farauti s.s..  
 
The enzyme-linked immunosorbent assays (ELISA) were performed using monoclonal 
antibodies to detect circumsporozoite protein of Plasmodium falciparum, Plasmodium vivax 
210 (and 247 variant) and Plasmodium malariae and the methods of Wirtz et al. (1987). 
Sporozoite positive specimens were scored as those with absorption values greater than 
twice the mean (n=5) negative control value (Beier et al., 1988). For species other than the 
Punctulatus Group the whole specimen was used in the ELISA. 
 
4.4 Results 
 
Collections were made from 258 locations throughout PNG (Fig 1), from these 22,970 
specimens were collected and processed by ELISA for sporozoites. Eleven species were 
identified from this material including 9,962 An. farauti s.s., 1,189 An. hinesorum (formerly 
An. farauti 2), 3 An. torresiensis (formerly An. farauti 3), 1,535 An. farauti 4, 245 An. 
punctulatus and 8,600 An. koliensis, all specimens were individually identified by PCR. 
Additionally, 793 An. longirostris, 476 An. bancroftii, 116 An. subpictus and 13 An. karwari 
were identified by morphology. All species were found positive for sporozoites except for An. 
torresiensis, An. subpictus and An. karwari (Table 1).  
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Anopheles punctulatus is under reported in this study, this species is not readily attracted to 
CO2 baited traps which was the main collection method used to sample anopheline 
populations.     
 
 
Fig. 1 Map of Papua New Guinea indicating sites where anophelines were collected (closed 
circles) and sites where anophelines positive for sporozoite protein were found (open 
circles). The numbers associated with open circles correspond to those in Table 1.  
.  
 
An additional species within the Farauti Complex has recently been recognised and 
tentatively named An. farauti 8 (Bower et al., 2008). This species displays the same ITS2 
PCR-RFLP as An. farauti s.s., but occurs inland while An. farauti s.s. is restricted to the 
coast. The two species can be separated using the ITS1 region and the digest enzyme 
Msp1. Two specimens of An. farauti s.l. positive for P. falciparum sporozoites were collected 
>50 km inland and upon re-examination were found to be An. farauti 8.   
 
From a number of collection sites a high incidence of infections were reported in An. 
longirostris;  this species is considered a minor vector at best, to confirm that the results were 
correct and not due to contamination all samples were rerun with the same results being 
recorded.    
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Table 1: Number of sporozoites found per species  
 
Species No. Pf Pv Pm 
Mixed
Pf/Pv Total % 
No. Sites 
Sampled  
 No. 
Sites 
pos Site no. from Fig. 1 
An. farauti s.s. 9692 9 23 7 0 39 0.40 110 11 
3,5,6,8,9, 12,15,17, 
33,39,47 
An. farauti 2 1,189 6 3 1 0 10 0.84 61 8 
1,2,4,10, 
14,20,25,26 
An. farauti 3 3 0 0 0 0 0 0 1 0  
An. farauti 4 1,535 12 3 0 0 15 0.98 46 4 27,40,41,42 
An. farauti 8 308 2 0 0 0 2 0.65 6 2 11, 13 
An punctulatus 245 0 2 0 1 3 1.22 10 2 19, 46 
An. koliensis 8,600 13 22 2 3 40 0.46 123 16 
7,10,11,16,18,21,28,29, 
30,31,32,35,36,37,38,45 
An. longirostris 793 69 1 0 0 70 8.83 21 8 1,21,22,23,24,25,44,43 
An. bancroftii 476 1 0 0 0 1 0.21 8 1 34 
An. subpictus 116 0 0 0 0 0 0 9 0  
An. karwari 13 0 0 0 0 0 0 2 0  
Totals 22,966 112 54 10 4 180 0.78 391 52  
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4.5 Discussion 
 
Historically An. farauti s.l., An. koliensis and An. punctulatus (the original members of the 
Punctulatus Group) have been considered the major vectors of malaria in PNG due to their 
wide distribution, ability to occur in high densities, association with humans and their ability to 
develop human malaria parasites. Accordingly these species have received the most 
attention when implementing and evaluating control strategies. 
 
However issues with the reliability of the morphological characters used to separate these 
three species and the recognition of additional isomorphic species within this group 
questions the vectorial status of these species. To overcome these problems in this study all 
specimens belonging to the Punctulatus Group were individually identified either by DNA 
hybridisation or by PCR. As a consequence An. punctulatus and An. koliensis were 
confirmed as major vectors of malaria in PNG due to their ability to develop the parasite, their 
wide spread distribution and their abundance.  
 
Within the Farauti Complex seven species are now recognised as occurring in PNG (Cooper 
et al., 2002; Bower et al., 2008). Within this complex three species have now emerged which 
are of considerable importance with regards to malaria transmission - Anopheles farauti s.s., 
An. hinesorum and An. farauti 4. Anopheles farauti s.s was found here to be the major 
coastal vector throughout PNG supporting earlier findings of Cooper and Frances (2002) 
from Buka and Bougainville Islands and Benet et al. (2004) from Madang. Anopheles 
hinesorum is widely distributed throughout PNG (Cooper et al., 2002) and here for the first 
time has been incriminated as a vector in a number of locations throughout its range. 
Anopheles farauti 4 is common throughout the northern part of the country, it has recently 
been incriminated as a vector in the Madang region (Benet et al., 2004), and here we confirm 
the vectorial status of this species in other parts of its range (Fig. 1 sites 27, 40, 41 and 42). 
Anopheles farauti 4 presents a particular problem where its distribution overlaps with An. 
hinesorum and An. koliensis as it shares morphological markers with both these species, 
markers that were previously considered diagnostically important (Cooper et al., 2002).   
 
A fourth species, An. farauti 8, has recently been recognised within the Farauti Complex 
(Bower et al., 2008), in the present study it was also found to be a vector of malaria 
parasites. This species appears to have a limited distribution occurring inland on the eastern 
edge of the Gulf of Papua (Fig. 1 sites 11 and 13) however within this range it was common 
and it may play an important role in malaria transmission locally within this region. 
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Four species outside of the Punctulatus Group have also been incriminated as malaria 
vectors in PNG: An. subpictus, An. karwari, An. bancroftii and An. longirostris.  
 
Anopheles longirostris has been little studied; a preference for particular breeding sites 
appears to limit its association with humans resulting in mixed reports of its affinity for human 
blood. Metselaar (1957), van den Assem and van Dijk (1958), Peters and Christian (1960) 
and Cooper et al. (2006) reported it biting humans while Lee and Woodhill (1944) and 
Charlwood et al. (1985) indicated that it was primarily zoophilic. Mackerras and Roberts 
(1947) found that An. longirostris were reluctant to feed on malaria infected patients and of 
those that fed none developed P. vivax though one developed P. falciparum. Burkot et al. 
(1988), working in the Madang area, processed 3,000 An. longirostris for sporozoite protein 
and found none positive, though sporozoite protein was regularly found in specimens of An. 
farauti s.l., An. koliensis and An. punctulatus collected at the same time and from the same 
area.  Anopheles longirostris was reported as sporozoite positive by van den Assem and van 
Dijk (1958) with no further reports until the early 1990s when Hii et al. (2000) found five 
positive specimens in a sample of 2,265 collected over a three year period in the Maprik 
area. In the present study infected An. longirostris were collected from 8 of its 20 collection 
sites; five closely related sites in the Madang area (sites 21 – 25) had very high numbers of 
infected specimens- site 21: 5 of 82, site 22: 8 of 111, site 23: 8 of 164, site 24: 37 of 197 
and site 25: 4 of 146, the majority of infections were P. falciparum (61) with one P. vivax. At 
three sites An. longirostris was the dominant species collected while at the other two sites 
(21 and 25) appreciable numbers of other species were collected and infections were also 
found in 5 of 312 An. koliensis at site 21 and 3 of 94 An. hinesorum at site 25. Collections at 
sites 22 and 23 were made by human landing catches while those from sites 21, 24 and 25 
were by CO2 baited light traps; all collections were made at the end of the wet season in May 
1995. Malaria transmission is intense in the Madang area with parasites rates of 37.5 – 
42.5% for all ages and 53.6 - 56.7% in the 1-9 yr age group, P. falciparum makes up 70-76% 
of infections and a high proportion of cases are asymptomatic (Cattani et al., 1986). Such 
transmission parameters may support the high incidence of sporozoite positive mosquitoes, 
but why such high infection levels should occur in a rather obscure species such as An. 
longirostris and not in one of the main vector species which also can occur in the area is 
unclear; it is possibly that climatic factors at the time of these surveys created favourable 
breeding conditions for An. longirostris at the expense of other anopheline species. Somboon 
et al. (1993) reported a factor in the blood of some bovine (25%, 4/16 tested) and pigs (8.3%, 
1/12 tested) that cross reacted with the P. falciparum monoclonal antibody resulting in false 
positives. Cattle are rare in the Madang area though pigs were quite common around the 
villages where the An. longirostris collections were made. However as none of the collections 
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were made directly off pigs but were made either by human landing catches or by CO2 baited 
light traps which attract unfed, host seeking mosquitoes, it is unlikely that the phenomenon 
reported by Somboon et al. (1993) could be responsible for the high incidence of infections 
recorded here. The findings here indicate that under certain climatic conditions An. 
longirostris may be an important local vector.        
 
Anopheles bancroftii has a wide distribution throughout PNG but does not appear to be 
abundant anywhere within its range, it appears to be an indifferent feeder on humans and 
has rarely been collected biting humans in large numbers.  It has been incriminated as a 
vector of malaria parasites by de Rook in 1929 (Lee et al., 1987), Metselaar (1957) in Papua 
Province on Indonesian side of New Guinea and in PNG by Hii et al. (2000), and in this 
study.  
 
Anopheles subpictus is an Southeast Asian immigrant, it has been collected from a number 
of locations in PNG (Cooper et al., 2006) but is only common along the coast from Port 
Moresby west around the Gulf of Papua, and from within this region it has been incriminated 
as a vector on two occasions (Bang et al., 1947; Afifi et al., 1980). From collections made in 
the Madang area 754 Anopheles subpictus were dissected for sporozoites but all were 
negative although in the same collections sporozoite positive specimens of An. farauti s.l., 
An. koliensis and An. punctulatus were found (Afifi et al., 1980). Anopheles subpictus is a 
species complex consisting of four species (Suguna et al., 1994) one of which is a 
recognised vector of malaria in parts of coastal Southeast Asia. The specific identity of the 
PNG material in relation to other members of the complex is unknown. In this study only a 
small number were collected for analysis and none were found sporozoite positive.  
Anopheles karwari, like An. subpictus, is a Southeast Asian introduction, and its present 
distribution is restricted to the north of PNG. Metselaar (1955) first incriminated it as a vector 
in Papua Province, Indonesia where he observed a sporozoite rate of 3.1%. In PNG it was 
first recorded as a vector of malaria by Afifi et al. (1980) but at the time was misidentified as 
An. subpictus. Hii et al. (2000) found it common in the Maprik area and recorded 14 
sporozoite positive specimens in a collection of 13,134 anophelines made by human landing 
and light trap catches over a three year period. Very few specimens were collected in this 
present survey and none were positive for sporozoites.  
 
Anopheles subpictus, An. karwari, An. bancroftii and An. longirostris because of their loose 
association with humans, their limited and patchy distribution and their normally low 
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abundance can only be considered as minor vectors of malaria. They may at times have 
some local importance under the right climatic and ecological conditions.     
 
Of the remaining ten Anopheles species found in PNG very little is known about their 
bionomics and their potential to transmit malaria. Species such as An. clowi, An. papuensis 
and An. farauti 5 appear to be quite rare with limited distributions and are unlikely to be 
involved in malaria transmission. Anopheles sp near punctulatus is an uncommon species 
that so far has only been found in a few remote areas of PNG; An. annulipes s.l., both the 
coastal and highlands populations, are zoophilic species; An. torresiensis, An. meraukensis, 
An. novaguinensis and An. hilli are all restricted to the southern plains of Western Province, 
a vast, sparsely populated region where few malaria vector studies have been performed. 
None of these species have been studied in any detail but owing to the fact that they appear 
to be uncommon with limited distribution their role, if any, in malaria transmission would be at 
a local level. 
  
Anopheles farauti 6, the large farauti of Lee (1946), is found exclusively in the highland river 
valleys of New Guinea (>1500m) (Cooper et al., 2002). It was studied by Peters and 
Christian (1960) who noted that it was the most common Anopheles species biting humans 
in the Waghi Valley where they recorded a sporozoite rate of up to 2.2 % in this species. 
Anopheles farauti 6, confirmed by PCR-RFLP, was the most common anopheline biting 
humans in the Baliem Valley, a similar highland valley in Papua Province, Indonesia (Cooper 
et al., 2002). Malaria is unstable in these highland river valleys with low levels of 
transmission and periodic epidemics (Bangs et al., 1999; Mueller et al., 2005). Anopheles 
farauti 6 is the only member of the farauti complex commonly found at these altitudes and is 
most likely an important malaria vector within its restricted range. 
 
This study if anything highlights the lack of knowledge with regards to the bionomics of the 
anophelines of PNG and their role in malaria transmission. Table 2 presents an overview of 
the currently recognised species and their vectorial status which with some species is based 
on very limited information. As indicated a number of species - An. torresiensis, An. 
meraukensis, An. novaguinensis, An. sp. nr. punctulatus and An. hilli  - have been too 
inadequately studied. Their limited distribution is partly responsible for this, however even in 
their restricted areas they may have the potential to occur in large numbers and may play an 
important, if local, role in malaria transmission. The findings in this study with regards to An. 
longirostris highlight the role that even a rather uncommon and obscure species can play in 
malaria transmission. 
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Table 2: Vectorial status of the currently known Anopheles species in Papua New Guinea. 
Species 
 
Vectorial 
Status 
Distribution/ 
Abundance 
Comments Reference 
    An. koliensis major widespread / common established vector 
three genotypes possible vectorial differences 
Hii et al. 2000, Benet et al. 2004, this  
paper 
    An. punctulatus major widespread / common established vector 
 
Hii et al. 2000, Benet et al. 2004, this  
paper 
     An. farauti s.s.  major widespread /common 
coastally 
established vector 
 
Cooper and Frances 2002, 
Benet et al. 2004, this paper 
    An. hinesorum major widespread / common several genotypes, zoophilic on Buka and 
Bougainville Is. PNG 
Cooper and Frances 2002, this paper  
    An. farauti 4 major limited / common common throughout northern PNG only Benet et al. 2004, this paper  
    An. longirostris minor wide spread / uncommon possible species complex Hii et al. 2000, this  paper 
    An. farauti 8 minor limited / uncommon recently discovered, species not studied   Bower et al. 2008, this paper 
    An. bancroftii minor widespread / uncommon possible species complex, with varying host 
preferences 
De Rook 1929, Hii et al. 2000, this 
paper 
    An. farauti 6  minor limited / common in the 
highlands (>1500m)  
the large farauti of Lee 1946,   incriminated on 
circumstantial evidence 
Peters and Christian 1960 
    An. subpictus s.l.  minor limited / uncommon  species complex – PNG species unknown Bang et al. 1947, Afifi et al. 1980 
    An. karwari minor limited / uncommon   previously misidentified as An. subpictus  Metselaar 1955, Afifi et al. 1980, Hii et 
al. 2000 
    An. meraukensis none limited / uncommon species not studied – potential unknown 
experimentally infected in Australia 
Mackerras and Roberts 1947 
    An. novaguinensis none limited / uncommon species not studied – potential unknown  
    An. torresiensis none limited / uncommon species not studied – potential unknown  
    An. sp. nr. 
    punctulatus                                                   
none limited / uncommon species not studied – potential unknown  
   An. hilli none limited / uncommon vector in Cairns, Australia; in PNG  
 species not studied – potential unknown 
Roberts and O’Sullivan 1948 
    An. annulipes s.l.                    none limited / uncommon  two genotypes in PNG both zoophilic 
experimentally infected in Australia 
Mackerras and Roberts 1947 
    An. farauti 5 none limited / rare species not studied  
    An. clowi none limited / rare species not studied  
    An. papuensis none limited / rare species not studied  
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Further, the use of PCR is now the standard for verifying species identification and thus the 
species role in malaria transmission, but this technology is also raising new issues. 
Anopheles farauti 8, a recently discovered species based on molecular evidence, is here 
incriminated as a vector of malaria in PNG but as yet nothing is know of its behaviour or its 
distribution in PNG. The An. koliensis taxon is now known to contain three independently 
evolving rDNA genotypes suggesting the presence of three cryptic species (Benet et al., 
2004; NW Beebe unpublished data) which differ in biting behaviour, a character important in 
determining control strategies. Anopheles longirostris and An. bancroftii also appear to be 
complexes of independently evolving rDNA genotypes, indicating the presence of several 
cryptic species (Beebe et al., 2001; NW Beebe unpublished data). Anopheles hinesorum, 
incriminated for the first time in this study, is a complex of several rDNA genotypes, the 
members of two of these genotypes appear not to feed on humans (Cooper and Frances 
2002;  NW Beebe unpublished data). Until we fully understand the bionomics of the extant 
and newly emerging species and genotypes we will never have a complete understanding 
how malaria is transmitted in PNG nor how it can be controlled or eliminated. 
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5.1 Abstract 
 
Background  
Primary malaria prevention on a large scale is essentially achieved through two main vector 
control interventions: indoor residual spraying (IRS) and insecticide-treated mosquito nets 
(ITNs). Up to now the effectiveness of IRS in reducing ill-health has never been properly 
quantified. 
Objectives  
To quantify the impact of IRS alone, and to compare the relative impacts of IRS and ITNs, on 
key malariological parameters. 
Search methods  
We searched the Cochrane Infectious Diseases Group Specialized Register (November 
2008), CENTRAL (The Cochrane Library 2008, Issue 4), MEDLINE (1966 to November 
2008), EMBASE (1974 to November 2008), LILACS (1982 to November 2008), mRCT 
(November 2008), reference lists, and conference abstracts. We also contacted researchers 
in the field, organizations, and manufacturers of insecticides (June 2007). 
Selection criteria  
Cluster randomised controlled trials (RCTs), controlled before-and-after studies (CBA) and 
interrupted time series (ITS) of IRS compared to no IRS or ITNs. Trials including studies 
examining the impact of IRS on special groups not representative of the general population, 
or using insecticides and dosages not recommended by the World Health Organisation 
(WHO) were excluded. 
Data collection and analysis  
Two authors independently reviewed trials for inclusion. One author extracted data, 
assessed methodological quality and analysed the data. Where possible, we adjusted the 
confidence intervals (CIs) for the clustering effect. 
Results  
Four RCTs, one CBA and one ITS met the inclusion criteria. Two of the four RCTs used 
adequate methods to generate allocation sequence and concealment. In unstable malaria 
settings, IRS significantly reduced the incidence rate of malaria infections with the protective 
efficacy ranging from 24% to 86%. No clear evidence was seen in reducing prevalence. 
Contradicting results were found assessing IRS versus ITNs in protecting against malaria 
incidence rates. Only one included trial measured the impact of IRS on incidence and 
prevalence in a stable malaria setting. For children under five, IRS was more effective than 
ITNs or no IRS in reducing incidence. Comparing IRS vs no IRS or vs ITNs, there was no 
difference in the prevalence rates (RR 1.01, 95% CI 0.84 to 1.22; 555 participants, 1 trial). 
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Authors' conclusions  
The number of high-quality trials is too low to provide solid evidence. IRS seems effective in 
reducing malaria incidence in unstable malaria settings. For stable malaria settings no 
conclusion about impact can be derived. There is an urgent need for more high-quality 
comparative trials between ITNs and IRS, as well as to quantify their combined effects. 
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5.2 Background  
There were an estimated 247 million malaria cases among 3.3 billion people at risk in 2006, 
causing nearly a million deaths, mostly of children under 5 years. 109 countries were 
endemic for malaria in 2008, 45 within the WHO African region (WHO 2008). Ninety per cent 
of all malaria cases occur in sub-Saharan Africa, in areas of stable endemic transmission, 
and around 20% of all deaths in children have been attributed directly to malaria (Snow 
1999). The disease causes widespread premature death and suffering, imposes financial 
hardship on poor households, and holds back economic growth and improvements in living 
standards. The rapid spread of resistance first to chloroquine and now to sulfadoxine-
pyrimethamine has greatly increased the cost and difficulty of malaria case management, 
particularly in Africa (RBM 2005). Estimates have suggested that malaria costs the African 
countries US$12 billion annually and may considerably retard economic development (Sachs 
2002). 
Primary prevention of malaria is essentially achieved through two main vector control 
interventions: indoor (house) residual insecticide spraying (IRS); and insecticide-treated 
(mosquito) nets (ITNs). The health effects of ITNs have been comprehensively summarized 
in two Cochrane Reviews, one for general populations (Lengeler 2004) and one for pregnant 
women (Gamble 2006). 
IRS has a long and distinguished history in malaria control. Using mainly dichloro-diphenyl-
trichlorethane (DDT), malaria was eliminated or greatly reduced as a public health problem in 
Asia, Russia, Europe, and Latin America (Schiff 2002; Lengeler 2003; Roberts 2004). IRS 
continues to be used in many parts of the world, with the services provided by the public 
health system or by a commercial company (usually for the benefit of its employees). There 
is no IRS programme known to us in which beneficiaries were expected to contribute 
financially. 
A historical review of IRS in Southern Africa investigated the malaria situation before and 
after the introduction of IRS in South Africa, Swaziland, Namibia, Zimbabwe, and 
Mozambique, where it continues to protect 13 million people (Mabaso 2004). Immediately 
after the implementation of control operations, spectacular reductions in malaria parameters 
and vector densities were recorded, and in certain instances the intervention led to local 
elimination. Another historical paper reviewed the health impacts of 36 successful IRS 
programmes in 19 countries throughout sub-Saharan Africa (Kouznetsov 1977). The 
analyses compared parasite rates and other malariological outcomes before and after the 
operation in each of the five major eco-epidemiological zones and demonstrated substantial 
epidemiological benefits. Unfortunately, most of these studies simply documented time 
trends of malaria parameters. This is also the case for the most recent programme impact 
assessments (Sharp 2002; Tseng 2008; Teklehaimanot 2009). 
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IRS operates both through repelling mosquitoes from entering houses and by killing female 
mosquitoes that are resting inside houses after having taken a blood meal. This implies that 
IRS is most effective against mosquito species that are resting indoors (so called endophilic 
mosquitoes). Spraying needs to be carried out between once and three times per year; the 
timing depending on the insecticide and the seasonality of transmission in a given setting. 
Reviewing the advantages and disadvantages of each insecticide is beyond the scope of this 
review and can be found in Najera (2001). 
 
IRS has the advantage of being able to make use of a much wider range of insecticide 
products in comparison to ITNs, for which pyrethroids are the only class of insecticide 
currently used. The World Health Organization (WHO) recommends a number of insecticides 
for individual residual spraying: DDT wettable powder (WP); malathion WP; fenitrothion WP;  
pirimiphos-methyl WP and emulsifiable concentrate (EC); bendiocarb WP;  propoxur WP;  
alpha-cypermethrin WP & SC; cyfluthrin WP; deltamethrin WP; etofenprox WP; and lambda-
cyhalothrin WP (WHOPES 2007). This extended range of insecticides has important benefits 
for the management of insecticide resistance and hence the long-term sustainability of vector 
control (pyrethroid resistance has already been reported in many parts of tropical Africa and 
other parts of the world among populations of the major malaria vectors). The potentially 
adverse effects of insecticides used for IRS, especially DDT, is an important issue but one 
that is beyond the scope of this review. 
 
Insecticide spraying is often done at very large scale, and thus randomised controlled trial 
designs may not always be feasible. However, controlled before-and-after studies are clearly 
feasible, as are interrupted time series. We plan to include these three study designs while 
excluding simple pre-test and post-test studies with no concurrent controls, as the many 
potential biases make interpretation a problem. In order to take into account the differences 
of design, the primary analyses will be stratified by study design. In all identified studies the 
allocation is expected to be by clusters rather than by individuals, since IRS is only effective 
if a large proportion of the population is protected. 
 
Two reviews have outlined the cost and health effects of IRS (Curtis 2001; Lengeler 2003) 
including a comparison of IRS against ITNs, but neither was conducted systematically or 
assessed the methodological quality of the included studies. Yukich et al. (2008) presented 
standardized cost and cost-effectiveness assessments for the major ITN distribution models 
as well as for two IRS programmes in Southern Africa. Here we aim to quantify the health 
benefits of IRS and to compare how IRS and ITNs in their ability to prevent ill-health from 
malaria. 
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5.3 Objectives  
To quantify the impact of IRS alone, and to compare the relative impacts of IRS and ITNs, on 
key malariological parameters. 
5.4 Methods  
 
5.4.1 Criteria for considering studies for this review  
 
Types of studies  
 
1. RCTs and quasi-RCTs, randomised by cluster (cluster RCTs) and with three or more 
units per arm; because of the mode of action of IRS we did not expect to find trials with 
individual randomisation. 
2. Controlled before-and-after studies with (1) two or more units per arm, (2) a 
contemporaneous control group, (3) monitoring of at least one transmission season before 
and after the intervention and (4) at least 60% coverage in the intervention arm. 
3. Interrupted time series, with (1) a clearly defined point in time when the intervention 
occurred, (2) monitoring of at least two transmission seasons before and after the 
intervention and (3) at least 60% coverage in the intervention arm.  
 
Types of participants  
Children and adults living in rural and urban malarious areas. 
Excluded: studies examining the impact of IRS on soldiers, refugees, industrial workers and 
other special groups not representative of the general population. 
 
Types of interventions  
 
Interventions 
IRS carried out with insecticides recommended by the World Health Organization at the 
correct dosage (WHO 2006;  WHOPES 2007). Selected insecticides should not have been 
used where site-specific insecticide resistance has been reported by the authors or in other 
available literature. To this effect, we searched for publications on insecticide resistance for 
each included trial site. 
For the comparison with ITNs, we used the same inclusion criteria as in Lengeler 2004: 
mosquito nets treated with a synthetic pyrethroid insecticide at a minimum target dose of: 
200 mg/m2 for permethrin and etofenprox;  30 mg/m2 for cyfluthrin;  20 mg/m2 for 
alphacypermethrin;  and 10 mg/m2 for deltamethrin and lambdacyhalothrin. 
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Controls 
• Should not have received another insecticide-based malaria intervention. 
• Should not have received a malaria-co-intervention(s) that differed from the intervention 
arm. 
• ITNs only for the comparison IRS versus ITNs. For this comparison we made a difference 
between situations in which ITNs were distributed to a population previously protected by 
IRS (which was obviously stopped for the time of the study) from situations in which the 
distribution of ITNs represents the first vector control intervention. 
Types of outcome measures  
Child (< 10 years) mortality from all causes as determined by a prospective demographic 
surveillance system. Severe disease: site-specific definitions, based on the WHO guidelines 
(WHO 2000). The definition includes demonstration of parasitaemia. Cerebral malaria is 
defined as coma or prostration and/or multiple seizures. The cut-off for severe, life-
threatening anaemia is set at 5.1 g/L. Uncomplicated clinical malaria episodes: measured 
using site-specific definitions, including measured or reported fever, with or without 
parasitological confirmation - as long as the case definition was similar in all trial arms. 
Results from both passive and active case detection were considered. Parasite prevalence: 
obtained using site-specific method for estimating parasitaemia, usually thick and/or thin 
blood smears. In the case of repeated cross-sectional surveys, we used the mean of all the 
measures and adapted the denominator to be equal to the average sample size of the 
surveys (to avoid inflating artificially the denominator with repeated surveys of the same 
individuals). High density malaria prevalence: same as for parasite prevalence but with a 
site-specific parasitological cut-off. Anaemia: haemoglobin levels measured in g/dL. Standard 
anthropometric measures: weight-for-age, height-for-age, weight-for-height, skinfold 
thickness, and/or mid-upper arm circumference. Splenomegaly: measured using Hackett's 
scale from 1 to 5. 
 
5.4.2 Search methods for identification of studies  
We attempted to identify all relevant studies regardless of language or publication status 
(published, unpublished, in press, and in progress). For details see Table 1. 
 
Databases 
On 28 November 2008 we searched the following databases using the search terms and 
strategy described in Table 1: Cochrane Infectious Diseases Group Specialized Register; 
Cochrane Central Register of Controlled Trials (CENTRAL) as published in The Cochrane 
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Library; MEDLINE; EMBASE; and LILACS. We also searched the metaRegister of Controlled 
Trials (mRCT) using 'insecticide$' and 'malaria' as search terms. 
 
Table 1: Detailed search strategy 
Search 
set 
CIDG 
SR^/LILACS^^ CENTRAL/MEDLINE^^ EMBASE^^ LILACS^^ 
1 malaria malaria malaria malaria 
2 insecticide* insecticide* insecticide* insecticide* 
3 indoor residual 
spray* indoor residual spray* 
indoor 
residual 
spray* 
indoor 
residual 
spray* 
4 IRS house spray* IRS IRS 
5 house spray* IRS house ADJ 
spray$ 
house 
spray* 
6 2 or 3 or 4 or 5 MOSQUITO CONTROL/INSTUMENTATION/METHODS 
VECTOR 
CONTROL 
2 or 3 or 4 
or 5 
7 1 and 6 INSECTICIDES/THERAPEUTIC USE INSECTICIDE 1 and 6 
8  PYRETHRINS/ADMINISTRATION AND DOSAGE 2-7/OR  
9  2-8/OR 1 and 8  
10  1 and 9   
^Cochrane Infectious Diseases Group Specialized Register ^^Upper case: MeSH or EMTREE 
heading;  Lower case: free text term 
 
Agencies and manufacturers 
We contacted the following agencies, which have funded malaria control studies, for 
unpublished and ongoing trials: World Bank; Rockefeller Foundation; UNICEF; World Health 
Organization; PAHO; and USAID. We also contacted the following manufacturers of 
insecticides: Bayer; BASF; Sumitomo; and Syngenta (June-July 2007). In June 2007 we also 
searched the US Armed Forces Pest Management Board web site for relevant trials, as well 
as all other sources that we identified in the process of the search. 
 
Reference lists 
We checked the reference lists of all studies identified by the above methods. 
 
5.4.3 Data collection and analysis  
 
Study selection 
BP screened the results of the search strategy for potentially relevant studies and retrieved 
full articles. BP and FT independently assessed all identified studies for inclusion in the 
review, using an eligibility form based on the inclusion criteria. We scrutinized each report to 
avoid study duplication. We attempted to contact the study authors for clarification if it was 
unclear whether a study met the inclusion criteria or if there were issues with the study 
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design. CL was asked to resolve any differences in opinion. We explain below the reasons 
for excluding studies ("Characteristics of excluded studies"). 
 
5.4.4 Assessment of methodological quality 
BP/FT and CL independently evaluated the methodological quality of each included study. 
We attempted to contact the study authors if key information was missing or unclear, and 
resolved any disagreements through discussion. 
 
RCTs and quasi-RCTs 
BP assessed the risk of bias of each included trial using the Cochrane Collaboration's risk of 
bias tool (Higgins 2008). We followed the guidance tool to make judgements on the risk of 
bias in six domains: sequence generation; allocation concealment; blinding (of participants, 
personnel, and outcome assessors); incomplete outcome data; selective outcome reporting; 
and other sources of bias. We categorized these judgements as 'yes' (low risk of bias), 'no' 
(high risk of bias), or 'unclear'. 
Controlled before-and-after studies 
We followed a strategy published elsewhere (Adinarayanan 2007); BP and FT independently 
assessed the quality of the included CBA study using a variety of criteria that we considered 
important and had specified a priori. These included: high intervention coverage in the 
community of interest (defined as at least 60% IRS coverage), presence of some type of 
comparison group with no intervention, reporting of outcomes for the entire community. We 
also attempted to identify concurrent control activities carried out at the same time or just 
before the IRS intervention by screening the primary study report and other relevant 
literature. 
Interrupted time series 
We used the criteria published elsewhere (EPOC 2002) to assess the study quality of the 
one included study. Criteria included protection against secular changes, sufficient data 
points to enable reliable statistical inference, protection against detection bias, and 
completeness of the data set. We also attempted to identify concurrent control activities 
carried out at the same time or just before the IRS intervention by screening the primary 
study report and other relevant literature. 
 
5.4.5 Data extraction 
BP independently extracted the data from each study into standardized data extraction 
forms. Again, we attempted to contact the corresponding author in any case of unclear or 
missing data. 
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RCTs and quasi-RCTs 
We extracted data according to the intention-to-treat principle: if any individuals allocated to a 
treatment group was analysed as if the person had effectively received the intervention. If 
there was discrepancy between the number of units/participants randomised and the number 
of units/participants analysed we calculated the percentage losses to follow-up in each group 
and reported this information. In trials that compared ITNs with IRS, we assessed the 
differences in coverage between the different groups and presented this information in a 
table. 
Cluster RCTs: Where results have been adjusted for clustering, we extracted the point 
estimate and the 95% confidence interval. If the results were not adjusted for clustering, we 
extracted outcome data as for individual RCTs and corrected the data in the analysis (see 
5.4.6). We always recorded the number of clusters, the average size of clusters, and the unit 
of randomizations (eg household, village or other). The statistical methods used to analyse 
the trials are described below in section 5.4.6. 
 
Controlled before-and-after studies 
We extracted data using the same methods as for the RCTs, but we added information on 
the comparability of baseline characteristics and the time period of data collection. 
 
Interrupted time series 
We extracted data using the same methods as for the RCTs, but we added information on 
the comparability of baseline characteristics and additional information relating to the 
assessments made before and after the initiation of the intervention, using the approach 
recommended by EPOC 2002. 
 
5.4.6 Data analysis  
 
Individual and cluster RCTs 
We had planed to meta-analyse the data from RCTs and quasi-RCTs using Review Manager 
4.2 and to stratify the analyses according to whether the trial had an individual or cluster 
allocation. However, no stratification was necessary as all trials were cluster randomised 
trials. Results are presented with 95% confidence intervals. Only reports of RCTs that had 
adjusted for the cluster effect (or could be done post-hoc in this review) were included in the 
analysis. We presented a narrative or tabulated summary of data for the other study designs. 
Cluster RCTs with two or three arms and at least three clusters per arm were used for the 
comparisons of IRS versus no intervention or IRS versus ITNs. The two other study designs 
(CBA and ITS) were used only for the comparison of IRS versus no intervention. We did not 
plan to summarize trials with these alternative designs in a meta-analysis. 
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Cluster RCTs: These trials require a more a complex analysis than that for individual RCTs 
(Hayes 2000). Observations on participants in the same cluster tend to be correlated and 
that intra-cluster variation must be accounted for during the analysis. If this correlation is 
ignored in the analysis the measure of effect remains a valid estimate but the associated 
variance of the estimate would be underestimated, leading to unduly narrow confidence 
intervals. In a meta-analysis trials analysed without allowing for the design effect would 
receive too much weight. 
 
When the results have been adjusted for clustering, we combined the adjusted measures of 
effect in the analysis. For dichotomous outcomes expressed as risk the results can be 
adjusted for clustering by multiplying the standard errors of the estimates by the square root 
of the design effect, where the design effect is calculated as DEff=1+(m-1)*ICC. This 
requires information such as the average cluster size (m) and the intra-cluster correlation 
coefficient (ICC). Unfortunately, the ICC was not reported by trial authors. Therefore, we 
carried out a sensitivity analysis using a range of values for the ICC to determine if the 
conclusions of the analysis would change as the ICC increased (Table 2 and Table 3). 
 
Table 2: Impact of ICCa on confidence interval: IRS vs control in Curtis (1998)  
Prevalence of malaria infections (any species); children aged 1 to 6 years 
Study Risk ratio ICC 95% Confidence interval 
Curtis 1998 
(Tanzania) 0.92 0 0.83 to 1.01 
  0.01 0.83 to 1.02 
Footnotes 
a
 ICC: Intra-cluster correlation coefficient 
 
Table 3: Impact of ICCa on confidence interval: IRS vs control in Rowland (2000)  
Prevalence of P. falciparum, children aged 5 to 15 years 
Study Risk ratio ICC 95% Confidence interval 
Rowland 2000 (Pakistan) 0.09 0 0.09 to 0.09 
  0.01 0.08 to 0.10 
  0.2 0.06 to 0.14 
  0.3 0.06 to 0.16 
  0.4 0.05 to 0.17 
Prevalence of P. vivax, children aged 5 to 15 years 
Study Risk ratio ICC 95% Confidence interval 
Rowland 2000 
(Pakistan) 0.32 0 0.30 to 0.33 
  0.01 0.26 to 0.38 
  0.2 0.13 to 0.76 
  0.3 0.11 to 0.92 
  0.4 0.09 to 1.09 
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For dichotomous outcomes expressed as rates, we applied the methods described in 
(Bennett 2002) using a rate ratio calculated from the mean incidence rates for each 
treatment group. In the case of the study by Misra 1999 the authors used a geometric mean 
of the incidence rates and we applied the method described by Bennett 2002 using a rate 
ratio based on the geometric mean incidence rates for the outcomes "P. vivax and P. 
falciparum combined". 
 
Heterogeneity: With enough trials we would have assessed heterogeneity by (1) inspecting 
the forest plots to detect overlapping confidence intervals, (2) applying the chi-squared test 
with a P value of 0.10 indicating statistical significance, and (3) implementing the I2 test with 
a value of 50% denoting moderate levels of heterogeneity. However, the number of trials was 
so low that combining of trials was not possible. 
 
We stratified the presentation of the results into two groups on the basis of the entomological 
inoculation rate (EIR < 1 and = 1), as well as on the basis of the main types of vectors. 
Where possible the analyses were stratified by parasite species (P. falciparum and P. vivax). 
Finally, consideration was given to the fact that in some areas the vector control activities 
have gone on for many years before the reported study, while in some other situations the 
investigated study introduced the vector control activities. While we have at present no way 
to assess the effect of this difference, areas having had vector control for a long time are 
clearly different from areas with no previous activities in many different aspects 
(entomological and human health parameters). 
 
Sensitivity analysis: There weren't sufficient trials to conduct a sensitivity analysis to 
investigate the robustness of the results. 
 
Controlled before-and-after studies 
We analysed the study in the same manner as RCTs and presented the results in tables. 
 
Interrupted time series 
We analysed the study in the same manner as RCTs and presented the results in tables. 
 
Assessment of risk of bias in included studies  
see 5.4.4. 
 
 
 
 
 
5 – Cochrane review on Indoor Residual Spraying 
 
  74 
5.5 Results  
 
5.5.1 Results of the search  
 
We identified 132 potentially relevant studies. Of these we excluded 126 studies (for details 
of reasons see below and "Characteristics of excluded studies"). The remaining six studies 
met al l the inclusion criteria. These trials are described below (for details see also 
"Characteristics of included studies"). 
 
5.5.2 Included studies  
 
Trial design and location 
Out of the six included studies, four were RCTs (Curtis 1998;  Misra 1999;  Mnzava 2001;  
Rowland 2000), and in all the allocation was by cluster (by villages, geographical blocks and 
sectors comprising several villages). One study was a CBA (Molineaux 1980) and one was 
an ITS (Sharp 2007). 
Four trials were conducted in sub-Saharan Africa: Tanzania (Curtis 1998), South Africa 
(Mnzava 2001), Nigeria (Molineaux 1980) and Mozambique (Sharp 2007) and one was 
conducted in Pakistan (Rowland 2000) and one in India (Misra 1999). 
 
Participants 
The trials included either all ages (Misra 1999;  Mnzava 2001;  Molineaux 1980;  Sharp 2007 
for 1st year) or specific age groups (different groupings among children aged 1 to 15 
years)(Curtis 1998;  Rowland 2000;  Sharp 2007 for subsequent years).  
 
Intervention 
RCT: 
One trial compared the impact of IRS versus the provision of ITNs to all inhabitants (Mnzava 
2001). Two trials had three arms and compared the impact of IRS to the impact of ITN and to 
an untreated control zone (Curtis 1998;  Misra 1999). One trial studied the impact of IRS in 
comparison to a control area without any intervention (Rowland 2000). For IRS, all studies 
used pyrethroids as insecticide. Two of them used deltamethrin (dosage = 20 mg/m²), and 
the two others used lambdacyhalothrin (30mg/m²) and alphacypermethrin (25mg/m²). Since 
there is no evidence to suggest that there is any difference between these insecticides in 
terms of impact and hence they were grouped for analysis. Two trials didn't specifically report 
the spray coverage (Mnzava 2001;  Curtis 1998), for the other two (Misra 1999;  Rowland 
2000) it ranged from 92.2% to 96%. For treating ITNs, lambdacyhalothrin (10 mg/m² and 
20mg/m²), deltamethrin (25 mg/m²) and permethrin (200mg/m²) were used. Again, available 
evidence (Lengeler 2004) does not suggest any difference in impact between these three 
pyrethroids. Coverage rates with ITNs ranged in two trials from 85.4% to 100% (Misra 1999;  
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Mnzava 2001), while one trial didn't report coverage (Curtis 1998) but it was very high since 
nets were given for free to the whole population (Curtis C. personal communication). 
In one of the three trials comparing IRS with ITNs (Mnzava 2001) IRS was done in the ITN 
areas before these were distributed. In the study area in KwaZulu-Natal there is a long 
history of IRS (around 50 years). Within the study area, all the houses in the ITN arm were 
sprayed in September 1996 before distributing the ITNs in January 1997. In subsequent 
years, house spraying was deliberately withdrawn in blocks with bed nets. In India (Misra 
1999) there was a similar situation because of the long history of IRS in the study area, 
which started in 1953. IRS is also nowadays still a mainstay of malaria control in the study 
area. 
 
CBA: 
The impact of IRS was compared to a control area without any intervention (Molineaux 
1980). Propoxur (2g/m²) was used as insecticide. The spray coverage ranged from 74% to 
100%. There was no history of IRS in the area before this trial. 
 
ITS: 
In the study of Sharp 2007 the change over time due to IRS was examined over the time 
period of 3 years before and 4 years after the introduction of IRS. The insecticide used was 
bendiocarb (400mg/m²) and no usage coverage was mentioned. No history of IRS has been 
reported within the area before this study. 
Some additional characteristics of the trials are given in Table 4.  
 
Table 4: Trial characteristics of major factors influencing the impact of IRS  
Trial EIRa Insecticide Insecticide 
resistance Main vector 
Dominant 
wall type 
Co-
intervention(s) 
Pre-trial 
control 
measures 
Pakistan 
(Rowland) < 1 
Alpha 
cypermethrin No A. stephensi Mud/brick 
Treatment of 
fevers 
IRS 
(for 25 years) 
India  
(Misra) < 1 Deltamethrin yes
b
 
A.culicifacies Mud/brick IECd IRS (for 60 years) 
South Africa 
(Mnzana) < 1 Deltamethrin No
c
 
A.arabiensis N/A IECd IRS (for 50 years) 
Tanzania  
(Curtis) > 1 
Lambda 
cyhalothrin No 
A.gambiae  
A.funestus  
A.arabiensis 
Mud None 
Clearing of 
malaria 
infections 
Nigeria 
(Molineaux) > 1 Propoxur No 
A.gambiae 
A.arabiensis 
A.funestus 
Clay None None 
Mozambique 
(Sharp) > 1 Bendiocarb No 
A.arabiensis 
A.funestus N/A 
Treatment of 
slide - positive 
participants 
None 
Footnotes 
a
 Transmission intensity (EIR: Entomological inoculation rate - indicates how many infectious 
mosquito bites a person receives on average per year) 
b
 Mortality range for WHO susceptibility test: 74.4% to 96.5% 
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c Within other areas in Kwa-Zulu Natal, A. funestus was shown to be resistant to 
deltamethrin. However, there was no evidence that pyrethroid-resistant A. funestus were 
present in the area during the reported study 
d
 IEC: Information, Education and Communication 
 
Outcomes 
Prevalence and incidence of malaria infections were the main outcomes that we could 
assess. Five studies looked at the prevalence rates of parasitaemia. Of these, two RCTs 
(Misra 1999;  Rowland 2000) and one ITS (Sharp 2007) were conducted in unstable malaria 
settings and one RCT (Curtis 1998) and one CBA (Molineaux 1980) in stable malaria 
settings. 
The incidence rate of malaria infections was assessed in four studies. Of these, three RCTs 
were conducted in unstable malaria settings (Rowland 2000;  Misra 1999;  Mnzava 2001) 
and one CBA in a stable malaria setting. 
Impact on infant parasitological conversion rates was measured by Molineaux 1980, while 
incidence of re-infection and anaemia as additional outcomes were collected within stable 
malaria settings by Molineaux 1980 (CBA) and Curtis 1998 (ITS). 
Infant mortality rates were measured by Molineaux (1980) but unfortunately not in a suitable 
control area, and hence this outcome could not be used. See Table 5 for details. 
 
Table 5: Outcomes of studies  
Comparison 
Study Study design IRS vs 
control 
IRS vs 
ITN 
Incidence  
    of 
re-infection 
Incidence 
     of  
infections 
Prevalence 
     of 
infection 
Anaemia  
Infant 
parasite 
conversion 
rate 
Tanzania 
(Curtis 
1998) 
RCT X X X X X X  
South Africa 
(Mnzava 
2001) 
RCT  X  X    
Pakistan 
(Rowland 
2000) 
RCT X   X X   
India 
(Misra 1999) RCT X X  X X   
Nigeria 
(Molineaux 
1980) 
CBA X   X X  X 
Mozambique 
(Sharp 
2007) 
ITS     X   
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5.5.3 Excluded studies  
 
126 studies were excluded due to the following reasons (for details see table "Characteristics 
of excluded studies" at the end of the paper): 
• 40 didn't have enough units/arm (minimum required: RCT: 3 clusters per arm, CBA: 2 
clusters per arm) 
 • 20 didn't have control sites which were comparable with the intervention sites 
• 8 used an insecticide or a dosage not recommended by WHO 
• 12 were only reviews or conference abstracts and did not provide enough data 
• 28 were ITS which didn't provide enough data for pre- or post-intervention assessment 
• 14 were ITS using a mix of interventions 
• 2 trials didn't collect contemporaneous data for the control and intervention sites 
• 5 measured non-eligible outcomes 
• 1 trial included refugees as study participants 
• 2 studies used a non - experimental approach (modelling) 
• 1 RCT had a randomised allocation of the intervention that was not acceptable 
• 2 studies had an IRS coverage under 60% 
• 1 trial experienced a population movement of over 10% 
•1 trial sprayed with DDT in an area with documented DDT resistant Anopheles. 
 
5.5.4 Risk of bias in included studies  
 
For an overview of the risk of bias see Figure 1 and Figure 2. 
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Figure 1: Methodological quality graph: review authors' judgements about each 
methodological quality item presented as percentages across all included studies. 
 
 
 
Figure 2: Methodological quality summary: review authors' judgements about each 
methodological quality item for each included study. 
 
Allocation  
Two of the four RCTs (Misra 1999;  Mnzava 2001) generated allocation sequences by public 
drawing/tossing of coins. The risk of bias with these methods is low and allocation 
concealment is ensured by the fact that the allocation was made in public. The remaining two 
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RCTs (Curtis 1998;  Rowland 2000) don't specify how the randomisation was done and how 
allocation concealment was secured. Therefore the risk for bias can't be assessed. 
 
Blinding  
Obviously, blinding is neither possible for IRS nor for ITNs and this criteria should therefore 
not be considered for assessing study quality. Given the type of interventions and the nature 
of the outcomes, the risk of bias resulting from the absence of blinding is thought to be 
minimal.  
 
Incomplete outcome data  
Two of the six included trials (Misra 1999;  Molineaux 1980) reported changes in the number 
of participants over time. In one trial (Misra 1999) the losses to follow-up were under 10% 
and therefore the risk of bias was considered to be low. In the other trial (Molineaux 1980), 
there was a large migration with 15% to 20% of the population changing per year. The 
migration was described in detail within the study. Furthermore, the study did an analysis to 
check for the risk of bias due to the population movements and it was considered to be low. 
The other trials didn't report on losses to follow-up. Since they were calculating "person-time-
at-risk" as denominators the rates were accurate but the risk of selection bias over time could 
not be estimated. 
 
Selective reporting  
For none of the studies there was enough information to permit a reliable judgment of the risk 
of this type of bias. 
 
Other potential sources of bias  
In one trial (ITS, Sharp 2007) the spraying was interrupted for 2 years during the intervention 
phase, before being re-started. In addition, all age categories were sampled in December 
1999, but subsequent surveys were confined to children two to 14 years of age. 
Unfortunately the authors did not give any details by age in the 1999 survey and hence we 
could not investigate the effect of that change. Whereas the first issue (interruption of 
spraying) obviously reduced the effect of spraying, the other issue (change in measured age 
group) might also lead to a lower apparent spraying efficacy. 
 
Mnzava (2001) compared IRS versus ITNs. However, houses in bed net blocks had already 
been sprayed by the time the nets were distributed in 2007. Even though there was 
immediately an effort by investigators to re-plaster these houses to cover the insecticide on 
the walls, the effect of ITNs might be overestimate due to the dual protection for a limited 
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time. In subsequent years, house spraying was deliberately withdrawn in blocks with bed 
nets. 
In the study of Misra (1999) a high incidence of plastering mud on the walls of houses was 
reported (Misra 1999). This most likely reduced the effectiveness of IRS and hence 
underestimated its real effect. Unfortunately the authors don't provide detailed data on the 
replastering to allow a judgment on its impact. 
 
5.5.5 Effects of interventions  
 
Randomised control trials 
 
1. Stable malaria setting 
 
Only one RCT assessed the impact of IRS in a stable malaria setting. Curtis (1998) 
compared the impact of IRS with lambdacyhalothrin versus ITNs treated with 
lambdacyhalothrin versus a control group with no intervention in a highly endemic malaria 
setting in Tanzania. The main study outcomes were (1) incidence of re-infection (active case 
detection in children aged one to five years, passive surveillance in all age-groups), (2) 
prevalence of infection (children aged one to five years) and (3) anaemia (children aged one 
to five years)(Table 5). 
 
IRS vs no IRS: 
 
IRS was shown to be effective in protecting children from re-infection with malaria over a 11 
months period (protective efficacy: 54%)(Table 6). Malaria incidence (assessed by passive 
surveillance) was significantly reduced in children aged one to five years (RR 0.86, 95% CI 
0.77 to 0.95 (unadjusted for clustering). For children older than five years no difference was 
seen in regard to malaria incidence (Table 7). For malaria prevalence no difference was seen 
between the IRS and the control group (Table 8). With regard to anaemia, the haemoglobin 
levels were significantly lower in the control group than in the IRS group (WMD 0.61 g/dl;  
95% CI IRS group 9.99 to 10.02;  95% CI no IRS group: 9.38 to 9.40) (Table 9). 
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Table 6: RCTs: Impact on Incidence of re-infection in children aged one to five years (stable 
malaria only)  
Comparison Study IRSa no IRSa Risk 
ratio 
95% 
Confidence 
intervalb 
Protective 
efficacy 
IRS versus no 
IRS: 
Curtis 
1998 
(Tanzania) 
468/3840 1014/3840 0.46 0.42 to 0.51 54% 
IRS vs ITN: 
Curtis 
1998 
(Tanzania) 
468/3840 384/3840 1.22 1.06 to 1.40 -22% 
Footnotes 
a
 Denominator are person-weeks 
b Not adjusted for clustering 
 
 
 
 
 
Table 7: RCTs: Impact on parasite incidence  
Comparison Age groups Study IRS 
Controls 
(no IRS 
or ITNs) 
Rate 
ratio 
95% 
Confidence 
Interval 
Protective 
Efficacy 
STABLE MALARIA (EIR >1), IRS versus no IRS 
Children 1 
to 5 years 
Curtis 1998 
(Tanzania) 228/413 304/471 0.86 0.77 to 0.95
b
 14% 
Any infection Older 
than five 
years 
Curtis 1998 
(Tanzania) 382/1007 365/984 1.02 0.91 to 1.15
b
 -2% 
STABLE MALARIA (EIR >1), IRS versus ITN 
Children 1 
to 5 years 
Curtis 1998 
(Tanzania) 228/413 255/405 0.88 0.78 to 0.98
b
 12% 
Any infection Older 
than five 
years 
Curtis 1998 
(Tanzania) 382/1007 346/893 0.98 0.87 to 1.10
b
 2% 
UNSTABLE MALARIA (EIR <1), IRS versus no IRS 
Misra 1999 
(India) 1497/19170 2195/21363 0.76 0.73 to 0.78
a 
 24% 
Any infection all ages Rowland 
2000 
(Pakistan) 
6/12000 24/12000 0.14 0.06 to 0.33a 86% 
Misra 1999 
(India) 834/19170 1244/21363 0.76 0.69 to 0.81
b
 24% 
P. falciparum all ages Rowland 
2000 
(Pakistan) 
25/12000 177/6000 0.07 0.02 to 0.39a 93% 
Misra 1999 
(India) 663/19170 951/21363 0.78 0.70 to 0.86
b
 22% 
P. vivax all ages Rowland 
2000 
(Pakistan) 
112/6000 47/12000 0.21 0.10 to 0.55a 79% 
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UNSTABLE MALARIA (EIR <1), IRS versus ITNs 
Any infection all ages Misra 1999 (India) 834/19170 494/16885 1.55 1.49 to 1.60
a
 
Any infection all ages 
Mnzava 
2001 
(South 
Africa) 
2094/7649 1038/5450 1.44 0.77 to 2.70c 
Footnotes 
a
 adjusted for clustering 
b
 not adjusted for clustering 
cadjusted for matching, but not for clustering 
 
Table 8: RCTs: Impact on parasite prevalence  
Comparison Age groups Study IRS 
no IRS or 
ITN 
Risk 
ratio 
95% 
Confidence 
interval 
Protective 
efficacy 
1. STABLE MALARIA (EIR < 1), IRS vs no IRS: 
Any infection Children 1 to 5 years 
Curtis 1998 
(Tanzania) 191/262 232/293 0.92 0.83 to 1.02
a
 8% 
2. STABLE MALARIA (EIR < 1), IRS vs ITNs: 
Any infection Children 1 to 5 years 
Curtis 1998 
(Tanzania) 191/262 211/293 1.01 0.90 to 1.13
a
 -1% 
3. UNSTABLE MALARIA (EIR < 1), IRS vs no IRS  
All age 
groups 
Misra 1999 
(India) 167/26085 237/26589 0.71 0.59 to 0.87
b
 29% 
Any infection Children 5 
to 15 
years: 
Rowland 
2000 
(Pakistan) 
72/12000 289/12000 0.25 
0.08 to 0.80 
(ICC = 0.01) 
0.05 to 1.29 
(ICC = 0.02) 
75% 
All age 
groups 
Misra 1999 
(India) 127/26085 197/26589 0.66 0.53 to 0.82
b
 34% 
P. falciparum Children 5 
to 15 
years 
Rowland 
2000 
(Pakistan) 
5/1232 28/719 0.10 0.08 to 0.10a 90% 
All age 
groups 
Misra 1999 
(India) 40/26085 40/26589 1.02 0.66 to 1.58
b
 -2% 
P. vivax Children 5 
to 15 
years 
Rowland 
2000 
(Pakistan) 
30/1232 54/719 0.32 0.26 to 0.38a 68% 
4. UNSTABLE MALARIA (EIR < 1), IRS vs ITNs 
Any infection All ages Misra 1999 (India) 167/26085 102/26849 1.69 1.32 to 2.15
b
 -69% 
P. falciparum All ages  Misra 1999 (India) 127/26085 114/25904 1.10 0.86 to 1.42
b
 -10% 
P. vivax All ages Misra 1999 (India) 40/26085 29/26849 1.41 0.88 to 2.29
b
 -41% 
Footnotes 
a
 Adjusted for clustering, ICC= 0.01 
b
 Not adjusted for clustering 
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Table 9: RCTs: Impact on Haemoglobin levels (stable malaria only)  
Comparison Study 
Haemoglobin (in g/dl)            
(95% CI) 
n=number of participants 
Haemoglobin (in g/dl) 
             (95% CI) 
n=number of participants 
WMDa 
IRS vs no 
IRS  
Curtis 1998 
(Tanzania) 
10.01 (9.99 to10.02) 
n = 752 
9.39 (9.38 to 9.40) 
n = 850 0.61 
IRS vs ITN Curtis 1998 (Tanzania) 
10.01 (9.99 to10.02) 
n = 752 
10.00 (9.99 to 10.01) 
n = 909 0.01 
Footnotes 
a
 WMD: Weighted Mean Difference 
 
IRS vs ITN: 
 
For the incidence of re-infection, ITNs were shown in one RCT (Curtis 1998) to have a 
significantly greater protective effect than IRS in the Tanzanian trial (Risk ratio IRS:ITN = 
1.22, CI 1.06 to 1.40) (Table 6). For children aged one to five years IRS showed a better 
protective effect than ITNs in reducing malaria incidence (RR 0.88, 95% CI 0.78 to 0.98 
(unadjusted for clustering). No difference was seen for children older than five years (Table 
7). Prevalence rates were found to be equal within the IRS and ITN groups (Table 8). No 
difference in haemoglobin levels were found (WMD 0.01; 95% CI IRS: 9.99 to 10.02; 95% CI 
ITN: 9.99 to 10.01) (Table 9). 
 
2. Unstable malaria setting 
 
Three clustered RCTs were done in unstable malaria settings (EIR < 1), of which one trial in 
Pakistan (Rowland 2000) assessed the impact of IRS vs a control group without intervention, 
one trial in India assessed IRS versus ITNs versus a control group (Misra 1999) and the last 
trial in South Africa assessed IRS versus ITNs only (Mnzava 2001). Two of the studies had 
incidence and prevalence as their main outcomes (Misra 1999 Rowland 2000), while one 
study assessed only incidence as outcome (Mnzava 2001). 
All the three countries in which the trials have been contacted, have a long history of IRS. In 
Pakistan (Rowland 2000) IRS is the primary method of malaria control. But also India (Misra 
1999) and KwaZulu Natal (Mnzava 2001) have a long history of IRS with 50 years and 60 
years of spraying, respectively. The effect of these different durations of spraying before the 
start of the trials on the measures of impact could not be explored in the present analysis. 
 
IRS vs no IRS: 
 
IRS was shown to significantly reduce the incidence rate of malaria infections with the 
protective efficacy ranging from 24% to 86% (Table 7). IRS also significantly reduced the 
incidence of malaria when looking separately at P.falciparum and P. vivax (P.falciparum: RR 
0.07, 95% CI 0.02 to 0.39, 1 trial (Rowland 2000); P. vivax: RR 0.21, CI 95% 0.10 to 0.55, 1 
trial (Rowland 2000)).  
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Different results were seen when assessing the impact of IRS on malaria prevalence (Table 
6). Overall, and for the all ages group, Misra 1999 did not find any effect of IRS in reducing 
malaria prevalence in India. However, looking at the effect of IRS on P. falciparum 
prevalence alone, in one year (1997) a statistically significant effect was seen, but not in the 
following year (1998). The opposite was found for P. vivax, where there was a significant 
effect in the second but not in the first year. In children aged five to fifteen in Pakistan, IRS 
reduced the risk of getting infected with P. falciparum as well as with P.vivax - by 90% and 
68% (Rowland 2000, Table 8). 
 
IRS vs ITN: 
 
Slightly different results were seen when comparing IRS to ITNs against malaria incidence 
rates (Table 7). Whereas Misra 1999 found a significant difference between IRS and ITNs 
(RR 1.55, 95% CI 1.49 to 1.60), Mnzava 2001 did not find a significant difference (RR 1.44, 
CI 95% 0.77 to 2.70 - unadjusted for clustering) 
Only one trial in India (Misra 1999) compared IRS to ITNs for the outcome of prevalence. 
ITNs were shown to give a better protection against any infection in 1998 but not in 1997 
(Table 8).  
 
Controlled before and after (CBA) and interrupted time-series (ITS) studies 
 
Stable malaria setting 
 
Two trials (one CBA in Nigeria Molineaux 1980 and one ITS in Mozambique Sharp 2007) 
were done in a stable malaria setting. They compared spraying with Propoxur (Molineaux 
1980) and lambdacyhalothrin (Sharp 2007) to a control area. Both of them were looking at 
the impact on prevalence data, whereas Molineaux 1980 also assessed the infant 
parasitological conversion (incidence) rates. 
 
IRS vs no IRS: 
 
In both trials, the malaria prevalence was reduced where IRS was applied. However, 
Molineaux 1980 found only a significant difference for the prevalence rates during the wet 
season in which IRS showed a protective efficacy of 26% (Table 10). In Mozambique (Sharp 
2007), the first year after spraying showed a clear drop in prevalence (2001), while in 2002 
and 2003 IRS had stopped for operational reasons and prevalence went up again. In 2004 
and 2005 IRS was resumed and prevalence had dropped again (Table 11). 
Molineaux 1980 found that the infant parasitological conversion rates had a stronger 
reduction in the areas with IRS compared to areas without (Table 12). These authors also 
measured infant mortality rates (IMR) but unfortunately without measuring it in a control area. 
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They then derived evidence of impact from the close correlation between reduced infant 
parasitological conversion rates and IMR. It is unfortunate that because of this limitation 
these unique mortality data can not be used in our analysis. 
 
Table 10: CBA: IRS versus no IRS: Crude parasite prevalence rates (seasonal average)  
Comparison Study IRS no IRS Risk 
ratio 
95% Confidence 
interval 
Protective 
efficacy 
STABLE MALARIA 
IRS vs no IRS: 
dry season: any 
infection 
Molineaux 
1980 
(Nigeria) 
700/2310 405/1261 0.94 0.85 to 1.04 6% 
STABLE MALARIA 
IRS vs no IRS: 
wet season: any 
infection 
Molineaux 
1980 
(Nigeria) 
809/2310 599/1261 0.74 0.68 to 0.80 26% 
 
 
Table 11 ITS: Prevalence of P. falciparum  
Study Year 1999 2000 2001a,b 2002b 2003b 2004 2005 
% (n) 73 (101) 
79 
(120) 
32 
(130) 
51 
(117) 
59 
(118) 
39 
(120) 
23 
(114) Sharp 2007 
(Mozambique) 95% CIc 62 to 82 70 to 86 23 to 43 38 to 64 
49 to 
69 28 to 52 15 to 34 
Footnotes 
a Start of spraying in February 2001 and data collection took place in June 2001 
b Interruption of spraying between second half of 2001 to second half of 2003 
c CI: Confidence interval 
 
 
Table 12: CBA: Infant parasitological conversion ratesa of P.falciparum (stable malaria)  
year Study Treatment 
1971b 1972c 1973c 
IRS 0.012 0.002 0.002 Molineaux 1980 
(Nigeria) no IRS 0.016 0.005 0.009 
Footnotes 
a
 Infant parasitological conversion rate: -ln(1-p)/t, where p= conversion rate and t= time 
b
 Before intervention 
c
 After intervention 
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5.6 Discussion  
 
Since the 1950s, IRS has been used widely in many areas of the world, especially in Asia, 
Latin America and Southern Africa. IRS with DDT and other insecticides has been one of the 
main interventions leading to the elimination of malaria in about half of the world's regions 
(Lengeler 2003). This was for example the case in much of southern Europe, North America, 
Japan, Central Asia and Latin America. Very low levels of malaria transmission have been 
achieved and maintained in countries as different as India, Tadjikistan and Colombia. Hence 
the effectiveness of this intervention is beyond doubt. Unfortunately, the epidemiological 
effect has never been quantified properly, so that a comparison with other malaria control 
interventions, for example with ITNs, is impossible. As a result, an accurate comparative 
cost-effectiveness assessment is also impossible. 
 
With the exception of Southern Africa (South Africa, Namibia, Botswana, Swaziland 
Zimbabwe) and the Ethiopian and Madagascar highlands, the implementation of IRS in the 
highly endemic areas of sub-Saharan Africa has been limited in geographical extent and 
usually only for a limited time period. Recently, IRS was introduced in southern Mozambique, 
Equatorial Guinea, Zambia, Ghana, Sao Tome, Zanzibar. There is also a new interest for 
IRS since 2007 in the wake of the United States President's Malaria Initiative (PMI). For 
many of the other endemic countries of SSA, vector control has been upscaled from 2000 
onwards through the increased deployment of ITNs. In this context, two important questions 
have emerged: (1) what are the comparative advantages, including feasibility, cost and 
impact of ITNs and IRS;  and (2) is there any benefit in combining both IRS and ITNs 
together to increase impact, especially in view of the goal of malaria elimination declared in 
2007. 
While there are now relatively good data on comparative feasibility and cost (see review by 
Yukich 2008) this review demonstrates a great paucity of high-quality evidence in the 
comparative assessment of health impact. There are too few high-quality randomised 
controlled studies on the health effects of IRS, with too few health outcomes and not enough 
geographical coverage. Only six out of 132 identified studies met the inclusion criteria (four 
RCTs, one CBA and one ITS) and not all key malariological outcomes were addressed within 
these studies. Unfortunately, none of the studies investigated the potential of IRS for 
reducing child mortality rates. In some ways, this results is not entirely surprising considering 
the fact that (1) IRS started to be implemented on a large scale after the invention of DDT in 
1943 (and hence before the conduct of the first RCT in 1948), and (2) IRS with DDT was 
outstanding in its health effects from the start and there was no strong rationale for public 
health officials in the 1950s and 1960s to test formally its effects. 
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Currently, our evidence on the second question (the impact of the combination of IRS with 
ITNs) stems only from very limited descriptive evidence and properly conducted RCTs are 
urgently required. 
 
Overall, the formal quality of the six included trials was considered to be satisfying. Two of 
the four RCTs used appropriate methods for sequence generation and allocation 
concealment, whereas the other two trials didn't mention their procedure. However, given the 
nature of the intervention and the fact that it is allocated by cluster, this is unlikely to lead to 
bias in the results. Due to the nature of the intervention, blinding is not possible, but no risk of 
bias is expected because of this. 
 
A much bigger issue for the validity of the results is the implementation of the interventions, 
which has been sub-optimal in some settings. IRS application was for example discontinued 
in one setting (Sharp 2007). In three (Misra 1999; Mnzava 2001; Rowland 2000) of the four 
RCTs, the control and/or ITN arms of the trials had a long previous history of IRS, and 
spraying was simply suspended for the duration of the trial. Obviously, the entomological 
baseline situation was not any more one of an untouched area. In addition, insecticide was 
sprayed shortly before ITN distribution in the ITN arms in India and Tanzania. Despite the 
best efforts by investigators to minimize the effects of this by re-plastering the walls, this is 
still likely to have had an independent effect on the outcomes. Unfortunately, it is impossible 
to quantify that effect. 
 
Only two different classes of insecticides (carbamates and pyrethroids) were used in the 
reviewed trials, to which the mosquitoes were fully susceptible in all settings. Insecticide 
resistance is an obvious threat to the effectiveness of IRS. However, unlike 50 years ago, 
when DDT was the only insecticide on hand, there are now 12 different insecticides within 
four different classes available for IRS. This gives the possibility to alternate the insecticide 
and to switch to others insecticides in case resistance appears. This is a clear advantage 
over ITNs, for which only one class of insecticide is available. On the other hand, ITNs still 
offer a physical barrier to the vector, even if the insecticide doesn't work anymore, whereas 
for IRS the protection through the insecticide will be strongly reduced when resistance 
occurs. 
 
The four randomised controlled trials meeting the inclusion criteria were distributed between 
Asia and sub-Saharan Africa. Only one of them was done in a stable malaria setting 
(entomological inoculation rate >1). Within this study (Curtis 1998, Tanzania) the risk for 
children under six to get re-infected with malaria was reduced approximately by half 
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(protective efficacy: 54%), but no change in incidence or prevalence rates was seen, which 
was surprising. However, the participants got treated at the start of the study to clear all 
infections. This is usually not the case in interventions and normally a reservoir of infected 
people is always present. Hence, the generalization of the results to other malaria endemic 
areas is questionable. 
 
Three trials were done in unstable malaria settings (entomological inoculation rate <1). Two 
of them in Asia (Misra 1999 (India);  Rowland 2000 (Pakistan)) and one in Africa (Mnzava 
2001 (South Africa)). Combining the trials from India and Pakistan showed that IRS 
significantly protects all age groups in these settings from malaria infections, irrespective of 
the type of infection. There was no difference seen in the effectiveness when comparing IRS 
with ITNs. 
 
The results of this review do not reconcile well with the impressive historical reductions of 
malaria in many areas of the world following the introduction of IRS. Among these areas 
were also a number of high transmission areas of Africa (Kouznetsov 1977; Mabaso 2004). 
Hence, the lack of positive evidence from formal trials should not, in the case of IRS, be 
interpreted as a lack of effect of the intervention, but rather as the consequence of a lack of 
high-quality and long-duration trials. As a result, the main aim of the review (to quantify the 
health effects of IRS) could not be achieved and our major conclusion is that high-quality 
evidence from RCTs is still required. For obvious ethical reasons a control group without 
vector control intervention is not acceptable any more and such trials should therefore have 
at least two arms, an IRS arm and an ITN arm. Given the importance of also assessing the 
combined effect of IRS and ITNs a third arm with both interventions together would be highly 
desirable. 
5.7 Authors' conclusions  
 
Implications for practice  
• Overall, good quality evidence on the impact of IRS is scarce. 
• The current evidence is insufficient to quantify properly the effect of IRS in high 
transmission settings.  
• At present, a quantitative epidemiological comparison between IRS and ITNs is not 
possible. 
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• Available good quality evidence confirms that IRS with pyrethroids works in reducing 
malaria in unstable malaria settings 
• No trial investigated the effect of IRS in reducing (child) mortality. 
• There is insufficient epidemiological evidence to assess the effect of other determinants of 
impact, such as the insecticide class used for IRS, the type of transmission, the dominant 
vector species, socio-cultural determinants. 
Implications for research  
• There is an urgent need for more RCTs comparing IRS with ITNs in a number of settings 
with different epidemiological and socio-cultural characteristics. 
• Ideally, such RCTs should have a third arm with a combination of high coverage IRS with 
high coverage ITNs. 
• Participants of all age-groups should be included in such trials. 
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Differences between protocol and review  
 
We planned to convert the outcomes for anaemia presented as g/dL into packed cell volume 
with a standard factor of 1:3. But Carneiro 2007 showed that this conversion is not always 
accurate and since we only had one trial providing haemoglobin measures, we presented 
them as they were presented within the paper (in g/dL). 
We did not find individually randomised RCTs in the frame of this review. However, the 
methods of extracting data and analysing such trials would follow the methods outlined in the 
protocol. 
We did not do a sensitivity analysis due to the small number of trials. However, the methods 
published in the protocol will be followed, if appropriate, in future updates of this review. 
We only found one eligible ITS for our review and presented its results as shown in the 
paper. If further trials will be included in future updates we will analyse them as published in 
the protocol. 
Methological quality was assessed using the Cochrane Collaboration's risk of bias tool 
(Higgins 2008). 
No summary of the major debates and findings of other reviews on DDT was included in the 
discussion as none of our included studies used DDT as insecticide. 
There was a change in the authorship. BP replaced FT as first author because she took the 
lead in this work. 
5.10 Characteristics of studies  
 
5.10.1 Characteristics of included studies  
 
Curtis 1998  
Methods Study design: cluster randomised controlled trial. 
Unit of allocation: village. 
Number of units: 4:4:4 
Length of follow-up: prevalence surveys and passive surveillance: 15 
months (3rd & 4th quarter 95 to 4th quarter 96). Incidence surveys: 
20 months (April 95 to Dec 1996). 
Incidence of re-infection was monitored once before the interventions 
and four times after introduction of intervention (once in each quarter 
of 1996) by taking weekly blood slides. Cross-sectional surveys were 
carried out monthly from April 1995 to December 1996. In addition, a 
passive surveillance system was set up. People feeling sick with 
fever were encouraged to visit a local research assistant, who was 
taking a blood slide from them, which were collected weekly. 
Different children were used for each cohort. 
Confidence intervals were not adjusted for clustering. We could 
retrospectively adjust for the prevalence, but not for the incidence 
data. 
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Participants Number of participants: 
Incidence: 60:60:60 (control:ITNs:IRS), prevalence: 104:93:86, 
passive surveillance: 500:357:795. 
Inclusion criteria: incidence: children aged 1 to 6 with cleared pre-
existing parasitaemia; prevalence: children aged 1 to 6, passive 
surveillance: people of all ages feeling sick with fever. 
Exclusion criteria: incidence: children away from home, for having 
missed the blood slide for more than 1 week; prevalence: children 
already included in the incidence group, children which were selected 
in the previous month and children with parasitaemia >4000/µl. 
Passive surveillance: no specific exclusion criteria mentioned. 
Interventions IRS: Microencapsulated lambdacyhalothrin (ICON™) 10%; dosage: 
30 mg/m². The wall and roof areas were sprayed with Hudson X-Pert 
spray pumps. Re-spraying in the villages was carried out seven to 
eight months after the initial spraying (July to August 1996). The 
spray coverage was not specifically mentioned but maximal coverage 
was aimed for. 
ITNs: Lambdacyhalothrin (ICON™); dosage: 10 mg/m² in 2 villages, 
and 20 mg/m² in the other 2 villages. Retreatment after seven 
months. The coverage rate was not specifically mentioned. 
Outcomes (1) Incidence of re-infection after parasitological clearance with 
antimalarials 
(2) Malaria prevalence 
(3) Haemoglobin levels 
Notes Study location: six villages near Muheza, Tanga Region and six 
villages near Hale, both in northeast Tanzania 
EIR: estimated to be above 300 
Malaria endemicity: high endemicity with intense perennial 
transmission 
Transmission season: April to June 
Main vector: Anopheles gambiae, Anopheles funestus and Anopheles 
arabiensis 
Material of wall sprayed: Mud 
Insecticide resistance: None (bioassay test showed mortality of 80-
100%) 
Risk of bias table  
Item Judgement Description 
Adequate sequence generation? Unclear Quote: "Random assignment of intervention" 
Comment: Insufficient information to permit a 
judgement 
Allocation concealment? Unclear Quote: "Random assignment of intervention" 
Comment: Insufficient information to permit a 
judgement 
Blinding? No  
Incomplete outcome data 
addressed? 
Unclear The study did not address this outcome 
Free of selective reporting? Unclear There is insufficient information to permit a 
judgement 
Free of other bias? Yes  
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Misra 1999  
Methods Study design: cluster randomised controlled trial. 
Baseline: 
Unit of allocation: village. 
Number of units: 15:15:15. 
Length of follow-up: two weeks (16th to 30th September 1996). 
Mass surveys in September 1996 (peak transmission season) in 45 
villages within the three ecological zones. 
Intervention: 
Unit of allocation: groups of three nearby villages (but at least one km 
apart) formed a cluster for random assignment of IRS, ITNs or 
control). The villages were not evenly distributed within the three 
ecological zones, 30 in coastal zone, 51 in the plains zone and 45 
within the foothill eco zone. The distribution of the randomised 
villages was equal within the three groups.  
Number of units: 42:42:42. 
Length of follow-up: 18 months. 
Active case detection by home visits twice a week by collecting blood 
smears from all fever cases. On Sundays, treatment was provided to 
any sick person calling on the health worker. Monitoring from May 
1997 until May 1999 (only data collected until 31.12.1998 were 
evaluated). 
Cross-sectional mass surveys once per year within the second half of 
September in 1997 and 1998. 
Drop out rates were 6.0% for IRS, 5.2% for ITN and 5.6% for the 
control group. 
Confidence intervals were adjusted for clustering for the incidence 
data when P. falciparum and P. vivax were combined, using a 
Poisson regression model with random effects. The retrospective 
adjustment of incidence confidence intervals for P. falciparum and P. 
vivax separately was not possible. Neither was the adjustment for 
prevalence data possible. 
Participants Baseline mass survey: 
Number of participants: 34,292. 
No explicit inclusion/exclusion criteria (all ages). 
Intervention:  
Number of participants: 93,210 (IRS: 30,989;  ITNs: 31,168;  control: 
31,053).  
No explicit inclusion/exclusion criteria. 
Interventions The first intervention round took place from 26.5. to 14.6.1997;  the 
second round from 23.5 to 14.6.1998. 
IRS: deltamethrin 2.5% WP;  dosage 20 mg/m². Indoor surfaces of 
the walls, ceiling, back of cupboards, cots, eaves and cattle sheds 
were sprayed. Overall spray coverage was 92.2% in 1997 and 95.1% 
in 1998. In 1997 spray coverage was least in the irrigated plain eco 
zone (87%) and over 95% in the foothill and coastal eco zone. In 
1998, coverage was 95% in all 3 zones. 1.36% and 19.3% of the 
houses which have received IRS were re-plastered after three and six 
months, respectively. 
ITNs: deltamethrin 2.5% SC;  dosage 25 mg/m². Overall net coverage 
of the whole population was very high, with 99.3% in 1997 and 85.4% 
in 1998, respectively. Overall, 86.8% of the nets were retreated, with 
the retreatment taking place one year after the distribution (May 
1998). In the irrigated plain eco zone, 88.3% were retreated, whereas 
95.7% of the nets in the foothill eco zone were retreated. The 
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coverage rate for the coastal area was not mentioned. Only 4% of the 
nets were washed after nine months of treatment. 
Outcomes (1) Malaria prevalence. 
(2) Malaria incidence. 
Notes Study location: Surat District in Gujarat State, India. 3.7 million 
population with 54% distributed in 1281 villages. The district is 
divided into three ecological zones: (1) Foothill: Eastern tract of hilly 
land, largely deforested, summer hot and dry, maximal rainfall (2) 
Irrigated plain: cultivation of paddy, sugar cane and plantains, dam 
which irrigates the entire plain area (3) Coastal: Western coast belt 
with sandy soil and heavy industries. 
EIR: <1. 
Malaria endemicity: coastal area: hypo-endemic; getting 
hyperendemic towards eastern hilly tracts. 
Transmission season: perennial transmission with peak from June to 
September. 
Main vector: Anopheles culicifacies (zoophilic and endophilic). 
Material of wall sprayed: mud or cement. 
Insecticide resistance: A. culicifacies is resistant to DDT and 
malathion, but highly susceptible to deltamethrin, the insecticide used 
within the study (mortality range for susceptibility tests: 74.4 to 96.5) 
Net ownership prior to distribution of nets for the trial was significant 
higher in the IRS group (16.5%) than in the other two groups 
(ITN:9.5%; control: 15.5%;  χ2 test=144.69, df=2, p=0.001) 
Risk of bias table  
Item Judgement Description 
Adequate sequence 
generation? 
Yes Quote:"Public drawing, witnessed by elected leaders, 
community members, and project government officials". 
Comment: Valid as randomisation procedure. 
Allocation 
concealment? 
Yes Quote: "Public drawing, witnessed by elected leaders, 
community members, and project government officials". 
Comment: As there were many witnesses, the adherence 
to the randomised allocation is secured. 
Blinding? No  
Incomplete outcome 
data addressed? 
Yes Losses to follow-up: 
Control: 1750/31053 losses to follow-up (344/31053 due 
to death; 1215/31053 due to emigration and 191/31053 
married and moved away). 
IRS: 1866/30989 losses to follow-up (319/30989 due to 
death; 1332/30989 due to emigration and 215/30989 
married and moved away). 
ITN: 1611/31168 losses to follow-up (346/31168 due to 
death; 1034/31168 due to emigration and 231/31168 
married and moved away). 
Additions to the study population: 
Control: 1035/31053 additions (603/31053 due to birth, 
249/31053 due to marriage and 183/31053 due to 
immigration. 
IRS: 1250/30989 additions (713/30989 due to birth; 
305/30989 due to marriage and 232/30989 due to 
immigration). 
ITNs: 1424/31168 additions (704/31168 due to birth; 
320/31168 due to marriage and 400//31168 due to 
immigration). 
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Free of selective 
reporting? 
Unclear There is insufficient information for judgement 
Free of other bias? No Quote: "a high incidence (24.3%) of plastering mud on the 
walls of houses..." (Bhatia et al. 2004) 
Comment: the re-plastering of the walls after spraying 
most likely reduced the effectiveness of IRS 
 
Mnzava 2001  
Methods Study design: cluster paired randomised controlled trial. 
Unit of allocation: geographical blocks (seven pairs of blocks formed 
on the basis of their average malaria incidence rate (being as similar 
as possible within each pair); randomisation to ITNs or IRS within 
each pair. 
Number of units: 7:7 blocks. 
Length of follow-up: 24 months. 
Routine active case detection took place monthly by malaria control 
teams. Blood slides were taken from any member of a household. 
Passive case detection was done by clinic and hospital staff. 
Whenever such a case was detected, all household members from 
where the case came from and including all people living within a 40 
km radius of the homestead where the index case occurred, were 
bled as well. This is the routine procedure for all zones under malaria 
control in the KwaZulu Natal Province. 
Monitoring from January 1997 to December 1998. 
Drop-outs were not taken into account. 
Confidence intervals were not adjusted for clustering. They could not 
be adjusted retrospectively (due to matching of the pairs). 
Participants IRS: 7649 
ITNs: 5450 
No inclusion/exclusion criteria mentioned (all ages). 
Interventions IRS: spraying with deltamethrin; dosage 20 mg/m², yearly from 
September to December, starting in 1996 (prior to the malaria 
season). The interior walls, ceilings and eaves of all homesteads 
were sprayed with Hudson X-Pert spray pumps. Spraying coverage is 
not explicitly mentioned. 
ITNs: distribution of permethrin treated nets in January 1997; target 
dose 200 mg/m². Annual retreatment in January, using deltamethrin 
(KO-Tab) in 1998 and permethrin in 1999. Over 90% of the nets were 
retreated. Usage of ITN in 1997 was 98% and 100% in 1998. 
Houses in bednet blocks had already been sprayed by the time the 
nets were distributed in 2007. There was immediately an effort by 
investigators to re-plaster these houses to cover the insecticide on 
the walls. In subsequent years, however, house spraying was 
deliberately withdrawn in blocks with bednets. 
Outcomes (1) Malaria incidence (cases per 1000 person-years)  
Notes Study location: homesteads within Ndumu and Makanis areas of 
Ingwavuma district in KwaZulu Natal Province. 14,000 inhabitants 
(predominantly Zulus) served by four clinics and one referral hospital. 
The area has a long history of IRS. Before 1995, it was sprayed with 
DDT, thereafter there was a switch to deltamethrin. 
EIR: not known but very low because of long-standing malaria control 
efforts (decades of IRS).  
Malaria endemicity: not known (annual malaria incidence of 5%). 
Main vector: Anopheles arabiensis (after elimination of A. funestus by 
IRS). 
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Material of wall sprayed: mud and cement. 
Insecticide resistance: within KwaZulu Natal Province, A. funestus 
was shown to be resistant to deltamethrin (Hargreaves 2000). 
However, according to Mnzava 2001 there is no evidence that 
pyrethroid-resistant A. funestus occurred in the area during the period 
of the study. For A. arabiensis no resistance was detected in the 
area. 
Risk of bias table  
Item Judgement Description 
Adequate 
sequence 
generation? 
Yes 
Quote: "Tossing of a coin during community meeting" 
Comment: Valid as randomisation tool 
Allocation 
concealment? 
Yes Quote: "Tossing of a coin during community meeting" 
Comment: As there were many witnesses, the adherence to 
the randomised allocation is secured 
Blinding? No  
Incomplete 
outcome data 
addressed? 
Unclear Quote: "Any population changes over the study period could 
not be taken into account" 
Free of selective 
reporting? 
Unclear There is insufficient information to permit a judgement 
Free of other 
bias? 
No Houses in bed net blocks had already been sprayed by the 
time the nets were distributed in 2007. There was immediately 
an effort by investigators to re-plaster these houses to cover 
the insecticide on the walls. In subsequent years, however, 
house spraying was deliberately withdrawn in blocks with bed 
nets. 
 
Molineaux 1980  
Methods Study design: controlled before-and-after study 
Unit of allocation: village 
Number of units: 5:6 (control : IRS) 
Every 10 weeks, house-to-house visits were done and a thick film 
taken. In case of absence a second visit to the home was done. 
Length of follow-up: 36 months. 
Drop-out rate unknown, high levels of migration - 15% to 20% per 
year. 
Participants IRS: 2310 
Control: 1861 
No explicit inclusion/exclusion criteria mentioned (all ages). 
Interventions Propoxur 50% WP;  dosage 2 g/m². Three rounds of spraying were 
applied in 1972, starting on 1 May, 5 July and 6 September, 
respectively. The intervals between successive rounds in the same 
village were 61 to 66 days. 
In 1973 spraying was applied in April, June and August and in the 
southern part in October. The intervals between successive rounds 
were 56 to 66 days. 
Spray coverage: 74% to 100% (99% on average). 
Outcomes (1) Prevalence rate. 
(2) Incidence rate. 
(3) Infant mortality rate 
Notes Study location: Garki District in Northern Nigeria. 
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EIR at baseline in treated villages: wet season:18 to 132;  dry 
season: 0 (except Sugungum:13). 
EIR at baseline in untreated villages: wet season:17 to 37;  dry 
season: N/A. 
Malaria endemicity: stable, seasonal. 
Main vector: Anopheles gambiae and Anopheles funestus. 
Material of wall sprayed: clay. 
Insecticide resistance: None mentioned. 
Risk of bias table  
Item Judgement Description 
Adequate sequence generation? Unclear 
 
Allocation concealment? Unclear  
Blinding? No  
Incomplete outcome data 
addressed? 
Yes 
 
Free of selective reporting? Unclear There is insufficient information to permit a 
judgement 
Free of other bias? Yes  
 
Rowland 2000  
Methods Study design: cluster-randomised controlled trial. 
Unit of allocation: sectors;  the study area comprising 60 villages was 
divided into nine sectors of approximately equal population size and 
surface area and then each sector was assigned at random to 
control, Wettable Powder, or SC formulation). 
Number of units: 3:3:3 sectors. During analysis the two insecticide 
groups (WP and SC) were merged into a single group because there 
was no evidence of difference between them. 
Length of follow-up: 10 month (one season). 
Active case detection by home visits every fortnight. Blood slides 
were taken from any member of a household reporting to having had 
fever during the previous three days. Monitoring from April 1997 to 
January 1998, covering the entire malaria transmission season. 
Two cross-sectional surveys were carried out in April-May and 
September 1997, i.e. before and after the spraying, which was done 
in June 1997 (one survey within and one survey outside the malaria 
season, which runs from June to November). 
To assess the prevalence rate, blood slides were taken from children 
of one or two schools selected from sentinel villages in each sector. 
Drop-out rates unknown. 
Confidence intervals were not adjusted for clustering by authors. We 
could adjust the incidence and prevalence data retrospectively. See 
Data collection and analysis for more details.The rate ratio (RR) of 
IRS vs no IRS was estimated by a generalized linear model with 
negative binomial mean and variance functions. This model sowed to 
best fit the observed cluster-level incidence rates (Generalized 
Pearson statistics=1.29). 
Participants (1) Active case detection: 
Number enrolled:18,000 (2000 in each of the 9 sectors). 
Inclusion criteria into active surveillance group: any member of a 
household who reported having had fever during the previous 3 days. 
Exclusion criteria: No explicit exclusion (all ages). 
(2) Cross-sectional surveys: 
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Inclusion criteria: School children aged 5 to 15 years present in 
school on the day of the survey. 
Number enrolled: 200 to 300 children per sector. 
Exclusion criteria: none. 
Interventions Alpha-cypermethrin WP and SC;  dosage 25 mg/m²;  living quarters, 
storage rooms and animals shelters were sprayed with Hudson X-
pert spray pumps 
Spray coverage: WP: 96%, SC: 97%. 
Outcomes (1) Malaria incidence through active case detection (P. falciparum 
and P. vivax). 
(2) Malaria prevalence through cross-sectional surveys (P. falciparum 
and P. vivax). 
Notes Study location: 3 Union Councils, covering 180 km² of Sheikhupura 
District, Punjab Province, approximately 60 km west of Lahore, 
Pakistan. 
EIR: < 1 
Malaria endemicity: not known (annual incidence of 50 episodes per 
1000 person years). 
Malaria season: June to November. 
Main vector: Anopheles stephensi. 
Material of wall sprayed: mud and brick. 
Insecticide resistance: no detected resistance, 100% mortality of 
laboratory-reared and wild-caught A. stephensi. 
Risk of bias table  
Item Judgement Description 
Adequate sequence 
generation? 
Unclear Quote: "..each sector was assigned at random to 
untreated, WP, or SC spraying..." 
Comment: Insufficient information for judgement 
Allocation concealment? Unclear Insufficient information for judgement 
Blinding? No  
Incomplete outcome data 
addressed? 
Unclear This outcome was not addressed by the study 
Free of selective reporting? Unclear There is insufficient information to permit a 
judgement 
Free of other bias? Yes  
 
Sharp 2007  
Methods Study design: interrupted time series. 
Length of follow-up before intervention: 3 years (1999 to 2001). 
Length of follow-up after intervention: 4 years (2002 to 2005). 
Cross-sectional studies were done once per year (in June) within 26 
sentinel sites. From a random sample of individuals malaria infections 
were tested by Rapid Diagnostic Tests (RDTs). 
Participants First year (1999): all age groups included. In subsequent years (2000 
to 2005) children between 2 to 14 years were included in surveys. 
Interventions Bendiocarb;  400 mg/m². 
Twice annual spraying was done using Hudson pumps. Spraying 
personnel were trained in spraying techniques, safety measures and 
received personal protection equipment. 
Outcomes (1) Malaria prevalence of P. falciparum 
Notes Study location: Maputo Province in Southern Mozambique. 
EIR: > 1 before control activities started. 
5 – Cochrane review on Indoor Residual Spraying 
 
  98 
Malaria endemicity: stable malaria before control activities started. 
Main vector: A. arabiensis; A. funestus. 
Material of wall sprayed: Not known. 
Insecticide resistance: None. 
Risk of bias table  
Item Judgement Description 
Adequate 
sequence 
generation? 
Unclear 
 
Allocation 
concealment? 
Unclear 
 
Blinding? No  
Incomplete 
outcome data 
addressed? 
Unclear 
This was not addressed by the study. 
Free of selective 
reporting? 
Unclear There is insufficient information to permit a judgement. 
Free of other 
bias? 
No Quote 1: "IRS was interrupted from 2001 to 2002 because of 
resource constraints, but resumed in the second half of 2003". 
Comment: Due to the interruption of IRS, it is likely that the 
effect of the spraying will be underestimated. 
Quote 2: "All age categories were sampled in December 1999, 
and subsequent surveys were confined to children two to 14 
years of age". 
Comment: In a malaria endemic area, the risk of infection is 
higher for children than for adults. Therefore the prevalence 
might be affected when comparing the year with all age groups 
compared to the years with children only. However, looking at 
the difference in the prevalence rates of the year with all age-
groups surveyed versus subsequent years, this effect seems 
negligible. 
 
 
5.10.2 Characteristics of excluded studies  
 
Afifi 1959  
Reason for exclusion Data collection for groups not contemporaneous. 
Afridi 1947  
Reason for exclusion Not enough units/arm. 
Alves 1953  
Reason for exclusion Usage of an insecticide (Benzene Hexachloride (BHC)) which is not 
recommended by WHO 
Andrews 1951  
Reason for exclusion Review, not enough data to analyse. 
Ansari 1986  
Reason for exclusion Inappropriate choice of control site (Hexachlorocyclohexane (HCH) 
spraying). 
Ansari 1990  
Reason for exclusion Inappropriate choice of control site (HCH spraying). 
Ansari 2004  
Reason for exclusion Inappropriate choice of control site (HCH spraying). 
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Ansari 2004a  
Reason for exclusion Inappropriate choice of control site (Malathion spraying);  not enough 
units/arm. 
Arredondo-Jimenez 1993  
Reason for exclusion Not enough units/arm. 
Arredondojimenez 1993  
Reason for exclusion Inappropriate choice of control site (DDT spraying). 
Barai 1982  
Reason for exclusion Review, not enough data to analyse. 
Barutwanayo 1991  
Reason for exclusion ITS with mix of interventions (IRS, ITN, drainage and improvement of 
health system). 
Bhatnagar 1974  
Reason for exclusion Dosage of insecticide application not concurrent with WHO 
recommendations. 
Bradley 1991  
Reason for exclusion Usage of an insecticide (Benzene Hexachloride (BHC)) which is not 
recommended by WHO 
Brieger 1996  
Reason for exclusion Not enough data to analyse (denominators missing); author was 
contacted but could not supply missing data. 
Cai 1999  
Reason for exclusion Not enough units/arm. 
Cavalié‚ 1961  
Reason for exclusion Not enough data for pre- and post-intervention assessment. 
Cavalié‚ 1991  
Reason for exclusion Not enough data for pre- and post-intervention assessment. 
Charlwood 1995  
Reason for exclusion Inappropriate choice of control site (lambdacyhalothrin spraying); not 
enough units/arm; not enough data for pre-intervention assessment. 
Conteh 2004  
Reason for exclusion Non-eligible outcomes measured. 
Coosemans 1978  
Reason for exclusion Review, not enough data to analyse. 
Coosemans 1989  
Reason for exclusion Not enough data for quality assessment and analyses of the data. 
Coosemans 1991  
Reason for exclusion ITS with mix of interventions (IRS, ITN, drainage and improvement of 
health system). 
Coppen 1999  
Reason for exclusion Not enough data, conference abstract only; author could not be 
contacted for additional information. 
Cot 1999  
Reason for exclusion Not enough data, conference abstract only; author could not be 
contacted for additional information. 
Cot 2001  
Reason for exclusion not enough units/arm. 
Cot 2002  
Reason for exclusion Non-eligible outcomes measured. 
Curtis 1999  
Reason for exclusion Not enough data, conference abstract only. 
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Curtis 2000  
Reason for exclusion Review, not enough data to analyse. 
Dapeng 1996  
Reason for exclusion Interrupted times series with mixed malaria control interventions (IRS 
and ITN). 
Das 1987  
Reason for exclusion Inappropriate choice of control site (DDT spraying). 
de Zulueta 1954  
Reason for exclusion Not enough units/arm; collection of data in control and survey area at 
different time points. 
de Zulueta 1961  
Reason for exclusion Not enough data for pre-intervention assessment;  ITS with mixed 
interventions (IRS and treatment). 
Deane 1948  
Reason for exclusion Not enough data for pre/post-intervention assessment. 
Dhiman 2005  
Reason for exclusion ITS with mixed interventions (IRS and treatment). 
Dodge 1965  
Reason for exclusion Not enough data for pre-intervention assessment. 
Doke 2000  
Reason for exclusion Not enough data for pre/post-intervention assessment. 
Dowling 1950  
Reason for exclusion Inappropriate choice of control site. 
Dowling 1951  
Reason for exclusion Inappropriate choice of control site. 
Eddey 1944  
Reason for exclusion Not enough data for post-intervention assessment. 
Edeson 1957  
Reason for exclusion Not enough units/arm. 
Farid 1954  
Reason for exclusion ITS with mixed interventions (IRS and larviciding); mix of refugee and 
general population. 
Faye 1992  
Reason for exclusion Not enough units/arm; wrong dosage of insecticide (1g/m2 
fenitrothion). 
Fontaine 1976  
Reason for exclusion Not enough units/arm. 
Fontaine 1978  
Reason for exclusion Not enough units/arm. 
Gandahusada 1984  
Reason for exclusion Non randomised allocation of intervention. 
Gill 1997  
Reason for exclusion Not enough units/arm. 
Gunasekaran 2005  
Reason for exclusion IRS coverage below 60%. 
Guyatt 2002  
Reason for exclusion Inappropriate choice of control site. 
Hamon 1954  
Reason for exclusion ITS with mixed interventions (IRS, larviciding and drug distribution). 
Hii 1993  
Reason for exclusion Study sites not comparable. 
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Ismail 1974  
Reason for exclusion Not enough data for post-intervention assessment. 
Ismail 1975  
Reason for exclusion High level of population movement. 
Ismail 1978  
Reason for exclusion Not enough data for pre- and post-intervention assessment. 
Jaggi 1984  
Reason for exclusion Not enough data for pre-intervention assessment. 
Jambou 2001  
Reason for exclusion Control group not comparable;  not enough data for pre-intervention 
assessment. 
Kamolratanakul 2001  
Reason for exclusion Not enough data for quality assessment. 
Kere 1992  
Reason for exclusion Non-eligible outcomes measured. 
Kleinschmidt 2006  
Reason for exclusion Not enough data for pre- and post-intervention assessment. 
Kleinschmidt 2007  
Reason for exclusion Not enough data for pre-intervention assessment. 
Lambrecht 1952  
Reason for exclusion Not enough data for pre-intervention assessment. 
Lantoarilala 1998  
Reason for exclusion Not enough units/arm. 
Lópes 1993  
Reason for exclusion Mix of intervention (IRS and drug distribution). 
Maharaj 2005  
Reason for exclusion Not enough data for post-intervention assessment. 
Mastbaum 1951  
Reason for exclusion Not enough units/arm. 
Matola 1981  
Reason for exclusion Usage of an insecticide (Dieldrin) which is not recommended by 
WHO. 
Metselaar 1954  
Reason for exclusion Not enough units/arm. 
Metselaar 1957  
Reason for exclusion Not enough units/arm. 
Metselaar 1960  
Reason for exclusion Not enough data for pre-intervention assessment. 
Metselaar 1961  
Reason for exclusion ITS with mixed interventions (IRS and drug distribution). 
Mnzava 1993  
Reason for exclusion Not enough units/arm. 
Najera 1965  
Reason for exclusion Not enough units/arm;  Inappropriate choice of control site. 
Najera 1967  
Reason for exclusion Not enough units/arm. 
Najjar 1959  
Reason for exclusion Not enough data for pre-intervention assessment. 
Nalim 1997  
Reason for exclusion Not enough units/arm. 
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Nasir 1982  
Reason for exclusion Not enough data on parasitological assessment. 
Nguyen 1996  
Reason for exclusion Not enough units/arm. 
Nyarango 2006  
Reason for exclusion Application of mixed interventions (IRS, ITN, larviciding and malaria 
case management). 
Onori 1975  
Reason for exclusion Not enough units/arm; not enough data for pre and post-intervention 
assessment. 
Over 2003  
Reason for exclusion Non-expermimental approach to analyse the impact of malaria 
intervention. 
Over 2004  
Reason for exclusion Non-expermimental approach to analyse the impact of malaria 
intervention. 
Pampana 1950  
Reason for exclusion Review, not enough data to analyse. 
Pardo 2006  
Reason for exclusion Not enough data for pre-and post-intervention assessment. 
Pattanayak 1980  
Reason for exclusion Not enough units/arm. 
Payne 1976  
Reason for exclusion Non enough units/arm. 
Pletsch 1954  
Reason for exclusion Not enough units/arm. 
Protopopoff 2008  
Reason for exclusion Control site not comparable. 
Pujara 1983  
Reason for exclusion Inappropriate choice of control site and not enough units/arm. 
Rachou 1966  
Reason for exclusion Not enough units/arm. 
Rafi 1954  
Reason for exclusion Not enough data for pre-intervention assessment. 
Rajendram 1951  
Reason for exclusion Insecticide (BHC) not recommended by WHO. 
Rajendram 1951a  
Reason for exclusion Insecticide (BHC) not recommended by WHO. 
Rakotomanana 2001  
Reason for exclusion Non-eligible outcomes measured. 
Reisen 1993  
Reason for exclusion Not enough units/arm. 
Rodriguez 1994  
Reason for exclusion Non-eligible outcomes measured. 
Romi 2002  
Reason for exclusion Not enough data for pre- and post- intervention assessment. 
Russel 1939  
Reason for exclusion Not enough units/arm. 
Russel 1942  
Reason for exclusion Not enough units/arm. 
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Sahondra 2001  
Reason for exclusion ITS with mixed interventions (IRS and drug distribution). 
Sahu 1993  
Reason for exclusion Not enough units/arm (only 1 control village). 
Sahu 1995  
Reason for exclusion Non-eligible outcomes measured. 
Saliternik 1977  
Reason for exclusion Review, not enough data to analyse. 
Sastry 1961  
Reason for exclusion Review, not enough data to analyse. 
Sexton 1994  
Reason for exclusion Not enough data, conference abstract only. 
Sharma 1982  
Reason for exclusion DDT spraying in area with DDT resistant A. culicifacies. 
Sharma 1985  
Reason for exclusion Not enough units/arm. 
Sharma 1986  
Reason for exclusion Inappropriate choice of control site. 
Sharma 1996  
Reason for exclusion Not enough units/arm;  spray coverage too low for malathion 
spraying. 
Sharma 2005  
Reason for exclusion Inappropriate choice of control site (DDT-spraying). 
Sharp 2002  
Reason for exclusion Not enough data for post-intervention assessment. 
Singh 2006  
Reason for exclusion ITS with mixed interventions (IRS, early detection and treatment, 
larvivorous fishes). 
Taylor 1986  
Reason for exclusion Not enough units/arm. 
Tewari 1990  
Reason for exclusion ITS with mixed interventions (IRS, space-spraying and anti-larval 
measures). 
Trapido 1946  
Reason for exclusion Not enough units/arm. 
van Thiel 1951  
Reason for exclusion Not enough units/arm. 
van Wyk 2002  
Reason for exclusion Not enough data, conference abstract only. 
Verdrager 1975  
Reason for exclusion Not enough units/arm. 
Viswanathan 1947  
Reason for exclusion Inappropriate choice of control site. 
Viswanathan 1950  
Reason for exclusion Mix of dosages used for IRS (two of them not in line with WHO 
recommendations). 
Wattal 1978  
Reason for exclusion Dosage of insecticide application not in line with WHO 
recommendations 
WHO 2007  
Reason for exclusion ITS with mixed interventions (IRS and anti-larval measures). 
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Wilson 1954  
Reason for exclusion Not enough units/arm. 
Wu 1984  
Reason for exclusion Not enough units/arm. 
Wu 1993  
Reason for exclusion Inappropriate choice of control site. 
Xu 1998  
Reason for exclusion Not enough units/arm. 
Xu 2002  
Reason for exclusion Inappropriate choice of control site. 
Zaphiropoulos 1959  
Reason for exclusion Not enough data for pre-intervention assessment. 
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6 Discussion 
 
This discussion is divided into three parts. Firstly, the methodological approaches will be 
reviewed and an overview over the projects will be given. This will be followed by the key 
contributions made by this work to malaria control. Finally the prospects for future research 
will be presented. 
 
6.1  Methodological issues and overview 
 
6.1.1 Investigation of the malaria situation with the Higaturu Oil Palms plantations  
 
The aim of our study within the plantations of the Higaturu Oil Palms (HOP) company was to 
provide an overview of the malaria epidemiology on the south-east coast of PNG, and to 
quantify the benefits of malaria control to the company. We used two different observational 
approaches in order to achieve this goal, namely by collecting routine health statistics data 
from the company aid posts and by conducting a cross-sectional survey within the study 
area.  
 
To the best of our knowledge, this is the first work describing the impact of malaria on an 
agro-industrial operation in PNG. In addition, we provide for the first time a snapshot on the 
malariological situation around Popondetta.  
 
Malaria was shown to be a major problem within the Higaturu Oil Palm plantations, with one 
third of the people (33.5%) having a positive blood slide. This is similar to surveys done in 
other non agro-industrial sites in PNG: a prevalence rate of 60% was found in the Wosera 
(Genton et al. 1995) and 35% to 43% surrounding Madang (Cattani et al. 1986b). Children 
and adults were both affected, which suggests there is little acquired immunity. Nevertheless, 
the prevalence was highest in the age group 5-9 years (40.3%), which is characteristic for a 
highly endemic area in PNG (Cattani et al. 1986a; Genton et al. 1995; Muller et al. 2003).  P. 
falciparum was found to be the dominant species, followed by P. vivax, which is generally 
observed throughout PNG (Cattani et al. 1986b; Schuurkamp 1992; Genton et al. 1995; 
Mueller et al. 2003). 
 
Since the HOP health staff routinely collects health data on all patients, it was operationally 
easy to compile the incidence rates of malaria patients. For HOP employees and their 
dependants the examination and treatment is provided for free at the company aid posts. 
The clinics are close by and easily reachable by foot. Once a month, the health staff holds 
health awareness sessions about TB, Malaria and HIV for all residents in every HOP village. 
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We therefore expected that almost everybody feeling sick with malaria symptoms would visit 
one of the clinics. This was confirmed with 99.5% of the participants having reported to have 
visited a health centre if feeling sick with ‘malaria’ within the last two weeks. This is 
substantially higher compared to other non-industrial PNG settings which experience 
attendance rates of 55% to 87% (Mueller et al. 2006; Mueller et al. 2007). However, care has 
to be taken when relying on routinely collected health data to monitor diseases, as the data 
quality is often poor (de Savigny & Binka 2004; Chilundo et al. 2004). Before the start of our 
survey, malaria was diagnosed by symptoms only. Symptoms of malaria are non-specific 
and many other diseases can present with the same clinical picture. Thus, a purely 
symptomatic diagnosis of malaria can lead to a vast over-diagnosis of malaria cases (Font et 
al. 2001; Wang et al. 2006). We therefore introduced rapid diagnostic tests (RDTs) for 
malaria in all aid posts. RDTs have been shown to perform well in routine practice 
(McMorrow et al. 2008; Hopkins et al. 2008) and they are now recommended for wider use 
(World Health Organization 2006a). In our study, the RDT sensitivity compared to reference 
microscopy was found to be 89%, which is excellent. As one drawback, the HRP2 may 
persist for several weeks after the parasites have been eradicated, posing a risk of obtaining 
false-positive results (Tjitra et al. 2001; Kyabayinze et al. 2008).  
 
In areas with a high level of endemicity, it is rather likely that people have still antigens in 
their blood due to frequent malaria infections. Within the study area, a third of the population 
was found to be infected in a cross-sectional assessment, which speaks for a high level of 
endemicity. If many individuals resort to self-treatment there is a real possibility of false-
positive results with RDTs. Nevertheless, after the introduction of RDTs, the number of 
malaria cases dropped significantly, highlighting that over-diagnosis did indeed take place on 
the basis of clinical suspicion alone. The feedback from the HOP health staff was also very 
positive.  On the other hand, they also reported of patients pushing for a malaria treatment 
despite a negative RDT result, which is also found in other parts of the world (Williams et al. 
2008).    
 
Microscopy is still the most commonly used method for the diagnosis of malaria parasites. 
Reading blood slides needs a lot of expertise and the quality can be poor in areas where 
training, equipment and reagents are substandard (Perkins & Bell 2008). The slides of this 
survey were read by experienced microscopists from the Institute of Medical Research (IMR) 
in PNG. The slides were read twice by different microscopists to check for any discrepancies. 
Overall, the consistency of the two datasets was only barely sufficient, with an agreement of 
78% (Kappa index of 0.43). Over 65% of the discrepancies were found in slides with very low 
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densities. This showed clearly the difficulty of reading accurately blood slides, even for 
experienced microscopists. 
 
To get an idea of risk factors associated with malaria infections, we applied a questionnaire 
and combined the answers with the results of the blood slides. Care was taken when 
interpreting the results of such cross-sectional studies since exposure and outcome were 
measured at the same time, which makes it difficult to assess causality. Employees and 
dependants had the same risk of getting infected with malaria. At times, people prefer 
sleeping outside on the veranda or on a shelter. Surprisingly, there was no difference seen 
between these people and people sleeping inside the house. Since houses are not mosquito 
proofed, and since A. punctulatus is endo – but also exophilic (Charlwood et al. 1986) it is 
likely that the mosquitoes enter the houses and bite the inside sleeping inhabitants.  
 
The company sells mosquito nets for half their commercial price, resulting in 70% of the 
people sleeping under a bednet. This is a higher coverage compared to findings of other 
studies done in the lowlands of PNG with 44% (Genton et al. 1995) and 55% (Genton et al. 
1994), or studies in the highlands with 25% (Mueller et al. 2006). Nevertheless, Cattani et al. 
(1986b) reported a higher usage of 82% around Madang. ITNs are well known to reduce 
morbidity in different transmission settings (Lengeler 2004). In the Wosera area with a similar 
prevalence level as in our study area, bednet use was shown to reduce the risk of getting 
malaria with a protective efficacy of 37% (Genton et al. 1994). We therefore expected people 
sleeping under a bed net to have a reduced risk of getting malaria. While this was true on 
village level, no difference was seen on individual level. This is likely to be the result of the 
homogeneously high level of net use within our study area.  
 
So far only few studies assessed the impact of malaria in a commercial company (Hedman 
et al. 1979; Yadav et al. 1991; Some 1992; Utzinger et al. 2002; Mills et al. 2008). At HOP, 
malaria impaired the company’s effectiveness in different ways. As direct impact, they lost 
their workforce on average for 1.8 days per malaria episode. This is consistent with a study 
in Kenya, where an average malaria episode of an employee resulted in 2.4 man-days lost 
(Some 1992). Yadav et al. (1991) reported a much higher number of man-days lost per 
episode, ranging from 3.9 days up to 7.6 days. However, this study was conducted in a 
mining company and malaria was mostly affecting labourers of a low socio-economic group, 
which were suspected to have a lower health status and not taking treatment in a timely 
manner (Yadav et al. 1991). In a low transmission setting the lack of immunity is also likely to 
lead to a more severe disease. These factors might have prolonged the duration of the 
malaria episodes. Besides lost working days, P. falciparum infections were associated with 
anaemia, as found in the Wosera area by Genton et al. (1995b). Anaemia is known to reduce 
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physical strength and this is clearly reducing the HOP business effectiveness, since over two 
- thirds of the employees are harvesting fruits, which is a physically strenuous work. 
Treatment costs are also directly reducing the company’s turn-over. More data on the impact 
of malaria on the company would have been highly interesting. However, shortly after the 
start of the project, the company was sold and the new owners reoriented their priorities, 
leading to a termination of the project.    
 
Generalizing the results of this work to the rest of the PNG population is difficult, since an oil 
palm plantation presents a special setting. Only employees and their dependants are allowed 
to live within the plantation, which resulted in 40% of the participants being aged between 20 
and 39, which is clearly not representative for the general population. In comparison, 40% of 
the population in PNG is under the age of 15 years (Hanson et al. 2001). The study 
participants also live in better houses than traditionally built houses in PNG, which reduces 
their risk of getting a malaria infection (Lindsay et al. 2002; Ye et al. 2006). In addition, all of 
the study participants have easy and free access to health care. Furthermore, an oil palm 
plantation represents an artificial environment with its own ecosystem, which is likely to have 
a different transmission rate than a natural habitat. Anopheles punctulatus - a major vector in 
PNG (Benet et al. 2004) - was found to be the main vector in the area (RD Cooper et al., in 
press).  
 
Malaria epidemiology is complex and it is influenced by many factors, such as malaria 
seasonality and transmission intensity, vector behaviour, resistance to drugs or insecticides, 
and the behaviour of the people. Depending on the availability of resources and feasibility, 
different control measures need to be applied. This highlights the importance of good 
knowledge of the local epidemiology in order to be able to apply the most feasible and 
effective malaria control measures.  
 
Businesses have good prerequisites for a successful malaria control. They have a broad 
knowledge in managing people as well as devising operations and they have the resources 
for financing programmes (Global Health Initiative 2006). As a company is a rather small 
setting, they have the further advantage of operational feasibility and better access to the 
people.  
 
6.1.2 Cochrane review on indoor residual spraying for preventing malaria 
 
In 2006, the Director of the WHO’s Global Malaria Programme declared his support for 
indoor residual spraying and especially the use of DDT for vector control in regions where 
malaria is a major health problem (Kochi 2006; World Health Organization 2006b). This 
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brought IRS back on the scene for malaria control and renewed interest has risen in 
evaluating IRS and to compare it to ITNs. While there is no doubt that IRS is effective in 
reducing malaria, this effect has never been quantified. In order to synthesize all information 
on IRS in an optimal way we produced a Cochrane systematic review. Cochrane reviews use 
a most rigorous methodological approach in order to minimise flaws and maintain a high 
standard of evidence (Olsen et al. 2001; Delaney et al. 2007; Moher et al. 2007). Though we 
included also a well designed controlled before-and-after study and one interrupted time 
series, we emphasised data from RCTs.  
 
Cluster-randomised controlled trials are commonly used for measuring the effects of 
intervention that require application at a high coverage level to be effective – which is the 
case with IRS (Hayes et al. 2000;  Donner & Klar 2002). Therefore, it was not surprising to 
find that all the included RCTs were cluster-randomised. Members within the same group 
tend to be more similar than individuals across different groups and this has to be accounted 
for in the analysis (Hayes et al. 2000; Donner & Klar 2002; Kim et al. 2006). Since the first 
comprehensive text on the design and analysis of clustered RCTs appeared in 1998 only 
(Murray et al. 2004) and since many of our included RCTs were published between 1998 and 
2001, only one study (Misra et al. 1999) took the ICC into account when analysing the data. 
For few outcomes we were able to adjust the data for clustering retrospectively, but this was 
not always possible.  
 
Cochrane reviews of interventions are considered to be the gold standard for determining the 
effectiveness of interventions (www.cochrane.org). However, due to the strict requirements 
of the Cochrane collaboration, we had to exclude 126 out of 132 studies in our review and 
remained with only six studies. In this case, a Cochrane review was not the right tool to 
assess whether IRS works. When assessing interventions with trials done in a time where 
the methodological and statistical methods were not as advanced as today, the risk of 
loosing a lot of studies and hence information is high. If in addition heterogeneity between 
the trials is high, a meta-analysis is not possible. However, our review also made clearly the 
point that a quantification of the effect of IRS is not possible at present, and this provides a 
strong rationale for further high-quality RCTs. 
 
The external validity of the results is limited. The effectiveness of IRS is dependent on 
several factors including for example the class of insecticide used, the vectors present, the 
types of walls which were sprayed, malaria endemicity etc. The combination of firstly having 
only few trials on IRS and secondly of not being able to account for the many factors 
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influencing the effectiveness of IRS makes it impossible to generalize the findings of the 
Cochrane review.  
 
6.2 Contribution to the knowledge on malaria control  
 
With the development of DDT in 1939 it was thought that malaria could be eradicated, and in 
the 1950s, the World Health Organisation lunched the global malaria eradication campaign. 
The campaign was initially very successful in countries such as Italy, Cyprus and Greece or 
the Soviet Union (Najera 2001). These first results of IRS were so convincing that no need 
was seen to conduct proper controlled trials, which is aptly stated by Professor A.E. Beljaev 
of the Martinowsky Institute in Moscow: “When I started my postgraduate studies in tropical 
medicine in 1963, the heroic era of malaria eradication in USSR was more or less over. We 
were taught that IRS was instrumental in interrupting the malaria transmission. This seemed 
so crystal clear to us youngsters that nobody sought of challenging this truth and verifying old 
reports (that were not so old in that time). One may compare DDT to Penicillin that became 
available roughly at the same time. Its effect in saving lives was so evident that nobody 
insisted on controlled clinical trial with placebo etc.”.  
 
Malaria eradication was unfortunately never achieved and in 1969 the malaria eradication 
strategy using IRS and chemoprophylaxis was officially stopped (Najera 2001). This timing is 
also reflected within our Cochrane review: about a third (28%, n= 32) of the studies were 
carried out between 1950 and 70s. All of the old trials had to be excluded due to their 
inadequate quality. With the exception of the Garki project (Molineaux 1980), all the included 
trials were done between 1998 and 2007.  
 
This situation contrasts with the high-quality effort to generate evidence on ITNs (Lengeler 
2004). Overall, 22 randomised controlled trials met the inclusion criteria for the Cochrane 
review on ITNs (compared to four within the Cochrane review on IRS). With the exception of 
three studies, the ITN trials were all conducted between 1992 and 2005 (Lengeler 2004). A 
new quality leap in the generation of public health evidence was taken in recent years with 
the foundation of the intermittent preventive treatment in infants (IPTi) consortium in 2003 
(Schellenberg et al. 2006).  In total 15 institutions around the world, including WHO and 
UNICEF, collaborated and coordinated approaches ranging from drug safety, to evaluating 
statistics, to generate evidence for policy recommendations in a timely and coordinated 
manner (Schellenberg et al. 2006).  
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The paradox of our review is that while there is not the least doubt that IRS works well in 
most settings (in the presence of susceptible mosquitoes), we have so far failed to quantify 
that effect in a way similar to ITNs. This, unfortunately, impedes rational decision making for 
policy makers and makes it impossible to make an informed choice between IRS and ITNs. 
Furthermore without knowing the effectiveness of IRS, evaluating its cost-effectiveness is 
hampered and often has either to rely on modelling-derived effectiveness data, or on 
assuming an effect similar to ITNs (Yukich et al 2008).  
 
Within our Cochrane review, only one RCT was conducted in a stable endemicity area, while 
three were done unstable malaria settings. Geographically, the RCTs were distributed in Asia 
(Pakistan and India) and in Africa (Tanzania and South Africa). No trials were available from 
South America. The few high-quality trials furthermore included different participants within 
the studies. While two RCTs included all age groups, two RCTs only included specific groups 
aged 1 to 15 years. A further problem was the previous history of malaria control within three 
trials, which obviously changed the entomological baseline situation and certainly the likely 
impact of vector control interventions. In addition, different outcomes were measured, but no 
sound data on the impact of mortality was available. As a result of this we clearly failed to 
achieve the stated goal of the review, to provide a clear quantification of the health effects of 
IRS and to compare it to ITNs.  
 
Interestingly, WHO suddenly changed its recommendation for IRS in 2006. With no 
additional evidence, it now recommends IRS for all types of malaria transmission settings, 
from unstable to stable-endemic transmission (World Health Organization 2006b). Also, the 
recent Global Malaria Action Plan (GMAP) recommends the application of either IRS or 
LLINs in high transmission settings (Roll Back Malaria 2008). Finally, the World Malaria 
Report 2008 also mentions that IRS and ITNs can be deployed together to further enhance 
their impact (WHO & UNICEF 2008). All these new recommendations are based on little 
evidence.  
 
In addition to the one RCT from Tanzania (Curtis et al. 1998) which is included in our review,  
one study in Kisumu, Kenya was conducted but with only one unit per arm (Payne et al. 
1976). They evaluated IRS using fenitrothion and found an impressive impact on the crude 
mortality as well as the malaria transmission rate with a reduction of 43% and 96%, 
respectively (Payne et al. 1976). The trial in Pare-Taveta, Tanzania on the other hand was 
using Dieldrin as insecticide – an insecticide no longer recommended by WHO due to its 
toxicity (Najera & Zaim 2003). Nevertheless comparing the mortality rate before the 
intervention and in the third year after the intervention, a dramatic fall in the infant mortality 
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rate was seen, from 165 per 1000 to 132 per 1000, as well as in the crude mortality rate from 
24 per 1000 to 16 per 1000. Infant parasite rates fell from 80% to 90% in 1955 to 
approximately 7% to 10% in 1959 (Bradley 1991).  
 
Recently, nationwide programme evaluations from Bioko Island, Mozambique (under the 
Lubombo Spatial Development Initiative (LSDI)) and the Democratic Republic of São Tomé 
and Príncipe (DRSTP) have been reported. On Bioko Island, the prevalence rate was 
reduced by 15% within one year with IRS using Deltamethrin and case management. A 
protective efficacy of 47% was reported and children less than 15 years have benefited from 
the intervention. However, prevalence was only reduced to a level of 31% (Kleinschmidt et 
al. 2006). A better result was found in Mozambique by Sharp et al. (2007) with a reduction in 
prevalence of 43% within one year of IRS using bendiocarb. However, after interruption of 
IRS, the prevalence immediately rebounded to 59% and then steadily decreased to 23% 
after resumption of IRS (Sharp et al. 2007). In DRSTP, IRS with alphacypermethrin was 
initiated in 2004. Within two years, malaria prevalence was nearly reduced to zero (0.7%), 
lowering the prevalence by 19.4% (Tseng et al. 2008). The deaths attributed to malaria were 
reduced from about 65% to 37% (Teklehaimanot et al. 2009). In 2005, in addition to IRS, free 
LLINs were distributed all over the island and ACTs were introduced. As a result of the 
combined interventions, mortality was reduced to 3 malaria-related deaths in 2007 compared 
to 400 malaria-related deaths before 2005 (Teklehaimanot et al. 2009). In Zanzibar in 2007, 
with the combination of LLINs and IRS using pyrethroids, incidence cases at health facilities 
for children less than two years of age were reduced from about 22% to approximately 0.5% 
(PMI 2009).   
 
The results of DRSTP and Mozambique were undoubtedly impressive. However, DRSTP is 
relatively small with only 150,000 inhabitants. This clearly simplifies malaria control 
compared to other countries on the African mainland such as e.g. Kenya with more than 22 
million people at risk of malaria (World Health Organization for Africa 2007). Furthermore, the 
risk of vector immigration will be very limited on the islands. Only one species of vector is 
present on DRSTP (Teklehaimanot et al. 2009), which is also simplifying vector control. 
Mozambique is an area with low transmission intensity (Thompson et al. 1997) and has a 
rather good infrastructure. Therefore, these findings are clearly not representative for other 
endemic settings. The results of Bioko Island, with a high transmission intensity 
(Kleinschmidt et al. 2006) on the other hand were not so impressive, as they were only able 
to reduce the prevalence to 31%, despite the advantage of being an island.  
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However, the effectiveness of IRS alone should not be the only deciding factor. The public 
health usefulness of IRS is influenced by many other factors as well, such as the operational 
demands of IRS (which require a well structured system in place (Lengeler & Sharp 2003)), 
vector behaviour and resistance status, acceptance by the population, the type of housing 
and the nature of the walls to be sprayed, Finally, there is also an element of cost which 
needs to be taken into consideration (Yukich et al. 2008). Both interventions were found to 
be highly cost-effective but long-lasting insecticidal nets were still 2 to 3 times cheaper per 
person protected than IRS, especially if ITN coverage can be achieved with demographic 
targeting (Yukich et al. 2008).  
  
There is nowadays broad consensus, that there is no global solution for malaria control as it 
should always be adapted to the local circumstances: “The first axiom of malariology, that 
lessons learnt in one part of the world may not be applied to other parts of the world, without 
local verification, is as true as ever; it is unfortunately as often neglected as ever” (D. 
Bagster) (Cambridge University Press 2009). This recommendation is particularly true for a 
country such as PNG, with several important vectors and malaria levels ranging from no 
malaria at all to high endemicity levels. In an oil palm plantation such as HOP, different 
control approaches are feasible and required compared to other parts of PNG.  
 
6.3 Prospects for future research 
More RCTs assessing the impact of IRS are urgently required. From a methodological point 
of view, the RCTs would ideally have three arms: one with IRS only, a second arm with ITNs, 
and a third arm in which IRS as well as ITN are implemented. In all arms, ITNs and IRS 
should be implemented at high coverage. Clearly, a control group not receiving any 
intervention would not be ethical since vector control was evidently shown to prevent malaria 
mortality and morbidity.  An arm combining both interventions would be highly desirable 
because the recent goal of malaria elimination and ultimately eradication calls for a much 
higher level of transmission control (Roll Back Malaria 2008). This should be seen as a great 
priority at present. The trials should be conducted in a range of settings ranging from low 
levels of transmission to holoendemic levels. In countries with a national policy of using ITNs 
for malaria control, it will be difficult to find an area in which IRS alone can be implemented. 
In such settings the trials are likely to have only two arms (ITNs and the combination ITNs 
plus IRS). Hence these trials should ideally be carried out in countries in which malaria 
control policy entails IRS only. The trials should aim to measure different outcomes, ranging 
from malaria morbidity including anaemia to all-cause mortality.  
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Besides quantifying the effectiveness of existing insecticides, there is also an urgent need for 
new insecticides for vector control. Insecticide resistance is emerging, reducing the 
effectiveness of vector control (N'Guessan et al. 2007). The most recent insecticide made 
available for vector use is etofenprox, which was commercialized more than 20 years ago (in 
1986). Up to now, no insecticides have been specifically produced for public health 
purposes. All were produced by large agro-chemical companies for an agricultural purpose 
(Tren et al. 2008). However, insecticides for public health use have different demands in 
comparison to the agricultural requirements: whereas public health insecticides should have 
a residual action and a broad spectrum of chemical activity, agricultural insecticides should 
be short acting and encompass a narrow activity spectrum (Tren et al. 2008). Unfortunately, 
the public health market for insecticides comprises only about 1.3% of the total pesticide 
market (Tren et al. 2008), and hence does not represent a big attraction for profit-making 
companies. The situation seems to be similar to the one for malaria drugs ten years ago. 
This could be impressively changed with the foundation of Medicine for Malaria Venture 
(MMV) (Medicine for Malaria Venture 2009), a not-for-profit public-private partnership (PPP) 
and such a collaboration of the public and private sectors should clearly also be considered 
for the research and development of new insecticides.  
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Conclusions 
•  Malaria poses a serious health problem for the Higaturu Oil Palms Company, but good 
conditions for control exist, provided the company management decides to act. 
•  Good quality evidence on the impact of IRS is scarce and the current evidence is 
insufficient to quantify properly the health effects of IRS even in the most general manner;   
specific recommendations for particular epidemiological situation are even more difficult to 
make. However, this should not imply that IRS lacks impact since the latter is amply 
demonstrated by historical evaluations. 
•  Available good quality evidence confirms that IRS with pyrethroids works in reducing 
malaria in unstable malaria settings but there is only very limited quality evidence on the 
effectiveness of IRS to reduce ill-health in stable malaria settings. 
•  There is no evidence of the effectiveness of IRS in reducing mortality, neither in stable nor 
unstable malaria settings. 
•  In absence of a robust quantification of the health effects of IRS, a meaningful comparison 
between IRS and ITNs is not possible. 
•  There is only very limited evidence to assess the effect of other determinants of impact, 
such as the insecticide class used for IRS, the type of transmission, the dominant vector 
species, and socio-cultural determinants. 
•  There is an urgent need for more RCTs comparing IRS and ITNs in a number of settings 
with different epidemiological and socio-cultural characteristics; if possible, child mortality 
should be measured as primary outcome. Ideally, such RCTs should have a third arm in 
which a combination of high coverage IRS with high coverage ITNs is implemented.
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